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Summary
The present study was concerned w ith the characterisation of the herpes 
simplex virus type 1 (HSV-1) UL25 gene product and analysis of the phenotype of 
the HSV-1 mutant ts l204 which has a temperature sensitive (ts) mutation in the 
UL25 gene. Previous work by Addison et al. (1984) suggested that rs l204 was 
unable to penetrate the cell membrane at the non-permissive temperature (NPT). 
This early defect could be overcome by brie f incubation of mutant infected cells 
at the permissive temperature (PT). Upon further incubation of mutant-infected 
cells at the NPT, low numbers of intermediate capsids lacking DNA assembled in 
the nucleus. No fu ll capsids were observed, indicating that tsl204 also had a defect 
in the production of virus particles. Although the work presented here confirmed 
that ts l204 has a defect in a step prior to the onset of viral protein synthesis, the 
data indicated that tsl204 had an uncoating defect at the NPT.
A rabbit polyclonal antiserum raised against an oligopeptide representing an 
amino acid sequence present in the UL25 polypeptide was used to study the 
synthesis, processing and location of the UL25 gene product. The antiserum 
recognized a 67,000MW protein in virus-infected cell extracts and in purified  
virions, suggesting that the UL25 protein was a structural component of the 
v irion. Using immunoprecipitation assays the UL25 gene product was detected at 
lh r  post-infection in virus-infected cells at 37° and reached a peak of synthesis at 
4-5 h r post-infection. Analysis of the synthesis of the UL25 protein in the 
presence of inh ib itors of v ira l DNA replication suggested that the UL25 protein 
was regulated as a leaky late viral gene product. Pulse chase analysis of infected 
cell extracts showed that the UL25 protein did not undergo any processing during 
synthesis. The location of the UL25 protein w ithin the v irion was determined by 
detergent extraction o f pu rified  radiolabelled virions. Although treatment of 
p u rifie d  v irions w ith  1% NP-40 was sufficient in removing a s ign ifican t 
p ro p o rtio n  o f the envelope and Vmw65, the UL25 p ro te in  rem ained 
predom inantly associated w ith the capsid. This finding suggests that the UL25 
protein forms a tight association with the capsid structure as might be expected if  
it were to function in capsid stability. Suprisingly, the UL25 protein was detected 
in L-particles, which lack capsids.
In general, HSV infection leads to a decrease in host cell protein synthesis 
(Fenwick and Walker, 1978). However, the converse is true fo r a m ino rity  of 
cellular proteins, whose expression is upregulated in HSV-infected cells (Kemp et 
al., 1986; Lathangue et al., 1988). Although the expression of many HSV-induced 
cellular genes is dependent on viral protein synthesis, a m inority of cell proteins 
appear to accumulate under conditions which restrict the induction o f HSV 
polypeptides. Thus, it is assumed that these cellular proteins are induced by events 
occuring p rio r to the onset of vira l protein synthesis, such as attachment of the 
virion to the cell membrane or entry of the nucleocapsid into the cytoplasm.
The abundant HSV-induced host cell protein p56 is an example of a cellular 
protein that is induced by events occuring p rio r to the onset of v ira l protein 
synthesis (Addison et al., 1984; Preston , 1990). The p56 polypeptide accumulates in 
human foetal lung (HFL) cells infected with the HSV-1 mutant ts l204 at the NPT. 
Further evidence indicated that the accumulation of p56 in infected cells occurs 
by the transcrip tiona l activation of the p56 gene. The significance o f p56 
induction in HFL cells during HSV-infection is unclear. Accumulation of p56 may 
assist in the establishment of the cellular antiviral state, or alternatively, p56 may 
facilitate viral infection in HFL cells.
The aim of the present study was to isolate cDNAs representing polyA4- RNAs 
that accumulate in ts l 204-inf ected HFL cells at the NPT.
In order to isolate cDNA clones derived from cellular genes that were induced 
in tsl204-infected HFL cells at the NPT, a cDNA library was prepared from polyA+ 
RNA prepared from tsl204-infected cells.
The d iffe ren tia l screening technique was used to identify  cDNA clones of 
genes encoding cellular proteins induced in tsl204-infected cells at the NPT. Some 
3000 bacterial clones were screened in this manner, of which 23 clones appeared 
to hybrid ize preferentia lly  to the probe synthesized from ts l204-in fected  cell 
p o ly A + RNA. These selected clones represented approximately 0.8% o f the 
members o f the lib ra ry  that were in itia lly  screened. Confirmation that these 
clones represented polyA+ RNAs that are induced during ts l 204-infection at the 
NPT was obtained by RNA slot blot analysis of each cDNA clone.
Two groups of clones were identified on the basis of DNA-cross hybridization 
analysis. The firs t group designated C6, comprised six members, each containing a 
cDNA insert o f approximately 1.5kbp. The relatedness o f these clones was
confirmed by sequence analysis and restriction enzyme mapping of each clone. 
Since all of the clones identified w ith in this group were 1.5kbp in size, it was 
assumed that the cDNA inserts represented fu ll length polyA+ RNA molecules. 
Transcription and translation of these clones in vitro revealed a protein of 
approximately 40,000 MW (p40). Southern blot analysis and immunoprecipitation 
studies suggest that p40 was distinct from the 42,000MW mitochondrial aspartate 
aminotransferase found to be increasedJn HSV-2 infected cells (Lucasson, 1992).
followed by
Partial sequence analysis of the C6 cDNAj^subsequent data base searching, failed to 
identify the protein product encoded by the C6 cDNA insert.
Four cDNA clones appeared to share similar DNA sequences on the basis of DNA 
cross-hybridization studies. This second group of clones termed C4 contained 
variable sized inserts, of which the largest was approximately 2kbp. An alu rich 
repetitive sequence was identified by sequence analysis of the 5' terminus of one 
member of C4. Further studies revealed that the members of C4 shared DNA
r
sequences distinct from  the alu repetitive sequence. The identification of the 
protein product encoded by this group of cDNA clones remains unknown.
The remaining 13 clones have yet to be analyzed.
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1 Chapter 1: Introduction
1. Introduction
S e c t i o n  1 . A  T h e
1. Description and Classification
Herpesviruses are found in a wide range o f animal species (reviewed by 
Roizman, 1990). Members of the Herpesviridae fam ily share a similar morphology. 
A typical herpesvirus particle (120-200nm in diameter) has a double stranded DNA 
genome enclosed w ith in an icosadeltahedral capsid (approximately 100-1 lOnm in 
diameter). The capsid is surrounded by the tegument, a proteinaceous layer 
comprising 65% of the total v irion  volume, which is enveloped in a trilam inar 
membrane containing the viral glycoprotein spikes.
An interesting property of many herpesviruses is the ab ility  to exist in a 
latent state w ith in the infected host. Following a prim ary infection, the viral DNA 
remains in an inactive form  in certain host cells, from  which it can be 
reactivated to produce a secondary lytic infection. In addition to the ab ility  of 
herpesviruses to form  latent infections, they share three other significant 
biological properties. All of the herpesviruses encode virus-specific enzymes, 
many of which are involved in the synthesis of v ira l DNA. Furthermore, v ira l 
DNA synthesis and capsid assembly occur w ith in  the infected-cell nucleus. 
Finally, the production of infectious progeny virus is accompanied by the death 
o f the host cell. Despite these similarities, the herpesviruses vary greatly in the ir 
biological properties, and on this basis have been divided into 3 sub-families 
(Alpha-, Beta- and Gamma-herpesvirinae)
Alphaherpesvirinae  have a variable host range in tissue culture, and exhibit 
a short reproductive cycle followed by destruction of infected cells and rapid 
spread of the virus in tissue culture. Latent infections are frequently but not 
exclusively established in sensory and autonomic ganglia. Members of this group
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include herpes simplex virus types 1 and 2 (HSV-1, HSV-2), Equine herpes virus 
type 1 (EHV-1), Pseudorabies virus (PRV) and varicella zoster virus (VZV). 
Betaherpesvirinae have a narrow host range both in vivo and in vitro and a 
slow ly spreading growth in tissue culture. Enlargement o f infected cells 
(cytomegalia ) occurs both in vitro and in vivo. Latent infections are generally 
established in secretory glands, lymphoreticular cells and the kidneys. Members 
o f th is sub-fam ily  include human cytom egalovirus (HCMV) and murine 
cytomegalovirus (MCMV).
Gammaherpesvirinae infect and establish latency in B or T lymphocytes. The 
experimental host range is very narrow. Members of this sub-fam ily include 
Epstein Barr virus (EBV) and herpesvirus samiri (HVS).
Hum an he rpesv irus  6 (HHV-6) was o r ig in a lly  assigned to the
Gammaherpesvirinae on the basis of its tropism for lymphocytes. However, on the 
basis of sequence homology and gene organisation, HHV-6 was later shown to be 
related to HCMV and was subsequently placed w ithin the Betaherpesvirinae.
2. Pathogenicity and Epidemiology
Seven different human herpesviruses have been identified: HSV-1, HSV-2, 
VZV, HCMV, EBV, HHV-6 and human herpes virus 7 (HHV7).
HSV-1 and 2 normally cause cold sores and genital sores respectively. The virus 
can establish a latent infection reactivating spontaneously. Reactivation of latent 
HSV can be triggered by nerve damage, UV-light exposure, fever or immune 
suppression. Occasionally, infection w ith HSV can result in  herpes simplex 
encephalitis. Although HSV-2 is the prim ary cause of genital herpetic lesions, 
changing patterns of sexual behaviour have resulted in an increase o f genital 
herpes associated w ith HSV-1 infection. HSV-2 infection has long been implicated 
in  the development of cervical carcinoma, but its role in  transform ation is 
unclear.
VZV causes two clin ically distinct diseases (reviewed by Gelb, 1990). Varicella or 
chicken-pox, as it is more commonly called, is the prim ary infection. Following 
the in itia l infection, VZV normally establishes latency in the dorsal root ganglia
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and remains so until an appropriate stimulus leads to its reactivation. Reactivation 
of the virus from sensory ganglia, leads to the eruption of painful vesicles and 
this clinical manifestation has been designated herpes zoster or shingles.
EBV infects B-lymphocytes in the peripheral blood and is the causative agent of 
infectious mononucleosis (reviewed by M iller, 1990). EBV is also strongly 
associated w ith Burkitt's lymphoma and nasopharyngeal carcinoma.
H C M V  in fections are norm ally asymptomatic. However, HCMV can cause 
opportun is tic  infections in patients w ith lower than normal resistance to 
infection, fo r example, AIDS sufferers, neonates and organ transplant patients. In 
addition, in utero infection can lead to a severe generalized infection, called 
cytomegalia inclusion disease, which can result in b irth  defects.
H H V -6  (reviewed by Lopez and Honess, 1990), previously called human B 
lym photrop ic virus, was discovered in 1986 during the search for a causative 
agent of lymphomas associated with AIDS. The virus can infect T cells in vitro and 
is the prim ary aetiological agent of exanthum subitium, characterized by high 
fever and the appearance of a rash.
HHV-7 was recently isolated from CD4+ T cells (Frenkel et al., 1990). The virus has 
yet to be connected with any specific disease in humans.
3. Structure And Genetic Content Of The HSV-1 Genome
The HSV genome is a linear, double stranded DNA molecule approximately 
152kbp in length and comprises a long (L) and a short (S) component which are 
covalently linked. A schematic representation of the arrangement of the HSV-1 
genome is represented in Figure 1 . The L component consists of the long
unique region, Ul flanked by a terminal repeat (TRL) and an in terna l repeat 
(IRl ) (Sheldrick and Berthelot, 1974). Likewise, the S component consists o f a 
short unique region (Us) flanked by inverted repeats, designated TRS and IRS. 
The L and S repeat elements are unrelated apart from a 400bp region termed the 
a sequence (Roizman, 1979). A single copy of the a sequence is norm ally found 
at the S terminus whilst multiple copies are detected at the L terminus and a 
variable number in inverted orientation at the L-S junction. During v ira l DNA
Figure 1. Structure Of The HSV-1 Genome
A representation of the HSV-1 genome as two covalently joined components, 
L and S. The unique sequences, UL and Us, are shown as solid lines. The major 
repeat elements, TRL, IRL, TRS and IRS, are shown as open boxes. The terminal 
a sequences and the internal inverted a sequence (a') are indicated. The 
re lative orientations of the L and S components in the fou r isomers, 
designated P, IL, Is and 1^ are indicated by the four arrowed lines
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replication, the L and S components can invert relative to each other, such that 
a wt virus DNA preparation usually contains 4 isomers in equimolar amounts 
d iffe ring  in the orientation of the L and S components (Hayward et al., 1975; 
Delius and Clements, 1976; Roizman, 1979).
The base composition of HSV-1 DNA is 68.3% G+C, although this figure is 
not constant throughout the genome. From sequence analysis of the HSV 
genome it was predicted that the HSV genome possessed 75 genes encoding 72 
proteins (McGeoch et al., 1985; 1986; 1988b; Figure 2). However, since these 
in it ia l observations fu rthe r open reading frames (ORFs), UL26.5 (Liu and 
Roizman, 1991a, b), UL49.5 (Barker and Roizman, 1992), UL49A (Barnett et al., 
1992), and y134.5/RLl (Chou and Roizman, 1990; Chou et al., 1990; McGeoch and 
Barnett, 1991; Dolan et al., 1992) have been identified. In addition, the latency- 
associated transcripts (LATs) which are derived from a region in the long 
repeat, and are the only v ira l transcripts to accumulate in la tently infected 
tissues, have been characterized (Rock et al., 1987; Stevens et al., 1987; Fraser et 
al., 1992). However, there is little  evidence to suggest that the LATs encode viral 
proteins. Table 1 indicates the HSV-1 genes, whether the gene is essential for 
growth of the virus in tissue culture, and what is known of the encoded protein 
and its function.
4 . H S V  L a te n c y
An interesting feature of HSV is the ability to establish a latent infection 
in neuronal ganglia. The v ira l genome exists as a circularised molecule in 
latently infected cells (Mellerick and Fraser, 1987; Rock and Fraser, 1983; 1985). 
Although the majority of viral genes remain dormant during latency, a few are 
expressed. The latency associated transcripts (LATs) were shown to accumulate 
in the nuclei of neurons of latently infected cells (Stevens et al., 1987). The 
LATs are transcribed in the opposite direction to the IE-1 mRNA, and are in part 
complementary to the 3’ terminus of the IE-1 mRNA. On this basis, it was 
postulated that the function of the LATs is to preclude the expression of Vm w llO  
(Stevens et al., 1987). Deletion mutants, lacking the LATs gene of HSV-1, were 
shown to be fu lly  capable of establishing a latent infection (Javier et al., 1988), 
although reactivation of latent virus in vitro and in experimental animals was
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Figure 2. Layout o f the HSV-1 genes.
The genome in the P orientation is represented by fou r successive lines 
w ith unique regions shown as solid lines and major repeat elements as open 
boxes. The lower scale represents kilobases, numbered from  the left 
terminus, and the upper scale represents fractional map units. The size and 
orientation of the proposed functional open reading frames are shown by 
the arrowed lines, with splicing w ith in coding regions indicated. Overlaps of 
adjacent, s im ilarly  orientated ORFs are not shown explicitly. Location of 
proposed transcription polyadenylation sites are indicated as short vertical 
bars. The location of the origins of DNA replication are shown as X. Genes 
UL1-UL56 indicated on the top three lines. The genes US1-US12 are shown 
on the bottom line. The position of the genes encoding the IE polypeptides 
Vm wl75 and Vm w llO  are indicated. This figure is reproduced from McGeoch 
et al. (1988b), w ith  the addition of UL26.5 (Liu and Roizman, 1991a,b), 
UL49.5/49A (Barker and Roizman, 1992; Barnett et al., 1992), y134.5/RLl (Chou 
and Roizman, 1990; Chou era/., 1990: McGeoch and Barnett 1991: Dolan et al., 
1992), and the major stable LAT (Rock et al., 1987; Stevens et al., 1987; Fraser 
et al., 1992) and US8.5 (Georgopoulou et al., 1993).
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5 Chapter 1: Introduction
greatly reduced (Hill et al., 1990). Thus it is likely that the LATs are not required 
fo r the establishment of latency.
No gene products have been shown to be specifically required for the 
establishment and maintenance of latency. However, V m w llO  (Russell et al., 
1987; Clements and Stow, 1989), the HSV-encoded thymidine kinase (TK) (Coen et 
al., 1989; Efsthathiou et al., 1989) and the HSV ribonucleotide reductase (RR) 
(Jacobsen et al., 1989) appear to be important for the reactivation of latent virus 
in various assays.
Section LB The HSV-1 Lytic Cycle
1. A d s o rp tio n  A n d  P ene tra tion
The in itia l interaction between HSV and cells is the adsorption of the 
virus to the cell surface and the subsequent fusion of the v irion  envelope with 
the plasma membrane, either at the cell surface or in endocytic vesicles (Fan 
and Sefton, 1978; Marsh, 1984). Early electron microscopy (EM) studies have 
suggested that both mechanisms of virus entry occur (Morgan et al., 1968; Dales 
and Silverberg, 1969). However, recent work has shown that compounds known 
to inh ib it the endocytic process do not inh ib it entry of HSV (Wittels and Spear,
1990). Moreover, virus internalised in an endocytic vesicle does not establish a 
ly tic  infection of the host cell probably because it is degraded in the vesicle 
(Campadelli- Fiume et al., 1988a).
At present, the majority of opinion favours the idea of entry by direct 
fusion o f the v irion  envelope w ith the cell membrane, resulting in the release 
o f nucleocapsids into the cytoplasm (Morgan et al., 1968). Immunological data 
supporting  this theory showed that neutra lising m onoclonal antibodies 
inh ib ited virus entry but not attachment of virus to the cell surface (Fuller and 
Spear, 1987; Fuller et al., 1989). Virus in fec tiv ity  was restored when the 
neutralized virus bound to the cells was treated w ith polyethylene-glycol (PEG), 
a membrane fusing compound. Other evidence in support o f the fusion model 
has come from  the work of Para et al., (1980) who showed that the v irion
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glycoprotein gE was transferred from the virion envelope to the cell membrane 
in infected cells prior to DNA synthesis.
HSV-1 specifies at least 11 glycoproteins; gB, gC, gD, gE, gG, gH, gl, gj, gK, 
gL and gM (Spear, 1976; Marsden et al., 1978; 1984; Bauke and Spear, 1979; 
Buckmaster et al., 1984; Roizman et al., 1984; Spear, 1985; Frame et al., 1986; 
Gompels and Minson, 1986; Longnecker et al., 1987; Johnson and Feenstra, 1987; 
Hutchison et al., 1992a,b; Ramaswamy and Holland, 1992). Five of the envelope 
glycoproteins, gB gD, gH, gK and gL are required for virus entry into cultured 
cells (Cai et al., 1988; Forrester et al., 1992; Hutchison et al., 1992ab; Ligas and 
Johnson, 1988; Roop et al., 1993). It is likely that all of the HSV glycoproteins are 
present in the v irion  envelope, although direct evidence is lacking fo r gL, gK 
and gj. It is possible that the product of UL34, which is a membrane-associated 
phosphoprotein (Purves et al., 1991; 1992), and the UL20 and UL43 gene 
products, which have m ultip le hydrophobic domains (Baines et al., 1991; 
MacLean et al., 1991) , may also be envelope proteins.
Immune electron microscopic analysis o f negatively stained virus 
preparations revealed that gB, gC and gD each form  distinct morphological 
structures pro jecting from the v ir io n  envelope (Stannard et al., 1987). 
A lthough the organisation o f the envelope proteins is unknown, the ir 
structure and location suggest that they may play im portant roles in both 
adsorption and entry of HSV-1 into the host cell.
The in it ia l interaction between HSV and the cell is via cell surface 
heparan sulphate proteoglycans (HS) (WuDunn and Spear, 1989). However, 
binding of HSV-1 to HS is believed to be only the first in a series of interactions 
between HSV-1 and the cell surface, culminating in the fusion of the v irion  
envelope w ith  the cell membrane. Observations that virions bind to heparin, a 
related glycosaminoglycan, and that heparin blocks virus adsorption support 
this conclusion. Furthermore, virus binding to cells which lack HS is greatly 
impaired. Interestingly, virus adsorbed to cells at 4° can be removed by b rie f 
exposure to low pH or soluble heparin, suggesting that HSV-1 binds to HS with 
low a ffin ity  (Huang and Wagner, 1964). In addition, virus bound to the low 
a ffin ity  receptor can be neutralized by HSV-specific monoclonal antibodies 
(Highlander et al., 1987).
G lycoprotein gC, a non-essential protein fo r v ir io n  in fe c tiv ity , is 
p rin c ipa lly  responsible fo r the in itia l adsorption o f wt HSV virions to cell
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surface HS (Herold et al., 1991). The conclusion that gC binds to HS was based on 
the find ing that gC bound to heparin-sepharose under physiological conditions 
in a ff in ity  chromatography experiments. This idea was supported by the 
observation that mutant HSV virions devoid of gC bound less efficiently to cells 
compared to wt virus (Langeland et al., 1990; Herold et al., 1991). Glycoprotein 
III, the gC homologue of PRV is also important for the adsorption of virus to 
cells and, like HSV-1, is not absolutely essential for virus in fectiv ity (Robbins et 
al., 1986; Schreurs et al., 1988). The idea that gC makes the in itia l contact with 
the cell surface is supported by the work of Stannard et al. (1987) who showed 
that gC formed long slender structures (up to 24nm in length) projecting from 
the virion envelope.
Neomycin and polylysine aminoglycoside antibiotics have been shown to 
inh ib it HSV-1 to a much greater extent than HSV-2 binding to cells (Langeland 
et al., 1987; 1988). These polycationic drugs are thought to block the attachment 
o f virus to the cell surface by binding to HS. This idea is supported by the work 
o f Oyan et al., (1993) who showed that the region on the HSV genome 
responsible fo r the resistance to polycationic drugs maps to the amino-terminal 
o f gC. Since gC of both HSV-1 and HSV-2 bind to heparin, it  is possible that the 
two serotypes may interact d iffe ren tly  w ith cell surface HS, e ither having 
different affinities for, or binding to separate epitopes on the HS molecule. An 
alternative explanation is that, in the presence of drugs binding to HS, HSV-2 
can in te ract w ith  another ce llu la r component via gC or another v ira l 
glycoprotein. The idea that HSV-1 and HSV-2 interact d iffe ren tly  w ith  cell 
surface HS was also suggested by WuDunn and Spear (1989) who showed that 
HSV-1 bound to soluble heparin with a much higher affin ity than HSV-2.
Although gC greatly facilitates adsorption of virus to cells it is not the 
on ly glycoprotein which can mediate this process. Kuhn et al., (1990) showed 
that gB, gC and gD formed complexes w ith cell membrane components during 
the adsorption process, confirming the results obtained by earlier workers who 
suggested roles for these glycoproteins in vira l attachment (Fuller and Spear, 
1985; Johnson et al., 1984). HSV mutants that lack gC, gB or gD can still attach to 
cells, indicating that th ij function of a missing glycoprotein can be replaced by 
other g lycoproteins. Evidence has been obtained suggesting tha t the 
attachment o f gC negative virus to the cell surface HS is mediated by gB, and 
that this mechanism is resistant to neomycin and polylysine (Herold et al.,
1991). The contribution, however, made by gB to the adsorption process must be 
small, since gB minus virions adsorb to cells as efficiently as wt virus (Cai and
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Person, 1988; Herold et al., 1991). Whether the cell component described by 
Kuhn et al. (1990) that binds to gB is HS or another cellular component is 
unknown. It is likely, however, that gB interacts w ith  another ce llu lar 
component as well as HS, since cells which lack HS are susceptible to wt virus 
infection (Tufaro et al., 1993).
Following the low a ffin ity  attachment of HSV to cell surface HS, tighter 
binding, presumably via a high a ffin ity  receptor then occurs, after which 
bound virus is resistant to acid treatment and neutralisation by monoclonal 
antibodies. Fuller and Lee (1992) speculated that the stable attachment of virus 
to the cell surface was necessary for the fusion of the v irion envelope w ith the 
cell membrane. Kohn (1979) proposed that high a ffin ity  binding involved 
interactions between a number of v ira l and cellu lar components. Evidence 
supporting m ultivalent attachment of virus to cells comes from Rosenthal 
(1984) who demonstrated that HSV-1 binding to cells rapid ly reduced cell 
surface protein mobility, sim ilar to that caused by the multivalent attachment 
of other ligands such as antibodies or other cells. The hypothesis that more 
than one type of HSV attachment can occur is consistent w ith the ab ility  of 
herpesviruses to bind to a wide range of cell types from diverse species.
In a recent report, Kaner et al. (1990) claimed that the basic fibroblastic 
growth factor (bFGF) receptor was a "porta l o f ce llu lar entry" fo r HSV-1. 
Evidence supporting this idea came from  two observations. Firstly, the 
attachment and in fectiv ity  of HSV-1 was reduced when cells were incubated 
w ith  bFGF p rio r to the addition of virus. Secondly, the uptake of HSV-1 in 
Chinese hamster ovary (CHO) cells, which have very few bFGF receptors, was 
increased after transfection of the bFGF receptor cDNA. Moreover, the uptake of 
virus in CHO cells which express the bFGF receptor was blocked by polyclonal 
antibodies specific for bFGF (Baird et al., 1990). From these results it was 
concluded that the interaction between HSV and the bFGF receptor is mediated 
by the association of bFGF w ith the v irion , rather than a direct interaction 
between a HSV glycoprotein w ith the receptor itself. The proposal that HSV-1 
entry occurs through the bFGF receptor was attractive because bFGF binds to 
cell surface HS prio r to binding to the bFGF receptor (Vlodavsky et al., 1987). 
However, subsequent studies have since disproved that the basic FGF receptor is 
involved in HSV-1 entry (Shieh and Spear, 1991; Mirda et al., 1992; Muggeridge 
et al., 1992). The observed effects were probably a result o f the interaction of 
basic FGF with cell surface HS (Shieh and Spear, 1991; Muggeridge et al., 1992).
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HSV-1 gD is a major component of both the virion envelope and infected 
cell membranes. The idea that a high a ffin ity  attachment occurs between gD 
and a cell surface receptor came from the work of Ligas and Johnson, (1988) 
who showed that virus which lacked gD adsorbed to cells as effic iently as wt 
virus, but the bound virus could not block infection by superinfecting wt virus. 
This defect could be overcome by treating the virus infected cells w ith PEG, a 
compound which promotes membrane fusion. Similarly, cell lines expressing 
gD were shown to be resistant to infection by both HSV serotypes (Campadelli- 
Fiume et al., 1988ab; Johnson and Spear, 1989), which suggests that gD present 
in the plasma membrane of transfected cells binds to and sequesters a cell 
surface receptor and thereby blocks the entry of HSV. Finally, fu rther studies 
demonstrated that the target of the gD mediated restriction to superinfection, 
was the gD present in the superinfecting virion (Campadelli-Fiume et al., 1990). 
Ligas and Johnson (1988) recently obtained evidence for a cell surface receptor 
required fo r the entry of HSV-1 and 2 into cells. The receptor sites are more 
lim ited  in number than HS and appear to bind to gD in the v irion  envelope 
(Johnson et al., 1990). The identity of this cellular receptor is presently being 
investigated (D. Johnson, personal comunication).
Cell lines expressing gB or gC are not resistant to HSV infection and there 
is no evidence to date for saturatable cell surface receptors fo r these vira l 
proteins.
Cell fusion is the next stage in virus en try  and follows the stable 
attachment of virus to the cell surface. Studies w ith ts mutants, monoclonal 
antibody resistant mutants, syncytial mutants and nu ll mutants have suggested 
tha t gB functions d irectly  in virus entry and virus induced cell fusion 
(Sarmiento et al., 1979; Bzik et al., 1984b; Cai et al., 1988; Highlander et al., 1988).
To date, four viral genes UL53 (gK) (Debroy et al., 1985; Pogue-Geile and 
Spear, 1987), UL27 (gB) (Kousoulas et al., 1984; Bzik et al., 1984a), UL24 (Sanders 
et al., 1982; Jacobsen et al., 1989), and UL20 (Baines et al., 1991) have been 
associated w ith  the syncytial phenotype. A f ifth  syncytia l locus has been 
suggested to map w ith in  the inverted repeats flanking UL although the gene 
product involved has not yet been identified (Romanelli et al., 1991).
While both gD and gB have been implicated in v irion  cell induced fusion, 
it  remains to be seen whether the attachment o f these proteins to cellular 
membrane components is a prerequisite to the ir role in v ira l penetration.
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Suggestions that gD and gB form a complex inducing membrane fusion are 
unfounded, since gB and gD are spatially separated in the v irion  envelope 
(Stannard et al., 1987). Furthermore, gB forms homodimers which are not found 
to be associated with any other glycoproteins (Claesson-Welsh and Spear, 1986). 
Nonetheless, it is possible that gB and gD may interact w ith  other v ira l 
components prio r to the initiation of cell fusion.
Using biochem ical and elecron microscopy approaches, the entry 
process of HSV-1 was examined in detail by Fuller and Lee (1992) who observed 
discernible changes of the v irion  envelope and tegument after contact of 
infectious v irus w ith  the cell plasma membrane. V irions rendered non- 
infectious by anti-gD or anti-gH neutralising antibodies bound to cells but 
failed to form  a visible fusion bridge. On the basis of these investigations, 
together w ith earlier findings, a model of HSV entry into cells was proposed, 
and this is illustrated in Figure 3.
According to the proposed model, virion attachment to cell surface HS is 
mediated by gC and to a lesser extent gB, after which, a more stable attachment 
o f the virus to the cell occurs via an unidentified cellular receptor. The viral 
glycoprotein thought to be involved in the stable attachment of virus to cells is 
gD, since bound virus lacking gD are more sensitive to removal by heparin or 
high ionic strength washes than wt virus adsorbed to cells. Moreover, soluble 
gD can reduce virus attachment when added to cells p rio r to or during virus 
adsorption (Fuller and Lee, 1992). The stable attachment o f the v irion  is 
believed to prime the virus for fusion with the cell membrane, on the basis that 
gD-minus and gD-neutralized virus bind to cells but are unable to penetrate the 
cell membrane (Fuller and Spear, 1987; Highlander et al., 1987; Ligas and 
Johnson, 1988). The model proposes that gD has two functions in v ira l entry. 
F irstly, gD interacts w ith a cellular receptor, bringing virus and cell closer 
together. Secondly, gD is believed to interact with another v ira l component that 
is d irec tly  involved in the fusion in itia tion event. The idea that gD is b i­
functional comes from  the observation that antibodies specific to gD, which 
prevent attachment, do not b ind in the same regions as those blocking 
penetration (Eisenberg et al., 1985). Furthermore, the find ing that cell surface 
gD interferes w ith superinfection, possibly by interacting w ith gD or another 
v ira l glycoprotein on the virion , is consistent w ith the hypothesis that gD 
interaction w ith  another v irion component triggers the fusion in itia tion  event. 
However, it can also be argued that gD mediated inh ib ition  o f superinfection 
results from the sequestering of a cellular receptor by cell surface gD. This idea
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is supported by the work of Johnson et al., (1990) who showed that gD bound to a 
170kDa cellular membrane protein that is much less numerous in number than 
cell surface HS.
According to the model (Fig 3), the formation of a fusion bridge is the 
next step in virus entry, which may be triggered by changes in the 
conformation of gD due to receptor interaction. Similarly, formation of a fusion 
bridge may be mediated in part by conformational changes in gC or gB (or 
o ther v ira l components) which occur after HS interaction. Fuller and Lee 
(1992) observed visible fusion bridges fo r virus inactivated by gH specific 
antibodies and subsequently proposed that gH interacts either d irectly or 
ind irectly  w ith  gD in cell fusion. Glycoprotein H, although essential for virion 
in fectiv ity , does not appear to form complexes w ith any cellular component 
(Kuhn, 1990), and no distinct structures of gH have been detected on the surface 
o f v ir io n  envelopes, suggesting that gH is probably not involved in virus 
attachment (Stannard et al., 1987). Interaction of gH with the cell is thought to 
follow  gD, since virus inactivated by gH neutralising antibodies appeared to be 
blocked at a later stage than gD inactivated virus (Fuller and Lee, 1992). 
Furthermore, high m ultip lic ity of infection (moi) of gH negative virus bound to 
cells inh ib ited  en try of superinfecting wt virus (Fuller and Spear, 1987; 
Forrester et al., 1992), whereas gD negative virus had little  effect (Johnson and 
Ligas, 1988). It is possible that gD or gH may independently mediate v irion 
fusion, since both are required for HSV-induced cell fusion (Fuller and Spear, 
1987; Highlander et al., 1987; Ligas and Johnson, 1988; Fuller et al., 1989). 
However, the finding that neither gD or gH alone mediate substantial fusion of 
most cells, supports the idea that gH and gD and perhaps other vira l 
glycoproteins (i.e gB and gK) act synergistically to mediate HSV fusion 
(Campadelli Fiume et al., 1988b; Butcher et al., 1990; Peeters et al., 1992). This 
proposal is supported by recent reports which show that most or all o f gH in 
infected cells is complexed w ith  gL and that the correct processing and 
intracellu lar transport of gH in infected cells, is dependent on the coexpression 
of gL (Hutchison et al., 1992a).
The model also proposes that during in itia tion  of the fusion bridge, 
rearrangement of the v irion envelope and tegument proteins occur (Fig 3 d), 
allowing the nucleocapsid to be positioned towards the cell.
The fina l stage of v ira l entry, involves the expansion o f the fusion 
bridge and the subsequent release of the nucleocapsid into the cytoplasm (Fig 3
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e and f). It is likely that gB has an essential role in virus induced cell fusion, 
since gB-null syncytial virus can cause complete fusion of gB-transformed 
cells, but no fusion on untransformed cells (Cai et al., 1988). Furthermore the 
recently iden tified  glycoproteins gK and gL, in add ition  to other v ira l 
components, may play im portant roles in mediating and con tro lling  the 
changes observed in the v irion  particle or cell membrane and subsequent 
release o f the nucleocapsid in to the cytoplasm (Hutchison et al., 1992b; 
Ramaswam y and Holland, 1992)
The role of non-glycosylated proteins in v ira l attachment and fusion 
have not been thoroughly addressed. Previous investigations showed that virus 
attachment can occur when glycosylation is inhibited, suggesting that other 
v ira l proteins are im portant in virus binding (Svennerholm et al., 1982; Kuhn 
et al., 1988). An alternative explanation is that glycosylation is not required for 
the interaction of v ira l attachment proteins to the cell receptors. Furthermore, 
the non-glycosylated UL25 gene product has been implicated in v ira l entry but 
not adsorption (Addison et al., 1984).
2. Uncoating Of The Virus Genom
Once HSV nucleocapsids have been released into the cytoplasm, they are 
transported across the cytoplasm to the nucleus (Batterson et al., 1983) by a 
mechanism probably involving host cell microfilaments (Lycke et al., 1984). At 
the nuclear membrane disassociation of the capsid occurs and v ira l DNA is 
released. Dissasociation of capsid pentamers may be prerequisite to the release 
of v ira l DNA, since these are frequently absent from preparations of flattened 
capsid sheets visualized in infected cells (Vernon et al., 1984).
V iral DNA enters the nucleus via nuclear pores (Hummeler et al., 1969). 
Since a ly tic  infection can occur w ith transfected vira l DNA, translocation does 
not appear to be dependent on the presence of viral proteins.
The uncoating process can take place in the presence of nucleic acid and 
protein synthesis inhibitors, indicating that de novo RNA and protein synthesis 
are not required for this process. In light of these observations it was proposed 
that a structura l component of the virus or a cellu lar enzyme mediates the 
uncoating step (Hochberg and Becker, 1968). A function  essential fo r the
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uncoating event has been mapped to the UL36 gene (Batterson et al., 1983), 
which encodes the tegument protein Vmw273 (Macnabb and Courtney, 1992b). 
The possib ility exists that other tegument proteins may also be required for 
uncoating.
3 . E ffec ts  O f H S V -In fe c tio n  On H o s t C e ll M a c ro m o le c u la r  
S ynthes is
3.1 Shut-Off Of Host Cell Protein Synthesis
One of the firs t changes to occur in HSV-1 infected cells is the 
margination of host cell chromatin (Nii et ai.,1968). Margination may be a 
function of a v irion  component or an IE gene or the cellular stress response, 
since mutant virus lim ited to the IE stage of replication are still able to induce 
this effect (Dargan and Subak-Sharpe, 1983). Other changes such as distortion 
of the nucleus and disintegration of the nucleolus occur early in HSV-1 infected 
cells and are possibly caused by HSV-1 IE proteins (reviewed by Dargan, 1986). 
A lterations in cell membrane permeability have also been observed (Kohn, 
1979).
Infection of cells with HSV-1 results in the rapid shut-off o f host protein 
synthesis by disruption of polysomes and degradation of host mRNA (reviewed 
by Fenwick, 1984). Virus entry is thought to be required fo r the induction of 
host cell shut-off, since protein synthesis is not inhibited in cells infected w ith 
virus, inactivated either by heat treatment at 56° or w ith human y-g lobu lin  
(Fenwick and Walker, 1978; Nishioka and Silverstein, 1978).
Two stages of shut-off of host cell protein synthesis have been defined 
(Nishioka and Silverstein, 1978). The first, termed virion associated shut-off, is 
mediated by a v irion  component. It occurs in the presence of actinomycin D 
( inh ib ito r of gene expression) and in cells infected with UV-inactivated virus 
(Fenwick and Walker, 1978; Fenwick et al., 1979; Kwong and Frenkel, 1987). A 
fu rthe r reduction in host cell protein synthesis, termed secondary shut-off, 
occurs later in infection, and requires viral gene expression. V irion  induced 
degradation of mRNA is not selective, resulting in both the shortening o f the 
half lives of both host and viral mRNA (Kwong and Frenkel, 1987). Read and
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Frenkel,(1983) isolated a series of v irion host shut o ff (vhs) mutants that were 
unable to mediate virion-associated shut-off of host protein synthesis. The vhs 
mutation was later mapped to a region on the HSV genome containing the UL41 
ORF, which is predicted to encode a 58 kDa protein (Kwong et al., 1988; McGeoch 
et al., 1988b). Subsequent work by Smibert et al., (1992), using rabbit 
antipeptide antisera specific for the UL41 protein, confirmed that the UL41 
gene product was a 58 kDa protein found in virions. Finally, the UL41 protein 
was shown to be a component of the virion tegument (McLauchlan et al., 1992a).
A lthough the UL41 protein has a role in host shut-o ff o f protein 
synthesis, the protein is expendable for growth o f virus in tissue culture, since 
mutants defective in host cell shut-off are able to produce ly tic  infection in 
cells (Fenwick and Clark, 1982; Read and Frenkel, 1983; Fenwick and Everett, 
1990b). Nonetheless, the vhs protein does confer a growth advantage to the wt 
virus, shown by the rapid selection of wt virus during serial virus propagation 
(Kwong et al., 1988). Since v ira l gene expression involves the sequential 
activation of groups of genes comprising the IE, E and L genes, nonselective 
degradation of mRNA may facilitate translation of the most recently transcribed 
mRNA (Kwong and Frenkel, 1987; Oroskar and Read, 1989).
3.2 Induction Of Cellular Proteins
Challenge of a susceptible host w ith HSV can result in abortive, latent 
and productive infections. HSV-2 has also been implicated in transformation 
and oncogenesis. This variability in the response to HSV-infection suggests that 
host cell factors may determine the outcome of the virus-cell interactions. The 
expression o f a number of cellular proteins has been frequently observed 
during viral infection.
a) Interferons
The interferons are a family of cellular proteins, not normally expressed, 
that are produced in response to viral infection. They are released from virus- 
in fected cells and b ind to interferon receptors on ne ighbouring cell 
membranes. Two classes of human interferon, IFN-a and IFN-p have been
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shown to bind to the same cellular receptor, whereas IFN-y binds to a separate 
cell receptor (Branca and Baglioni, 1981; Sarkar and Gupta, 1984). Binding of 
interferon to the cellular receptor prom ptly activates the transcription of a 
defined set of cellular genes, many of which are involved in establishing an 
antiv ira l state whereby vira l replication is inhibited. In this respect they are 
believed to be the body’s f irs t line of defence against v ira l infection. 
Development of the antiviral state by interferon involves the induction of two 
enzymatic activities, a protein kinase and a 2’-5’- oligoadenylate synthetase 
(Farell, 1979), both of which are involved in the degradation o f mRNA and 
inhib ition of viral protein synthesis.
In addition to the establishment of an an tiv ira l state, the effects of 
interferons are accompanied by changes in surface membrane proteins 
(Lengyel, 1982), and in the morphology of the cytoskeleton (Fellous et al., 1982).
A number of other cellular proteins, several o f which are in the same 
size range (Colonno, 1981), are known to accumulate in IFN-treated cells. Ball 
(1979) showed that interferon treatment induced the synthesis of a 56 kDa 
protein that appeared to be related to the 2’-5’-oligoadenylate synthetase. Since 
then, fou r other 56 kDa cellular proteins have been shown to accumulate in 
interferon-treated cells. Although these proteins are the same size, they appear 
to be distinct. For instance, the 56,000 Mr protein (C56) identified by Chebath et 
al. (1983) does not have any detectable synthetase activ ity or share common 
sequences w ith the 2’-5’-oligoadenylate synthetase cDNA, suggesting that the 
C56 is distinct from the protein described by Ball (1979). The synthesis of the 
56kDa protein identified by Kusari and Sen (1987) occurs in cells treated with 
IFN-a or IFN-p but not in cells treated w ith IFN-y. This prote in is probably 
d istinct from  the 56,000Mr IFN-induced protein described by Rubin et al., 
(1988), which is induced in both IFN-a, IFN-p and IFN-y treated cells. The 
functions o f the m ajority of IFN-induced proteins in mediating the effects seen 
in IFN-treated cells have yet to be determined.
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b) Heat shock proteins
The cellular stress response occurs in cells subjected to environmental 
stresses such as increases in temperature. During the stress response, the 
synthesis o f cell proteins that are curren tly  being synthesized is down- 
regulated, and a new set of proteins is synthesized. These proteins are known as 
the heat shock or stress proteins. The high degree of conservation of the amino 
acid sequences among the heat shock proteins in all organisms together w ith 
the observation that many of these proteins are present when the organism is 
not subjected to stress, suggests that they have functions essential to normal 
cellular operations but are required to a higher degree under stress conditions. 
Recent studies of the hsp70 and hsp90 classes of heat shock proteins support the 
notion that these proteins act as molecular chaperones (Ellis, 1990). Molecular 
chaperones are defined as a fam ily of unrelated proteins that mediate the 
correct assembly of other polypeptides. Thus it was proposed by Pelham (1986) 
that the heat shock proteins not only mediate protein assembly but also promote 
the disassembly of proteins that have been damaged as a result of stress.
As well as heat shock, the heat shock proteins are synthesized in 
response to other conditions, such as viral infection (Nevins, 1982; Collins and 
Hightower, 1982; Wakakura et al., 1987). There have been numerous reports of 
the induction  of heat shock proteins during HSV-infection. For instance, 
Notarianni and Preston (1982) showed that heat shock proteins accumulated in 
cells infected with the HSV-1 strain 17 tsk but not in wt virus-infected cells. The 
tsk mutant carries a lesion in the IE protein Vmwl75 and it was proposed that 
accumulation of heat shock proteins was im portant in e lim inating  non­
functional forms o f Vm wl75 or neutralizing the ir damaging effects, rather 
than merely resulting from viral IE protein accumulation (Russell et al., 1987). 
This effect may be important in vivo, since natural isolates frequently show ts 
mutations in the gene encoding Vmwl75 (Knipe et al., 1981)
LaThangue et al. (1984) identified a 57,000 Mr cellular protein (p57) that 
was transcrip tionally induced in heat-shocked cells and in HSV-2 infected cells. 
An accumulation o f this protein was also shown to occur in HSV-1 infected cells, 
albeit to a lower level (Patel et al., 1986). The fact that p57 accumulated both in 
HSV-infected cells and during heat shock suggests that these stim u li activate 
the stress response and it is likely therefore that p57 has a sim ilar function in 
both cases. Thus induction of heat shock proteins in HSV-infection may 
represent an attempt by the cell to deal with the presence o f foreign v ira l
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proteins. Clearly in the majority of cases the viral lytic cycle is not inhibited by 
the stress response. Nonetheless, it is possible that induction of the stress 
response in HSV-infection of some cell types in vivo may cause the lytic cycle 
to be aborted, resulting in the establishment of ce llu lar transform ation 
(Minson, 1984).
c) Cellular Proteins and HSV-induced Transformation.
The involvement of herpesviruses w ith tum our induction has been 
observed fo r some time (reviewed by Macnab, 1987). Although there are no 
direct links between HSV-infection and subsequent cancer development, there 
is nonetheless a tenuous association between previous infection w ith HSV-2 and 
the development of cervical neoplasia, inasmuch as a higher prevalence of 
HSV-2 seropositivity has been demonstrated in cervical cancer patients than in 
normal control patients (Rawls, 1983).
The mechanism of HSV-2 induced cell transformation is unclear but 
may involve in part the amplification of some cellu lar genes (reviewed by 
Macnab, 1987).
A number of heat shock proteins have been shown to accumulate in 
HSV-transformed cells (Kelley and Schlesinger, 1982). In immunoprecipitations 
with the monoclonal antibody TG7A, which was raised against the DNA-binding 
proteins of HSV-2 infected cells (LaThangue and Chan, 1984), LaThangue and 
Latchman (1988) identified two cell encoded polypeptides, p90 and p40, that 
accumulated during HSV-infection. Previous studies indicated that sim ilar sized 
polypeptides were overexpressed in transformed and im m ortalized cells 
(Macnab et al., 1985). The expression of p90 was also induced by heat shock and 
it was proposed that p90 was related to the previously defined heat shock 
prote in  o f th is molecular weight, hsp90 (Kelley and Schlesinger, 1982; 
LaThangue and Latchman, 1988). Interestingly, p40 accumulated p rim arily  in 
HSV-1 infected cells, whilst p90 was overexpressed during HSV-2 infection. In 
addition to p40, TG7A reacted with a 32kDa cell protein in HSV-1 infected cells, 
albeit at a lower concentration relative to p40. The differential accumulation of 
p40 and p90 suggests that the infecting virus possesses the factors which 
determine whether p40 or p90 accumulates. It is intriguing to speculate that the 
accumulation of these proteins in HSV-infection and in HSV-transformed cells
*
M itochondria l aspartate amino-transferase is the target o f an ti-tum our drugs 
(Thomasset et al., 1992; Vila et al., 1990).
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may have im portant implications fo r the mechanism of HSV-induced cellular 
transformation. However, the d ifficu lty  with this suggestion is that p40 and p90 
are present in many d iffe ren t transform ed cell lines, not just those 
transformed by HSV, suggesting that the overexpression of p40 and p90 is a 
general feature of all transformed cells (Macnab et al., 1985).
Work recently carried out by Hewitt et al. (1991) led to the identification 
of a transform ation-specific polypeptide U90 that accumulated in HSV-2 
infected cells. U90 represents the upper polypeptide band of a 90kDa doublet. 
Both U90 and the polypeptide L90 from the lower 90 kDa band can be 
immunoprecipitated from transformed cells by antisera from tum our bearing 
animals (TBS) or by the mouse monoclonal antibody TG7A (Macnab et al., 1985). 
In contrast to p90 that was identified using TG7A in western blot analysis by 
LaThangue and Latchman (1988), neither U90 or L90 were induced by heat 
shock. Indeed, Hewitt et al., (1991) failed to identify any heat shock proteins in 
HSV-infected and transfo rm ed cells using the TG7A an tibody in 
im m unoprecipitation assays. Thus it was concluded that while TG7A and TBS 
recognize s im ila r U90 and L90 polypeptides in im m unoprecip itations, in 
western blots TG7A recognizes a different epitope to that recognized by TBS. 
Therefore, U90, immunoprecipitated from rat cells w ith TG7A, is distinct from 
p90 that was recognized by TG7A in western blots. On the basis of this data, it 
was proposed that the heat shock proteins recognized in HSV-infected cells by 
western b lo t analysis using TG7A (Lathangue and Latchman, 1988) do not 
express the epitopes characteristic of U90 or L90 that were recognized by the 
immunoprecipitation assays using the same antibody. In support of this idea is 
the observation that TG7A recognizes an epitope on the E. coli Ion protease 
(Latchman et al., 1987a), whereas TBS fails to react w ith any E. coli proteins (D. 
McNab and J.C.M. Macnab, unpublished results).
Recently, it  was shown that patients with cervical cancer produced an 
antibody response to a tumour specific cell polypeptide that is overexpressed in 
HSV-2 in fected cells (Macnab et al., 1992). The 40kDa pro te in  was 
immunoprecipitated from tumour cells using TBS and TG7A, and lim ited amino 
acid sequence analysis suggested that it was homologous to the m itochondrial 
aspartate amino-transferase (Huynh et al., 1981; Lucasson, 1992). There has
* ■  ibeen evidence to suggest an involvement of this enzyme in cancer, a.^<d 
disturbances in  m itochondria l function  have been im p lica ted  in  the 
development of malignancy (reviewed by Shay and Werbin, 1987).
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To date, the role of the HSV-inducible cell polypeptides in the lytic cycle 
is unknown. The fact that HSV-infection can result in the overexpression of 
some cellu lar proteins which also accumulate in transformed cells may have 
im portant implications fo r the mechanism of HSV-induced transformation. 
However, it remains to be seen whether the overexpression of certain cellular 
prote ins is d ire c tly  involved in the establishment o f the transformed 
phenotype, or is simply a consequence of it.
d) Mechanisms of Induction
The accumulation of the m ajority of cellu lar proteins during HSV- 
in fection appears to be mediated by the transcrip tional induction of the 
corresponding cellular gene (Kemp et al, 1986a; Patel et al., 1986). Many of 
these gene products require functional viral IE proteins, in particular Vmwl75, 
fo r the ir induction (Patel et al., 1986; Latchman et a l, 1987b; Kemp and 
Latchman, 1988; Esteridge et al., 1989; reviewed by Everett, 1987). In the case of 
adenovirus, the induction of a 70kDa heat shock protein is dependent on the 
expression of the early gene product El a (Kevins, 1982; 1989). The accumulation 
of the cell polypeptide p40 in HSV-infected cells (LaThangue and Latchman,
1988) was shown to be dependent on the expression of the HSV IE protein 
Vmw63 (Esteridge et al., 1989). However, in the absence of v ira l replication, 
transfection w ith a plasmid containing the gene encoding Vmw63 either alone 
or in concert w ith  the other IE genes or that encoding Vmw65, was not 
sufficient to induce significant p40 accumulation. This finding suggested that 
Vmw63 alone was not sufficient for maximal p40 accumulation and that other 
factors in infected cells are required. Since p40 accumulation occurs in tsk- 
infected cells, where lytic infection is lim ited to the IE stage, i t  is like ly that 
these factors must be a component of the v irion  other than Vmw65 or a 
relatively non-specific stimulus such as viral attachment or entry of the capsid 
into the cytoplasm. Since the activation of the majority of cellular genes during 
v ira l in fection is dependent upon the expression of the IE proteins, it  is 
in trigu ing to speculate that the cellular promoters have sequence homology to 
v ira l promoters and as a result are transcriptionally activated by the IE 
proteins during  ly tic  infection. However, evidence has suggested that the 
activation of cellu lar genes requires no specific cis-acting sequences w ith in  
the cellular promoter. In support of this idea was the observation that active 
endogenous (3-globin genes were shut off by HSV infection in a manner that
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was characteristic of the m ajority of cellular genes, whilst transfected globin 
genes were activated in apparently the same manner as HSV genes, (Everett, 
1984a; 1984b; Everett and Dunlop, 1984; Everett, 1985). These observations 
suggest that an open chromatin structure is an important factor in the non­
specific activation o f cellular genes during vira l infection. Thus cellular genes 
which are transcribed during ly tic  infection may simply have easily accosible 
promoters (Everett, 1985). This idea is supported by the fact that the heat shock 
genes, which accumulate in HSV-infections, have open promoters in normal 
cells (Wu, 1980).
A few cellular genes can be induced in herpesvirus infected cells in the 
absence of v ira l protein synthesis (Kemp et al., 1986b; Preston, 1990). During 
HCMV infection, Boldogh et al., (1990) detected a rapid increase in the RNA 
levels o f three proto-oncogenes, in conditions which severely inh ib ited the 
synthesis of the vira l IE proteins. These workers concluded that the expression 
of these oncogenes was induced by events occuring before the onset of v ira l 
protein synthesis, perhaps by the interaction of the virus particle w ith the cell 
surface. Although the cellular receptor to which HSV binds remains to be 
determined, it  is likely that it is a normal cell surface component. The cellular 
receptors of many viruses have been determined and all perform  normal 
functions in cells. For instance, EBV infects T-lymphocytes by means of the C3d 
complement receptor (Fingeroth, 1984), human immunodeficiency virus (HIV) 
p rim a rily  uses the CD4 glycoprotein receptor (Dalgleish et al., 1984), and 
vaccinia virus can enter the cell by firs t interacting w ith  the epidermal 
growth factor receptor (Eppstein et al., 1985). It is conceivable that in HSV 
binding to its cellular receptor, the virus may mimic the normal ligand for this 
receptor and subsequently cause the induction of cellu lar genes norm ally 
induced by this binding.
There is some evidence to suggest that regulation of cellular genes may 
also occur in the absence of vira l protein synthesis, at stages subsequent to 
receptor b inding (Kemp et al., 1986b). In this case the induction of cellu lar 
genes may be regulated in a similar manner to the viral IE proteins. Induction 
of the HSV IE proteins is mediated by the viral trans-activator, Vmw65 and is 
dependent on the presence of certain cellular factors and the TAATGARAT m otif 
w ith in the promoter region of the induced gene (see section^-*). However, there 
is no evidence yet to suggest that TAATGARAT-like motifs exist w ith in  the HSV- 
inducible cell promoters.
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Although the exact mechanisms of induction of cellular proteins during 
v ira l infection are unknown, it is like ly  that this effect is o f functional 
significance to the infected cell. For instance, the induction o f interferon 
during v ira l infection is im portant in establishing the antiv ira l state, which 
serves to restrict the spread of infection to other cells. Furthermore, the 
activation of the stress response by infecting virus would have a sim ilar effect. 
However, the possib ility remains that the virus may induce some cellu lar 
proteins that may facilitate or affect the outcome of a v ira l infection. In the 
case of HSV, vira l infection can result in both lytic and latent infections as well 
as transformation of the infected cell. Indeed, the observation that HSV can 
induce a number o f ce llu lar proteins, which appear to accumulate in 
transformed cells, suggests that HSV-transformation may occur in part by the 
activation of cellular genes.
4. T e m p o ra l R egu la tion  O f HSV-1 Gene E xpression
HSV genes were in itia lly  classified into three broad groups, immediate 
early (IE o ra ), early (E or p) and late (L or y ) (Honess and Roizman, 1974; 
Clements et al., 1977). The IE proteins are the firs t v ira l proteins to be 
synthesized in the virus growth cycle and in general are involved in the 
regulation of gene expression. Studies using metabolic inhibitors revealed that 
IE gene expression does not require p rio r v ira l protein synthesis. Early 
proteins are synthesized after the expression of the IE proteins, p rio r to DNA 
replication. Indeed, many of the early proteins are involved in v ira l DNA 
metabolism. The late genes are defined as genes whose expression requires 
p rio r synthesis 6f IE and E proteins in addition to viral DNA synthesis and, in 
general, encode structural proteins (reviewed by Wagner, 1985; 1991). The 
identification of several late viral genes expressed prio r to v ira l DNA synthesis 
lead to the classification of two groups of late genes: the leaky late v ira l genes 
(Py or Yi) and the true late genes (Y2). The maximal expression of both o f these 
groups of genes is dependent on viral DNA replication. However, in contrast, to 
the true late vira l proteins, the leaky late proteins can be detected p rio r to the 
synthesis o f v ira l DNA (Wagner, 1985). More recently, Johnson et al., (1986), 
reported the detection of very low levels of the protein encoded by the true late 
gene US11, under conditions of severely restricted vira l DNA synthesis. These
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workers subsequently proposed that a true late gene is a gene whose expression 
under conditions which severely restrict viral DNA synthesisis is reduced to 
less than 95% of normal levels.
4.1 The IE Proteins
Five IE proteins , Vm wllO , Vmw63, Vm wl75, Vmw68 and Vm wl2, which 
are encoded by the HSV IE 1, 2, 3, 4 and 5 genes respectively have been 
described.
a) Vmwl2 and Vmw68
In contrast to the other IE proteins, Vm wl2 is non-phosphorylated and is 
located w ith in the cytoplasm (Marsden et al., 1982). Since viruses w ith deletions 
of the Vm wl2 gene are viable, Vmwl2 is not essential for virus growth in tissue 
culture (Longnecker and Roizman, 1986). The function o f Vm w l2 is poorly 
understood.
Vmw68 appears to have a role in the regulation of late gene expression. 
Analysis of a deletion mutant indicated that Vmw68 was only essential in some 
cell types, suggesting that a cellular function may replace its activ ity (Post and 
Roizman, 1981)
b) Vmw63
The observation that ts mutant viruses carrying lesions in the Vmw63 
gene over-expressed early gene products and did not synthesize detectable 
amounts of late genes (Sacks et al., 1985), suggested that Vmw63 was essential 
fo r virus growth in tissue culture. The requirement of Vmw63 fo r late gene 
expression and possibly the down regulation of IE genes was confirmed by a 
subsequent study of Vmw63 deletion mutants (McCarthy et al., 1989). Recent 
studies have showed that Vmw63 plays an important role in the regulation of 
late gene expression through a post transcriptional mechanism (Sandri-Goldin 
and Mendoza, 1992; Smith et ai, 1992 ), probably by increasing the processing at 
the 3' poly(A) signal of late transcripts (McLauchlan et a i, 1992b). Recently, it
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was reported that purified Vmw63 could bind to zinc ions and interact with 
single-stranded DNA (Vaughn et al., 1992). Furthermore, the aminoterminal 
acidic region was shown to be important for the regulatory activities of Vmw63 
in both transfected and infected cells (Rice et al., 1993).
c) VmwllO
V m w llO  is a transactivator of a variety of v ira l promoters (O'Hare and 
Hayward, 1985a, 1985b; Quinlan and Knipe, 1985; Gelman and Silverstein, 1986; 
Everett, 1986; Everett et al., 1991b). Although, V m w llO  is not essential for virus 
growth in tissue culture, it does, however, confer a strong growth advantage on 
the virus (Stow and Stow, 1986; Sacks and Schaffer, 1987). Transactivation by 
V m w llO  was shown to be increased in the presence of Vm wl75, and vice versa 
(Everett, 1984b), however, this synergism was shown to depend greatly on the 
experimental conditions used (Everett et al., 1988). Nonetheless, further studies 
showed that Vm w l75 affected the intranuclear location of V m w llO , which 
suggests that the two proteins interact (Knipe and Smith, 1986).
d) Vmwl 75
V m w l75 is the major vira l transcriptional regulatory protein and is 
essential fo r virus growth (Preston, 1979), and the transcriptional activation of 
the E and L genes (Preston, 1979; Everett, 1984a, 1984b; Gelman and Silverstein, 
1985; O'Hare and Hayward, 1985a; DeLuca and Schaffer, 1985; Quinlan and Knipe, 
1985). In addition, Vmwl75 can repress its own synthesis as well as that of the 
other IE proteins (O'Hare and Hayward, 1985b; DeLuca and Schaffer, 1985). 
Whilst most of the IE proteins have been shown to bind non-specifically to DNA 
(Hay and Hay, 1980), V m w l75 is the only one known to interact w ith a specific 
target sequence. It binds to the sequence 5’-ATCGTC-3’ which was identified 
w ith in  the IE-3 promoter (Muller, 1987; Faber and Wilcox, 1986, 1988). It is 
generally believed that self-repression occurs by binding o f V m w l75 to this 
sequence at its own transcription start site (Roberts et al., 1988; DeLuca and 
Schaffer, 1988). Stimulation of gene expression mediated by V m w l75 is thought 
to result from  V m w l75 binding to sites within the promoter region (Tedder et 
a/., 1989). The region of Vmwl75 involved in DNA binding, transactivation and 
repression was located near the N-terminus of the protein, between amino acid 
residue 275 and 495. Mutations in this region of V m w l75 were shown to greatly
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affect these functions (Paterson and Everett, 1988a; 1988b; Shepard eta/., 1989; 
Paterson et al., 1990). A polypeptide corresponding to this region retains the 
sequence specific DNA-binding properties of the whole protein (Wu and Wilcox, 
1991; Everett eta/., 1990; 1991a).
4.2 Transactivation Of IE Gene Expression By Vmw65
The transactivation of the IE vira l genes is mediated by the UL48 gene 
product termed Vmw65 (a-TIF, VP16) (Batterson and Roizman, 1983; Campbell et 
a/., 1984; Dalrymple et a/., 1985; Pellet et a/., 1985). Vmw65 is a 65kDa 
phosphoprotein located w ith in the tegument of the v irion  particle (Roizman 
and Furlong, 1974; Marsden et a/., 1978; Szilagyi and Cunningham, 1991; 
McLauchlan and Rixon, 1992). Previous data have suggested a structura l 
function fo r this protein as well as a role in mediating IE gene transactivation 
(Post eta/., 1981; Campbell eta/., 1984; Ace eta/., 1989).
An upstream element containing the sequence TAATGARAT (R= purine) 
which was required fo r IE gene transactivation, was identified in all of the IE 
gene promoters (Mackem and Roizman, 1982; Murchie and McGeoch, 1982; 
Cordingly et a/., 1983; Campbell et a/., 1984). The functional relevence of the 
TAATGARAT m otif in the transactivation of IE gene expression was questioned 
following observations that Vmw65 showed no detectable in vitro DNA binding 
properties (Marsden et al., 1987). Thus, attention was focused on the 
identification of cellular proteins which interact w ith  both Vmw65 and the 
TAATGARAT motif. A likely candidate protein was subsequently identified as the 
cellular transcrip tion factor OCT-1 (OFT-1, NFIII, TRF), which interacts w ith 
both Vmw65 and the TAATGARAT motif resulting in the formation of an infected 
cell complex (Preston eta/., 1988; O'Hare and Goding, 1988). Vmw65 appears to 
alter the specificity of OCT-1 so that it binds to the TAATGARAT m otif (O'Hare et 
a/., 1988; Gerster and Roeder, 1988; Aphrys eta/., 1989). Mutational analysis of 
the Vmw65 protein led to the identification of eight amino acids w ith in  the N- 
terminal portion of the protein that are involved in its interaction w ith OCT-1 
(Hayes and O'Hare, 1993), whilst the carboxy-terminal 80 residues function in IE 
gene transactivation (Ace et al., 1988; Triezenberg et al., 1988; Greaves and 
O'Hare, 1990). At least one other cellular protein, termed CFF, is also required for 
the formation of the infected cell complex (Katan et al., 1990).
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5. HSV-1 DNA Replication
Seven HSV genes: UL5, UL8, UL9, UL29, UL30, UL42 and UL52, are essential 
fo r v ira l DNA replication (reviewed by Challberg, 1991). These genes are all 
located in the UL region of the genome. Circularisation of the HSV DNA takes 
place prio r to the onset of viral DNA synthesis (Jean and Ben-Porat, 1976; Jacob 
et al., 1979; Poffenberger and Roizman, 1985). The "a" sequences, which are 
present in the same orientation at both ends of the DNA molecule, permit 
circularisation. At early stages in infection, v ira l DNA replication occurs at 
discrete sites w ith in  the infected cell nucleus. At later stages, the nucleus 
becomes filled with replicating v ira l DNA (Rixon et al., 1983). The in itia l sites of 
v ira l DNA replication have been designated replication compartments (Quinlan 
et al., 1984; reviewed by Knipe, 1989). Following the onset of v ira l DNA 
replication, DNA molecules greater than one un it length start to appear (Jacob 
and Roizman, 1977; Hirsch et al, 1977). At later stages in vira l infection, large 
masses of DNA are observed (Jacob and Roizman, 1977; Ben-Porat and Rixon, 
1979), consisting of multiple head to ta il concatemers (Jacob et al, 1979). 
According to these observations, these workers proposed that HSV DNA 
synthesis occurs by the ro lling circle method of replication, which involves 
the continuous synthesis of one strand of DNA and discontinuous synthesis of 
the second strand.
The HSV genome has 3 origins of replication, one copy of OriL and two 
copies of Oris (Frenkel et al, 1975; Vlazny and Frenkel, 1981; Spaete and Frenkel, 
1982). OriL is located near the middle of the long unique region whilst a copy of 
Oris lies w ith in each of the inverted repeat segments flanking the Us region of 
the genome (Stow, 1982; Stow and McMonagle, 1983; Weller et al, 1985; Quinn 
and McGeoch, 1985). The Oris and OriL are probably functionally equivalent on 
the basis of sequence sim ilarity and complementation assays.
Most studies on the HSV origin sequences have been performed w ith Oris, 
since plasmids containing the OriL sequence are unstable in E. coli. (Weller et 
ai., 1985). The Oris sequence is divided into the core region, containing UL9 
binding sites, and the surrounding sequences which enhance DNA replication 
(Elias et al, 1986; Elias and Lehman, 1988; Olivo et al, 1988; Weir et al, 1989; 
Wong and Schaffer, 1991). The core region can be fu rther divided into fou r 
domains, three of which are UL9 binding sites and the fourth an AT rich region 
between two of the sites. All three UL9 binding sites are necessary for optimum
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DNA replication in transient assays (Lockshon and Galloway, 1988; Weir and 
Stow, 1990; Hernandez et al., 1991). Two of the UL9 recognition sites (sites I and 
II) cooperatively bind the UL9 protein (Olivo et al., 1988; Elias and Lehman, 
1988; Weir et al., 1989; Elias et al., 1990; 1992). Binding of UL9 to sites I and II, 
results in the looping out and distortion of the DNA (Koff et al., 1991; Fierer and 
Challberg, 1992).
The portion of the UL9 protein (apparent Mr 83,000), which binds to Oris 
has been located to the carboxyterminal th ird  of the protein (McGeoch et al., 
1988a; Weir et al., 1989; Deb and Deb, 1991). Recent data have shown that the DNA 
binding activ ity  of UL9 is essential for replication (Arbuckle and Stow, 1993; 
Stow et al., 1993). The UL9 protein also has helicase activ ity which is required 
fo r replication (Stow, 1992; Stow et al., 1993). The UL9 helicase activity may be 
involved in the unwinding of the DNA prio r to replication, although origin- 
specific unwinding by UL9 has not yet been shown.
Establishment of the replication fork is dependent on the products of the 
remaining six v ira l genes essential fo r v ira l DNA synthesis. The v ira l DNA 
polymerase exists as a heterodimer of the UL30 (Pol gene) and UL42 gene 
products. Comparative analysis of the catalytic activities o f the pol/UL42 
complex and the isolated pol protein suggested that the UL42 gene product 
increased the processivity of the enzyme (Gottlieb et al., 1990; Hernandez and 
Lehman, 1990). The importance of UL42 interaction w ith pol was demonstrated 
by the characterisation of a mutant polymerase, which was unable to bind to 
the UL42 protein. Although the pol retained enzymatic activ ity  it could not 
synthesize long DNA products (Digard et al., 1993; Tenney et al., 1993; Stow, 
1993). Therefore, it is likely that the UL42 product holds the pol enzyme and the 
DNA substrate in close proximity, preventing disassociation after each catalytic 
step.
The helicase and primase activities required fo r DNA replication have 
been located to a three subunit enzyme complex composed o f the products of the 
UL5, UL8 and UL52 genes which encode proteins of 97kDa, 70kDa and 120kDa 
respectively (Crute et al., 1989; Crute and Lehman, 1991). Expression of the UL5 
and UL52 proteins in a baculovirus expression system resulted in a dimeric 
enzyme w ith  sim ilar helicase and primase activities to the native enzyme 
(Calder and Stow, 1990; Dodson and Lehman, 1991), suggesting that the UL8 
product is not required fo r helicase or primase activ ity . Further studies 
suggested that helicase activity could be attributed to the UL5 gene product (Zhu
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and Weller, 1992a,b). Thus, primase activity is probably mediated by the UL52 
gene product. Recent studies suggest that UL8 may increase the efficiency of 
prim er utilisation by stabilizing the primer-template complex and facilitating 
nuclear uptake of the helicase/primase complex (Calder et al., 1992)
The UL29 gene encodes a protein of about 130kDa which is the major 
vira l DNA binding protein (DBP) (Bayliss et al., 1975; Purifoy and Powell, 1976; 
Purifoy et al., 1977). It binds non-specifically to single stranded DNA with high 
a ffin ity  (Ruyechan and Weir, 1984). The protein stimulates the activ ity of the 
DNA polymerase and is required fo r the synthesis o f long DNA strands 
(Ruyechan and Weir, 1984; Hernandez and Lehman, 1990). Further evidence 
suggested that the UL29 product may be neccessary fo r the structura l 
organisation o f nuclear rep lication compartments in  which v ira l DNA 
synthesis occurs, and the correct localisation of pol and other replicative 
proteins into pre-replicative sites w ith in  the nucleus (de Bruyn Kops and 
Knipe, 1988: Gao and Knipe, 1989; Parris eta/., 1988). The DBP has also been 
shown to stimulate the activity of the DNA polymerase as well as the activity of 
the UL9 gene product (Hernandez and Lehman, 1990; Boehmer et al., 1993; 
Boehmer and Lehman, 1993).
5.1 Enzymes Involved In Nucleotide Metabolism
a) Thymidine Kinase
The HSV-encoded pyrim idine deoxyribonuclease kinase enzyme, which is 
commonly referred to as thym idine kinase (TK), is not required fo r ly tic  
infection in actively growing cells in vitro (Dubbs and Kit, 1964; Elion et al., 
1977; Fyfe et al., 1978). However, tk~ mutants were shown to grow less 
efficiently in serum starved cells (Jamieson et al., 1974), suggesting that it may 
be necessary fo r virus replication in non-dividing cells. The observation that 
tic virus has a low incidence of latent infection (Field and Wildy, 1978) led to 
the proposal that TK may be necessary for the establishment of latency in vivo . 
However, recent studies showed that latency-associated transcripts (LATs) could 
be detected in cells infected with tk 'v iru s  (Coen et al., 1989; et al.,
1989), suggesting that tic- virus was capable of establishing a latent infection. 
Thus, it was concluded that TK may be required for the reactivation of virus 
from latency (Coen et al., 1989; Efstathiou et al., 1989).
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b) Ribonucleotide Reductase
Ribonucleotide reductase (RR) catalyses the reduction o f the four 
ribonucleotides to the corresponding deoxyribonucleotides, creating a pool of 
substrates for DNA synthesis. The enzyme is composed of a large (Mr 144,000) 
and a small (Mr 38,000) sub unit, the products of the UL39 and the UL40 genes 
respectively (Dutia, 1983; Bacchetti eta/., 1984; Preston et al., 1984; Frame et al., 
1985). Analysis of the tsl207 mutant, which has a lesion in the large sub unit 
and fails to induce RR activity at the non-permissive temperature, suggested 
that RR may be required for viral growth and viral DNA synthesis (Dutia, 1983; 
Preston et al., 1984). Subsequent data indicated that although RR has an 
essential role in DNA synthesis, it is not essential fo r virus growth in tissue 
culture at low temperatures. This suggests that the host cell RR can substitute 
fo r the v ira l enzyme at low temperatures (Goldstein and Weller, 1988a,b,c; 
Preston et al., 1988).
c) Deoxyuridine 5 ’ triphosphatase (dUTPase)
The v ira l dUTPase catalyses the hydrolysis of dUTP to dUMP and 
pyrophosphate (Wohlrab and Francke, 1980), leading to a reduction in the 
in trace llu la r concentration of dUTP, there by reducing the incorporation of 
urid ine in to  DNA. The dUTPase was shown not to be essential fo r virus 
rep lica tion  in exponentia lly growing or serum starved cells in vitro, 
presumably because the cellular counterpart is present in sufficient quantity 
(Fisher and Preston, 1986). Recent studies have indicated that the dUTPase may 
be im portant in neurovirulence and neuroinvasiveness as well as in virus 
reactivation from latency (Pyles et al., 1992).
d) Urac i 1-DNA glycosylase
The HSV encoded urac» 1-DNA glycosylase is the product of the UL2 gene 
(Caradonna and Cheng, 1981; Caradonna et al., 1987; Mullaney et al., 1989). This 
enzyme acts to correct the insertion of dUTP and deamination of cytosine 
residues in DNA. The extremely high G+C content of HSV DNA makes this enzyme 
an important element of error correction in HSV DNA replication. Analysis of a 
UL2 deletion mutant showed that this enzyme was dispensable fo r growth in 
tissue culture (Mullaney et al., 1989).
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Section l.C  Virion Structur
1. The Core
Early observations suggested that packaged v ira l DNA was wound in a 
toroidal manner around a central core (Furlong et al., 1972). However, more 
recent studies using cryoelectron microscopy and image reconstruction have 
shown that packaged viral DNA assumes a liqu id crystalline state and forms a 
un ifo rm ly dense ball (Booy et al., 1991). In this respect, HSV DNA packaging 
closely resembles that of the double stranded DNA bacteriophages T4 and X 
(Lepault et al., 1987). The toroid structure observed by Furlong et al. (1972) was 
probably an artefact of the fix ing and drying procedures used in sample 
preparation (Puvion-Dutilleul et al., 1987).
2. The C apsid
The HSV nucleocapsid is organized into 162 capsomers, of which 150 are 
hexons and 12 are pentons. The capsomers are organized in a T=16 icosahedral 
lattice w ith the pentons positioned at the vertices and the hexons forming the 
faces and edges (W ildy et al., 1960; Schrag et al., 1989). VPS, the major capsid 
protein (apparent Mr 155kDa) is thought to be the major component of both the 
hexons and pentons (Steven et al., 1986; Newcomb et al., 1993). Three capsid 
forms have been identified w ith in the infected cell nucleus. The A (empty), B 
(intermediate) and C (fu ll) capsids can be distinguished by the ir appearance in 
electron micrographs and by their protein content. The A capsids appear lack 
an internal structure and are composed of VP5, VP 19c, VP23, VP24 and VP26 
(Marsden et al., 1978; Morse et al., 1978; Rixon et al., 1990; Davison et al., 1992; 
McNabb and Courtney, 1992a). B capsids have internal components comprising 
VP21 and VP22a (Gibson and Roizman, 1972; Rixon et al., 1988). C capsids have an 
identical protein content to A capsids but unlike A capsids, they contain the 
viral genome.
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3. The Tegument
The HSV-1 tegument appears as an amorphous layer between the 
envelope and capsid in electron micrographs and is the most poorly
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characterized part of the virion. Proteins^are assigned to the tegument on the 
basis that they are not capsid or envelope proteins. Although over half of the 
proteins encoded by HSV-1 have been assigned to the tegument, little  is known 
about the ir structural organization or indeed the role of these proteins in the 
v ira l ly tic  cycle. Some tegument proteins, in particular Vmw65 and the vhs 
protein, have been shown to influence the course of infection (see section 
1B4.2 and 1B3.1 respectively). It was proposed that the vertices of the capsid 
serve as anchors fo r the tegument (Vernon et al., 1982). Subsequent reports, 
however, indicate that condensation and organization o f proteins into the 
tegument can occur in the absence of the capsid (McLauchlan and Rixon, 1992), 
suggesting that the vira l factors responsible for the in itia tion of tegumentation 
are located w ithin the tegument or envelope.
A lternatively, the v ira l factors required for the in itia tion  o f tegumentation may 
not be retained in the mature virion.
4. The Envelope
The HSV-1 envelope is a complex structure, derived from the host cell 
membrane, which is modified by the presence of viral proteins. To data, 9 viral 
glycoproteins have been identified in the virion envelope and five o f these (gB, 
gD, gH, gK and gL) are necessary for virus entry into cultured cells (Cai et al., 
1988; Ligas and Johnson, 1988; Forrester et al., 1992; Hutchison et al., 1992a,b; 
Roop et al., 1993). Several putative transmembrane proteins, predicted to cross 
the membrane several times, have been identified from analysis of HSV-1 
sequence data (McGeoch et al., 1988b). These proteins are the products of the 
UL10, UL20 and UL43 genes respectively.
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Section l.D  Virus Assembly
1. Capsid Morphogenesis
Capsid assembly takes place w ithin the nuclear matrix of the infected cell 
(Morgan et a l, 1954; Bibor-Hardy et al., 1982) and probably involves 
interactions between VP22a and the protease, resulting in the condensation of 
the capsid proteins to form B capsids. The transient association of VP22a with 
the capsid structure during assembly, led to the suggestion that this protein 
represents the herpesvirus equivalent of the bacteriophage scaffolding 
proteins (Casjens and King, 1975). The VP22a polypeptide has been shown to 
assemble into 60nm diameter structures, which could act as templates for the 
assembly of the capsid shell (Newcomb and Brown, 1991).
The protease and VP22a are encoded by UL26 and UL26.5 respectively 
(Preston et al., 1983; Liu and Roizman, 1991a,b; Figure 4). The relationship 
between VP22a and the protease is unusual, in that they arise from two separate 
but overlapping ORFs. Thus, the protease is an N-terminal extension of VP22a. 
The UL26.5 protein product is cleaved at the carboxy term inal end by the 
protease to form  VP22a, which is the major component of the core of B capsids 
(Liu and Roizman, 1991b; Preston et al., 1992). The protease also undergoes self 
cleavage at the same site, and at a second site upstream of the UL26.5 ORF 
(Davison et al., 1992; Liu and Roizman, 1993). Cleavage of the protease at both 
sites results in the formation of two polypeptides which have been identified as 
capsid components, the N-terminal portion of the protease corresponding to 
VP24 and the C-terminal portion to VP21 (Davison et al., 1992). The proteolytic 
activity responsible fo r cleavage of the UL26.5 gene product and the protease 
itself has been assigned to VP24 (Liu and Roizman, 1992). The ts l201 mutant, 
which has a lesion in  the N-terminal portion of UL26 affecting proteo lytic 
activ ity (Preston et al., 1983), has proved invaluable in elucidating the steps 
involved in capsid morphogenesis. At the non-permissive temperature, ts l201- 
infection results in the accumulation of large cored B capsids w ith in  the 
infected cell nucleus (Preston et al., 1983). After downshift to the permissive 
temperature, proteolytic activity is restored and A, C and small cored B capsids 
are formed (Rixon et al., 1988). These results suggest that cleavage o f the UL26.5
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Figure 4. Organisation Of The HSV-1 Genes UL26 And UL26.5.
The 3' coterminal transcripts are shown by arrows, which are overlayed by 
open boxes indicating the position of the open reading frames specifying the 
UL26 and UL26.5 gene products. Proteolytic cleavage sites a and b are indicated 
by vertical lines'*Cleavage of the UL26.5 gene product at site b gives rise to 
VP22a, whilst cleavage of the protease (UL26) at site a and b releases the capsid 
proteins VP21 and VP24. Reproduced from Rixon (1993).
#The codon numbers corresponding to the proteolytic cleavage sites a and b are 
also indicated.
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gene product is not required for the formation of intermediate capsids and that 
cleavage can occur after capsid assembly.
2. DNA Packaging
Electron microscopy studies indicate that DNA is packaged into preformed 
capsids, since ts mutants unable to package DNA are not defective in capsid 
assembly. (Addison et ah, 1984; 1990; Al-Kobaisi et al., 1991). Furthermore, 
mutants showing defects in DNA packaging also fa il to cleave DNA into unit 
length molecules, suggesting that simultaneous cleavage and packaging of 
v ira l DNA occurs (Preston et al., 1983; Addison et al., 1984; 1990; Sherman and 
Bachenheimer, 1988). Packaging of DNA and the removal o f VP22a and VP21 
from  B capsids appear to occur concurrently, as shown by experiments with 
tsl201 and other ts mutants deficient in DNA packaging (Preston et al., 1983; 
1992; Gibson and Roizman, 1972). Empty A capsids are considered to be the end 
products o f abortive DNA packaging. Replication of v ira l DNA results in the 
formation of high molecular weight concatemeric DNA which must be cleaved 
into un it length genomes p rio r to packaging. The signals required fo r DNA 
cleavage and packaging are located w ithin the a sequence (Stow et al., 1983; 
Varmuza and Smiley, 1985; Deiss et al., 1986; Deiss and Frenkel, 1986).
Two vira l gene products, Vmw273 and an unidentified v ira l protein, have 
been shown to interact w ith  the a sequence, and functions in  the DNA 
cleavage/packaging process have been suggested for these two proteins (Chou 
and Roizman, 1989). Previous data suggested a role for Vmw273 in the release of 
v ira l DNA from the capsid (Batterson et al., 1983). The UL6 (Weller et al., 1987), 
UL12 (Shao et al., 1993), UL15 (Poon and Roizman, 1993), UL21 (deWind et al., 
1992), UL25 (Addison et al., 1984), UL26 (Preston et al., 1983), UL28 (Addison et 
ai., 1990; Tengelsen et al., 1993), UL32 (Coen et al., 1984); UL33 (Al-Kobaisi et al., 
1991) gene products have been shown to be essential fo r the assembly of fu ll 
capsids, inasmuch as mutants in these genes form partia lly cored capsids which 
fail to package viral DNA
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3. T eg u m e n ta tio n
The intracellular sites w ith in which tegumentation occurs have not been 
iden tified . Recent reports have suggested that tegumentation o f human 
herpesvirus-6 (HHV-6) occurs w ith in intranuclear structures called tegusomes 
derived from cytoplasmic invaginations into the nucleus (Roffman et al, 1990). 
A sim ilar tegusome-like compartment has not been identified in HSV-1 infected 
cells. Since enveloped L-particles have not been observed w ith in the inner and 
outer nuclear lamellae, as would be expected i f  tegumentation were to occur in 
the nucleus, Rixon et a l (1992) proposed that assembly of the tegument occured 
in the cytoplasm either around a capsid or as independent condensations. These 
observations are in accordance w ith previous reports by Stackpole (1969) who 
showed capsids free in the cytoplasm at different stages of tegumentation.
4. E n ve lo p m e n t a nd  Egress
It is generally believed that in itia l envelopment o f DNA-containing 
capsids occurs at modified patches of the inner lamellae of the nuclear 
membrane (Darlington and Moss, 1969; Nii et al., 1968). The observation of 
naked capsids w ith in the cytoplasm of infected cells led some investigators to 
propose that capsids undergo a series of sequential envelopments and de­
envelopments as they proceed from the nucleus to the plasma membrane 
(Morgan et al., 1954; Nii etal., 1968; Cheung et al., 1991; Whealy et al., 1991). 
However, other authors argued that naked cytoplasmic capsids represent 
v irions whose envelopes have fused w ith cytoplasmic membranes and are 
arrested in the process of egress (Campadelli-Fiume et al., 1991).
Although, many investigators fa il to agree on the exact sequence of 
events involved in v ir ion  envelopment and egress, they have provided 
unquestionable evidence implicating the Golgi apparatus and Golgi-associated 
vesicles in v irion  maturation and transport to the cell exterior. D isruption of 
the host cell secretory apparatus with monensin or Brefeldin A prevents viral 
glycoprotein maturation, export to cytoplasmic membranes and v irion  egress 
(Johnson and Spear, 1982; Cheung etal., 1991; Whealy etal., 1991). Furthermore, 
virus maturation and egress were shown to be greatly impaired in cells which 
have defective Golgi glycosyltransferases (Campadelli-Fiume, 1982; Serafini-
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Cessi, 1983). The possibility that the egress of virions is directed, and mediated 
in part by viral proteins was recently suggested by Baines et al. (1991). These 
workers identified an HSV-1 putative membrane protein, the UL20 gene 
product, which is required for the efficient transport of virions from between 
the inner and outer lamellae into the extracellular space.
Section l.E  Alternative Products of HSV-1 
Infection
During Ficoll gradient centrifugation of HSV-1, two distinct bands were 
observed. The lower band comprised HSV-1 virions, whilst the upper, more 
diffuse band consisted of previously uncharacterized HSV-1 particles termed 
ligh t particles (L-particles) (Szilaygi and Cunningham, 1991). L-particles were 
la ter shown to lack capsids and v ira l DNA, consisting predom inantly of 
tegument and envelope proteins. Further studies revealed that certain proteins 
which do not exist in virions are present in L-particles. In particular, L- 
particles contain at least three phosphoproteins, including the IE protein 
Vm wl75, that are not detectable in virions (Szilaygi and Cunningham, 1991; 
McLauchlan and Rixon, 1992). Since L-particles contain proteins which are 
absent from virions, it is un like ly that they are the result of virions losing 
their capsids during sample preparation.
To determine whether L-particles and virions share sim ilar pathways of 
assembly, workers analysed the HSV-1 mutant tsl201 which at the NPT fails to 
produce virions and its capsids are restricted to the nucleus (Preston et al., 
1983). Since tsl201 was able to produce L-particles at the NPT in quantities 
s im ilar to those produced by wt virus (Rixon et al., 1992), these studies 
illustrated that L-particle formation is independent of virus assembly. Thus, the 
factors involved in the assembly of the tegument and acquisition o f the 
envelope are likely to be components of L-particles.
The role of L-particles in viral infectivity is unclear. Some authors have 
suggested that L-particles provide additional proteins which may facilitate 
infection. Indeed, recent studies have shown that L-particles are as effective as 
virions at supplying functional Vmw65 and vhs protein into cells (McLauchlan 
etal., 1992).
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2. Materials and 
Methods
Section 2. A Materials
1. V iruses
The HSV-1 wt virus used in this study was strain 17syn+ which has a non- 
syncytia l plaque morphology (Brown et al., 1973). Two HSV-1 temperature 
sensitive (ts) mutants of strain 17syn+ , 17ts l204 and 17rs 1213 were 
characterised. Tsl204 and tsl213 were each isolated from  an experiment in 
which a UV-mutagenized HSV-1 DNA fragment was recombined into wt HSV-1 
DNA. Since the ts l204  lesion did not map in the region of the genome 
corresponding to the mutagenized fragment it was considered to have arisen 
spontaneously (Matz et al., 1983, V.G.Preston unpublished results). The ts 
mutation in rsl213, on the other hand, mapped w ithin the same region of the 
genome that was mutagenized.
2. Tissue C u ltu re  Cells
Baby hamster kidney (BHK) 21 clone 13 cells, a fib rob lastic line 
established by MacPherson and Stoker (1962), and low passage HFL cells)(Flow 
2002) were used throughout this study. Cell lines were obtained from Dr V.G. 
Preston.
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3. Tissue C u ltu re  Media
BHK cells were grown in lx  Glasgow modified Eagle's medium (Busby et 
al., 1964) (supplied as a lOx concentrate by Gibco Ltd.), supplemented with 100 
un its /m l penicillin, lOOpg/ml streptomycin, 10% new born calf serum, and 10% 
tryptose phosphate. HFL cells were cultured in the same medium except that 
10% foetal calf serum and 1% non-essential amino acids were used instead of 
calf serum and tryptose phosphate. The following modified media supplemented 
with antibiotics were also used:
4. Bacteria
Escherichia coli strain DH5a(F', <j) 80d lacZ M l5, recA l, endAl, gyrA96, 
thi-1, hsdrlT  ( r 'k , m+k), supE44, re lA l, deoR, (lacZYA-argF) U169 was used for 
propagating plasmids.
5. Plasmids
The m u ltifunc tiona l phagemid, pT7T3 18U, was purchased from  
Pharmacia P-L Biochemicals, Milton Keynes, UK.
6. C hem ica ls
Chemicals were obtained from the following sources: BDH chemicals, 
Poole, England; Bio-Rad Laboratories, California, USA; Pharmacia Fine 
Chemicals, Uppsala, Sweden; and Sigma Chemical Co. Ltd., Dorset, UK. Reagents 
fo r electron microscopy were obtained Irom Agar Aids, Stanstead, Essex and 
Taab Laboratories, Emmer Green, Reading. Analytical grade reagents were used 
wherever possible.
Eagles medium containing n% new born calf serum 
Eagles medium containing n% foetal calf serum 
Eagles medium containing n% human serum
-ECn
-EFn
-EHn
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7 . Enzymes
Restriction and DNA modifying enzymes were supplied by Boehringer 
Mannheim Ltd, Germany. Lysozyme, DNase, and RNase were purchased from 
Sigma Chemical Co. Ltd.
8. O lig o n u c le o tid e s
EcoRI oligonucleotide linkers, pd(N)6 random primers, oligo dT12-is, M l3 
universal and reverse sequencing primers were all supplied by Pharmacia P-L 
Biochemicals, Milton Keynes, UK.
9. Antibodies
A polyclonal antiserum, specific to the UL25 gene product, was 
previously raised in a rabbit to an oligopeptide of 15 amino acid residues (David 
Smith unpublished results). The oligopeptide represented the region on the 
UL25 prote in  from  amino acid residues 135 to 150. A polyclonal rabbit 
oligopeptide antiserum, specific for the major DBP, was supplied by Dr Nigel 
Stow. TBS was generously supplied by Dr J. Macnab w ith in  the Institute. 
Isothiocyanate-conjugated goat anti-rabbit im m unoglobulin was purchased 
from Nordic Immunological Laboratories Ltd, Berkshire, UK.
10. Im m u n o lo g ic a l Reagents
A 10% w /v  suspension of formalin fixed Staphylococcus aureus was 
provided by Dr V.G.Preston.
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11. R ad iochem ica ls
All radiochemicals were obtained from Amersham International Pic.
12. M isce llaneous
The rat aspartate amino-transferase cDNA (MasPAT) was kindly supplied 
by Dr J. Macnab from w ithin the Institute. Hybond-Map Messenger A ffin ity  
Paper and cDNA Synthesis System Plus were supplied by Amersham 
International Pic, Buckinghamshire UK. Nuclease treated rabbit reticulocyte 
lysate and the TNT T7 Coupled Reticulocyte Lysate System were supplied by 
Promega. Photographic film  was obtained from Kodak Ltd., London, England. 
Plastic petri-dishes and 96-well m icro titre  plates were purchased from 
Nunclon Ltd. Plastic 850cm2 roller bottles used in cell culture were supplied by 
Becton Dickinson Ltd. Genescreen Plus nylon membrane was obtained from 
DuPont, Boston USA.
13. S ta n d a rd
Tissue Culture Reagents and Buffers.
Phosphate buffered 
saline (PBS)
Tris-saline
Trypsin
170mM NaCl, 3.4mM KC1, lOmM Na2 HP04 
and 2mM KH2 P04 pH 7.2 (Dulbecco and 
Vogt, 1954)
140mM NaCl, 30mM KC1, 28mM Na2 HP04 , 
1 mg/ml glucose, 100 un its/m l 
penicillin, lOO^ig/ml streptomycin,
25mM Tris-HCl pH 7.4.
0.25% (w/v) trypsin (Difco) in tris- 
saline, containing 0.002% (w /v) phenol 
red.
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Versene
DNA Gel Electrophoresis Buffers
Formyl dye
0.6mM EDTA dissolved in PBS 
containing 0.002% (w/v) phenol red.
0.1% (w/v) Bromophenol blue, 0.1% 
(w/v) Xylene-cyanol, 20mM Na2 EDTA 
in deionized formamide.
Alkaline loading buffer (6X)
Alkaline electrophoresis buffer
300mM NaOH, 6mM EDTA, 18% (w/v) 
Ficoll, 0.15% (w/v) bromophenol blue 
and 0.25% xylene-cyanol.
ImM EDTA pH 8.0, 50mM NaOH.
TAE buffer
Sequencing tank 
buffer (10X)
TE buffer
40mM Tris-acetate, ImM EDTA pH 8.0
890mM Tris-borate, 890mM boric acid, 
20mM EDTA pH 8.3
lOmM Tris-HCl pH7.4, O.lmM EDTA.
SDS-PAGE Solutions
Destain
Fix
Resolving gel buffer(4X) 
Stacking gel buffer (4X)
Boiling mix
Tank buffer
5% methanol, 7% acetic acid.
50% methanol, 7% acetic acid.
1500mM Tris-HCl pH 8.9, 0.4% (w/v) SDS.
490mM Tris-HCl pH 6.7, 0.4% (w/v) SDS
2% (w/v) SDS, 10% (v /v) glycerol, 5% 
(v/v) (3-mercaptoethanol, 50mM Tris-HCl 
pH 6.7, 0.004% (w/v) bromophenol blue.
53mM Tris, 53mM glycine, 0.1% (w/v) 
SDS.
Hybridisation Buffers
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Denhardt's buffer (5X)
0.8M Sodium phosphate buffer 
(pre-hybridisation buffer)
SSC buffer (10X)
RNA:DNA hybridisation 
buffer
Neutralising Buffer 
Denaturing buffer 
Immunoprecipitation Buffers 
RIPA bu ffer
Wash buffer
Bacterial Growth and Cloning Solutions 
L -b ro th
Ligation buffer (10X)
0.1% (vv/v) Ficoll, 0.1% (w/v) 
polyvinylpyrollidone, 0.1% (vv/v) BSA.
0.7M Na2HP04 ,0.15M NaH2P04.2H20 
(pH7.4).
3M NaCl, 300mM tri-sodium citrate, 
adjusted to pH 7.5 with 300mM citric acid
6X SSC, 2X Denhardt's buffer, 0.1% (w/v) 
SDS.
1.5M NaCl, 1M Tris-HCl pH 7.5 
1.5M NaCl, 0.5M NaOH.
0.1% (w/v) SDS, 1% (w/v) sodium 
deoxycholate, 1% (v/v) NP40, ImM EDTA, 
150mM NaCl, lOmM Tris-HCL pH 7.4.
600mM LiCl, lOOmM Tris-HCl pH 7.4, 1% 
(v/v) [3-mercaptoethanol.
170mM NaCl, 5g/l yeast extract, 10g/l 
Difco Bactotryptone, supplemented with 
25-50ng/ml of the appropriate 
antibiotic.
200mM Tris-HCl pH 7.5, lOOmM MgCl2 
lOOmM dithiotheritol (DTT) and 5mM 
ATP.
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STET buffer 
SOB
SOC
TFB
DTT buffer
RNA Purification Buffers 
Lysis buffer
TSE buffer
Miscellaneous 
Elution buffer
Sequencing gel top mix
8 % (w/v) sucrose, 5% (v/v) NP40, 50mM 
EDTA, 50mM Tris-HCl pH 8.0.
2% Difco Bactotryptone, 0.5% yeast 
extract, lOmM NaCl, 2.5mM KC1, lOmM 
MgCl2 and lOmM MgS04. SOB was 
sterilized by filtration.
SOB containing 20mM glucose, sterilized 
by filtration
lOmM K-MES, pH 6.2, lOOmM RbCl, 45mM 
MnCl2 , lOmM CaCl2 and 3mM 
HACO.CI3. and sterilized by filtration.
2.25M in 40mM potassium acetate pH6.0. 
The solution was sterilized by filtra tion
0.2M Tris-HCl pH 8.5, 0.14M NaCl, 2mM 
MgCl2, 5% NP40.
lOmM Tris-HCl pH 7.4, ImM EDTA and 
0.5% (w/v) SDS.
50mM Tris-HCl pH 7.5, lOOmM NaCl and 
0.5% (w/v) SDS.
150ml 40% polyacrylamide:N,N'- 
methylene bis acrylamide (20:1), 540g 
urea dissolved in water and made up to 
1 litre with 50ml 10X TBE. For 100ml of , 
gel mix 160|il 25% ammonium 
persulphate and 160(il TEMED were 
added.
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Oligonucleotide labelling 
buffer (5X)
250mM Tris-HCl pH 8.0, 25mM MgCb, 
5mM [3-mercaptoethanol, 2mM each of 
dATP, dGTP and dTTP, 1M HEPES pH 6 .6  
and pd(N ) 6 random primers (1  mg/ml).
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Section 2.B
1. C e ll C u ltu re
1.1 Growth Of Cells
BHK cells were grown at 37° in rotating plastic 850cm2 culture bottles 
containing 200ml ETC10 in an atmosphere of 5% C02, 95% air. A confluent 
monolayer of approximately 3 x 10s cells was sufficient to seed five 850cm2 
bottles. Before harvesting the cell monolayers were washed once w ith 20ml 
versene followed by 40ml trypsin:versene (1:1 v/v). The detached cells were 
resuspended in tissue culture medium.
HFL cells were grown in a similar manner to BHK cells using EF10 as 
culture medium. Non-essential amino acids (1% v /v) were added to EF10 every 
second cell passage. A confluent monolayer of l x l0 8 cells was sufficient to 
seed four 850cm2 culture bottles.
Both BHK and HFL cells were seeded onto 90mm, 50mm, and 35mm petri 
dishes at densities of 1.5xl07, 2 x l0 6, and lx lO 6 cells per dish respectively, to 
obtain 75% confluent monolayers in 24 hrs.
1.2 Cell Storage
A ll cell lines were stored at -140°. Cells were harvested as previously 
described, pelleted and resuspended in tissue culture medium containing 1 0 % 
(v /v ) DMSO, at a concentration of 107 cells/ml storage medium. Cells, stored in 
vials, were frozen slowly to -140°.
Cells were recovered by thawing the contents o f the via l rapid ly, 
washing the cells in culture medium to remove the DMSO and fina lly  
resuspending the cells in fresh culture medium.
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2. V iru s  C u ltu re  A n d  P u r if ic a tio n
2.1 Production Of Virus Stocks.
A 90% confluent monolayer of BHK cells in a 850cm2 plastic bottle was 
infected with virus at a moi of 0.003 pfu/cell in 20mls of EC10 and incubated 
for 2-4 days at 31° until the cells exhibited obvious CPE. The infected cells were 
pelleted by centrifugation at 1500 rpm at 4° fo r 10 min. Cell-associated virus 
was prepared by sonicating the cell pellet until it was homogenous. Debris was 
removed by centrifugation at 1500rpm at 4° for 10 min. The cell associated 
virus stock was divided into aliquots and frozen at -70°.
The clarified culture medium was centrifuged in a Sorvall GSA rotor at 
12000rpm at 4° for 2 hrs to pellet cell-released virus. The cell-released virus 
was resuspended in 2ml EC 10 by sonication, divided into aliquots and stored at 
-70°.
2.2 Virus Sterility
The s te rility  o f virus stocks was checked by streaking a sample onto 
blood agar plates and incubating the plates at 31° for 3-5 days. Any virus 
stocks containing bacteria which grew on blood agar were discarded.
2.3 Titration Of Virus Stocks
Monolayers of BHK cells, seeded with 2 x l0 6 cells per 50mm petri dish, 
were infected in duplicate with serial 1 0 -fold dilutions of virus in lOOjil PBS, 
4% calf serum. Titrations of the ts mutants used in this study were carried out 
at 31°, the permissive temperature (PT), and 38.5°, the non-permissive 
temperature (NPT). After 1 hr incubation at the required temperature, the 
plates were overlaid w ith 4ml EH5 to prevent secondary plaque formation. 
Infected monolayers were incubated for 3 days at 31° or 2 days at 38.5° and 
then stained w ith Giemsa stain. The plates were washed w ith  water after 30 
min and the plaques counted using a dissection microscope.
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2.4 Preparation O f Purified Radiolabelled Virions A nd L- Particles.
Confluent BHK monolayers in 850cm2 roller bottles were infected w ith a 
moi of 0.002 pfu of virus per cell in 20ml EC10. At 7 hrs post-infection at 31° 
the culture medium was removed and replaced with EC1 containing 1/5 the 
normal concentration of methionine and the cells incubated for a fu rthe r 2 
hrs. [35S]-m ethionine (500^iCi ) was added to each ro lle r bottle and
incubation at 31° was continued overnight. A fu rthe r 500|iC i/m l of [35S]- 
methionine was added to each ro ller bottle and the incubation continued for 
another 24 hrs.
The infected cells were pelleted at 1500 rpm at 4° for 10 min and the 
supernatant centrifuged at 12000 rpm at 4° for 2 hrs in a Sorvall GSA rotor to 
concentrate cell-released virus particles. The pelleted virus was resuspended 
in EC5 without phenol-red.
Virus and L-particles were purified by centrifugation through a 5-15% 
Ficoll 400 gradient as described by Szilagyi and Cunningham (1991). Gradients 
(35m l) were prepared in EC1 w ithout phenol-red in cellulose n itra te  
centrifugation tubes. The crude virus preparation was layered gently onto the 
gradient surface and spun at 12000rpm at 15° for 2 hrs in a Sorval OTD-50 
Ultracentrifuge using an AH629 rotor. Following centrifugation, the v irion  
band (lower) and the L-particle band (upper) were visualized by shining a 
high intensity light from above and removed by insertion of a wide bore 
needle through the wall of the tube. The virion and L-particles were pelleted 
in EC1 w ithout phenol-red at 18000 rpm at 4° for 1 hr in a TST41 rotor. The 
virus and L-particle pellets were resuspended in EC1 w ithout phenol-red, 
containing lOmM Hepes pH7.4 and stored at -70°.
2.5 Virus Particle Counts
A 5ul aliquot of a virus particle preparation was mixed w ith  equal 
volumes o f a latex bead suspension (of known concentra tion) and 
phosphotungstic acid. A sample was spotted onto a parlodium coated copper 
grid, a ir dried and visualised under an electron microscope. The number of 
virus particles relative to latex beads were determined from at least 1 0  fields of 
the grid and the number of virus particles per ml calculated.
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3. H a n d lin g  ts M u ta n t In fe c tio n s
Infections with ts mutants used in this study were carried out at 31° (PT) 
and 38 .5°/ 39.7° (NPT). Cell monolayers were placed at the required 
tem perature fo r at least 20 m in p rio r to infection. A ll media fo r cell 
monolayer manipulations were prewarmed to the required temperature 
before use. Manipulations involving virus-infected cells were carried out as 
rapidly as possible, and incubator temperatures monitored regularly.
4. P o lye th y le n e  G lyco l T re a tm e n t O f V iru s -In fe c te d  Cells
Polyethylene glycol (PEG) treatm ent o f v irus-in fected cells was 
performed essentially as previously described by Sarmiento et al. (1979) with 
modifications described by Addison et al. (1984). Briefly, HFL cells seeded 
sparsely on 13mm coverslips were infected with 5 pfu of virus per cell at the 
required temperature. After 1 hr adsorbtion, unbound virus was removed by 
washing the monolayer once with PBS. The virus-infected cells were treated 
w ith PBS containing 50% (w/v) PEG 6000 for 1 min. Further washes with ECo 
containing decreasing amounts of PEG were carried out as described by 
Sarmiento etal., (1979). Following this treatment the cells were incubated for 
a fu rthe r 4 hrs in growth medium before being fixed in methanohacetone (3:1 
v /v ) fo r immunofluorescence assay.
5. D e te rg e n t E x tra c tion  Of Virion
fvU i6«e4
NP-40, at a final concentration of 1%, was added to^virus resuspended in 
EC1 w ithout phenol red. The sample was incubated on ice for 30 min then spun 
in a microfuge at 4° for 10 min. The supernatant and the pelleted fractions 
were made up to equal volumes in Eagles medium w ithout phenol-red, then 
mixed thoroughly with an equal volume of 2x RIPA buffer. The fractions were 
sonicated and stored at -70°.
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6. A n a lys is  O f V irus -Induced  P o lypep tides
6.1 Preparation Of Radiolabelled Virus-Infected Cell Extracts.
Confluent BHK or HFL monolayers were infected w ith virus at a moi of 
20 pfu per cell at the required temperature. After 1 hr incubation to allow the 
virus to adsorb to the cells, the monolayers were ove.flou‘4  w ith growth 
medium until the appropriate labelling time.
6.2 Preparation Of Radiolabelled Early Virus-Infected Cell Extracts
Virus-infected cell polypeptides, synthesized in the absence of viral 
DNA rep lica tion , were prepared by treating v irus-in fected cells w ith 
phosphonoacetic acid (PAA). Cells were infected w ith virus at a moi of 20 pfu 
per cell. After 1 hr the monolayers were overlaid w ith growth medium until 
the appropria te labelling time. Virus absorbtion and the subsequent 
incubation steps were carried out in the continuous presence of PAA.
6.3 Pulse Labelling Virus-Infected Cell Polypeptides With [35S]- 
Methionine.
At the required labelling time, growth medium was removed from the 
cell monolayers, cells were washed twice w ith PBS and incubated in PBS 
containing lOOuCi/ml [35S]-methionine. After 15 min or 60 min, the cells were 
washed 3x in PBS and harvested immediately in the appropriate lysis buffer or 
incubated further in tissue culture medium.
6.4 Harvesting Virus-Infected Cell Extracts.
Virus-infected cell extracts were harvested in 500^1 o f lysis buffer per 
35mm dish and the samples boiled for 5 min imm ediately p rio r to SDS- 
po lyacry lam ide  gel electrophoresis. Extracts fo r im m unoprec ip ita tion
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analysis were prepared as described in section 2B7.1. All radiolabelled infected 
cell extracts were stored at -2 0 ° prior to analysis.
7. Im m u n o lo g ic a l A n a lys is  O f V ira l P o lyp e p tid e s
7.1 Immunoprecipitation
Radiolabelled cell monolayers were harvested into 500jil of RIPA buffer, 
transferred to glass vials and sonicated un til homogenous. The extracts were 
centrifuged in 2ml Beckman TLA. 100 tubes at 50000 rpm for 30 min at 4 ° in a 
Beckman TL-100 centrifuge to remove cell debris and protein aggregates. The 
supernatant was stored on ice p rio r to analysis. The im m unoprecipitation 
procedure was based on a method described by Kessler (1975). A volume of 
labelled cell extract ranging from 5 x l0 5 to lx lO 6 cpm, was incubated w ith the 
required d ilu tion of rabbit polyclonal antibody or mouse monoclonal antibody 
fo r 1 hr at 4°. Rabbit polyclonal antiserum was spun at 50000 rpm at 4° for 30 
min p rio r to addition to the labelled cell extracts. Typically, 50pl of polyclonal 
sera, diluted 1 in 10, was added to 200^1 of labelled cell extract. A volume of 
lOOpl of prewashed Staphylococcus aureus (10% w/v) was added to the tubes to 
bind the immune complexes and the samples incubated on ice fo r 1 hr. The 
bacteria were washed 3x for 5 min in 700pl lith ium  chloride wash buffer. The 
pelleted bacteria were resuspended in 40pl of boiling mix, heated to 100° for 5 
m in and centrifuged fo r 5 min in a microfuge. The imm unoprecipitated 
proteins in the supernatant were analyzed by SDS-PAGE and visualized by 
fluorography.
7.2 Immunofluorescence
HFL cells on 13 mm coverslips were infected with a moi o f 5 pfu of virus 
per cell. At the required time post-infection the coverslips were removed 
from  the growth medium and fixed for 1 0  min in a solution o f methanol: 
acetone (3:1) at -20°. The coverslips were washed 3x in PBS before use and not 
allowed to d ry  out at any stage of the assay. V irus-infected cells were
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incubated with 50pl of monoclonal antibody (diluted 1 in 30) for 30 min at RT. 
Cells were washed 6 x in PBS, then treated w ith  50|il fluo resce in  
isothiocyanate-conjugated (FITC) goat anti-mouse imm unoglobulin (1 /40 
d ilu tion), and incubated for a fu rthe r 30 min at RT. The coverslips were 
fina lly  washed 6 x in PBS and mounted in 50% glycerol in PBS on glass slides. 
Fluorescence was visualised under a Nikon Microphot-SA microscope.
8. SD S -P olyacrylam ide Gel E lec trophores is
A stock of 30% polyacrylamide, containing a ratio of acrylamide to 
c ro s s -lin k in g  agent (N ,N '-m e thy lene  b is -a c ry la m id e  or N ,N '- 
diallyltartardiam ide) of 40:1, filtered through Whatman nol filte r paper, was 
used fo r analysis of proteins. A fina l concentration of 9% polyacrylamide in 
resolving gel buffer was prepared. Polymerisation was achieved by the 
addition of ammonium persulphate (APS) (0.006% w /v) and TEMED (0.004% 
v /v ) to the gel solution just before pouring. The gel was overlayed w ith 
resolving gel buffer, to ensure a smooth interface upon polymerisation. A 
stacking gel, containing 5% polyacrylamide in stacking gel buffer, was 
prepared shortly  before sample loading. Wells were formed w ith Teflon 
combs. Protein samples were denatured by boiling for 5 min in boiling mix 
and centrifuged for 5 min before loading. Denatured proteins were separated 
by electrophoresis at either 0.45mA/cm2 for 3-4 hrs or 0.09mA/cm2 for 18 hrs 
in freshly prepared electrophoresis buffer.
9. F lu o ro g ra p h y
Gels were washed three times in a 1:1 mixture of fix and destain fo r 20 
min each wash then dried immediately or soaked in En3hance (New England 
Nuclear, Boston. USA) fo r 1 hr at RT. Gels, soaked in En3hance, were rinsed 
thoroughly in deionized water fo r 5 min. Finally, gels were dried under 
vacuum at 80° onto sheets of Whatman 3mm paper and placed in contact with 
Kodak X-omat XS-1 film  in conjunction with an intensifying screen at -70°-
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10. Preparation Of Radiolabelled DNA Probes.
10.1 Synthesis Of Radiolabelled Probes By Primer Extension.
DNA (10ng-200ng) in a volume of 20pl was boiled for 10 min, cooled to 
RT, then mixed with lx  oligo labelling buffer, BSA (0.4mg/ml), [a-32P]-dCTP 
(50fiC i) and 6  units of Klenow polymerase (LFP-labelling grade) in a final 
volume of 50^1. The reaction was incubated overnight at RT, boiled for 5 min, 
then chilled on ice immediately before use. Since 90% of the labelled dNTP is 
usually incorporated into DNA during the incubation step, the labelled DNA 
probe was not purified before use.
10.2 Synthesis Of cDNA Probes Complementary To PolyA+ RNA Using 
Oligo dT12-18 As Primer.
PolyA+ RNA ( ljug) in RNAse free water was heated to 70° for 5 min, then 
rap id ly  cooled on ice. The chilled polyA+ RNA was added to a reaction mix 
containing a final concentration of 0.5u/|d of RNAsin (Promega), 50ng oligo 
dT12. 18 primer, 20mM dGTP, dATP and dTTP, 120pM dCTP, 50nCi/ml [32P]-dCTP, 200 
units o f moloney murine leukaemia virus reverse transcriptase (Pharmacia) 
in  lx  reverse transcription buffer in a volume of 25jil. The reaction was 
incubated for 1 hr at 37° then stopped by the addition of EDTA pH8.0 to a final 
concentration of 20mM. The radiolabelled probe was separated from the 
unincorporated dNTPs using Geneclean II described later in section 2B13.4. 
The radiolabelled cDNA was used without denaturation in hybridisations.
10.3 [32P]-Labelling Of DNA Termini
Plasmid DNA was digested with the desired restriction enzyme in the 
app rop ria te  buffer. Three of the fou r dNTPs were added at fina l 
concentrations of 80jiM, together with 2|iCi of the fourth [a-32P]-dNTP and 2 
units of T4 DNA polymerase. After incubation for 15 min at RT, the sample was 
heated to 70° for 5 min to terminate the reaction. The end labelled DNA
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fragments were separated by DNA gel electrophoresis and the fragments 
identified by autoradiography.
11. C o n s tru c tio n  A n d  Screen ing O f A  cDNA L ib ra ry
11.1 Isolation Of Total Virus-Infected Cell Cytoplasmic RNA.
Total cytoplasmic virus-infected cell RNA was isolated essentially as 
described previously by Preston et al. (1979). HFL cell monolayers in 90mm 
petri-dishes were infected with virus at a moi of 20 pfu per cell. After 1 hr 
virus absorbtion, the cells were overlaid w ith EF10 and incubated at the 
required temperature for a further 6 hrs. The plates were placed immediately 
on ice and washed twice with ice cold PBS. The cells were scraped from the 
plates w ith rubber policemen and pelleted by centrifugation at 1500rpm at 4° 
fo r 10 min. Five volumes of cell lysis buffer was added to the pelleted cells and 
the sample drawn back and forth 4x through a 10ml plastic syringe to disrupt 
the pellet. The resulting cell lysate was centrifuged at 2500rpm at 4° for 10 
min and the supernatant added to 5ml TSE, 15ml phenokchloroform (1:1) and 
10ml RNAse free water. The suspension was gently shaken in te rm itten tly  for 
10 min at RT, then centrifuged at 2500rpm at RT for 10 min. The aqueous phase 
was retained and extracted twice with an equal volume of phenohchloroform 
(1:1). F inally, the cytoplasmic RNA was extracted w ith  chloroform  and 
precipitated overnight at -20° in the presence of 0.1M NaCl and 2 volumes of 
ethanol. RNA was pelleted, washed with 70% ethanol and dried before being 
resuspended in RNAse free water containing RNAsin (Promega) at a final 
concentration o f 0.5units/p.l. Total cytoplasmic RNA was stored in aliquots at 
-70°-. The integrity of the RNA was assessed by translation of the RNA in vitro 
and by analysis of the products of first strand cDNA synthesis described in 
sections 2B11.3 and 2B11.4 respectively.
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11.2 Selection O f PolyA+ RNA From Total Cytoplasmic RNA
PolyA4- RNA was purified from total cytoplasmic RNA using Hybond- 
mAP-Messenger A ffin ity  Paper (Amersham), according to the protocol 
supplied which was based on the method described by Wreschner and 
Herzberg (1984). Briefly, the total RNA preparation was spotted onto an 
appropriately sized piece of paper and allowed to air dry. The dried paper was 
washed twice in a solution containing O.IM NaCl to remove po lyA ' RNA, 
followed by a brie f wash in 70% ethanol to remove the salt. The paper bound 
PolyA+ RNA was eluted into RNAse free water by heating to 70° for 5 min. 
RNAsin (Promega) was added to the eluted PolyA+ RNA to a final concentration 
of 0.5 units/pl, and the RNA was aliquoted and stored at -70°. Prior to use, all 
wash solutions were incubated in 0.1% (v/v) DEPC at RT for 12 hrs and then 
autoclaved. The integrity of the polyA+ RNA was assessed as for total RNA.
11.3 Translation OfPolyA+ RNA In Vitro
The nuclease treated rabbit reticulocyte lysate in vitro translation 
system supplied by Promega was used to translate polyA+ RNA. Up to 5pg of 
PolyA+ RNA was added to a reaction mixture containing 70% nuclease treated 
rabbit reticulocyte lysate, 0.02mM of each amino-acid except methionine and 
0.8mCi/ml [35S] -methionine in a volume of 25|il. The sample was incubated at 
30° fo r 1 hr. The reaction was terminated by the addition of an equal volume 
of boiling mix and the translation products analysed by SDS-PAGE.
11.4 First Strand cDNA Synthesis
First strand cDNA synthesis, using polyA+ RNA as template and oligo 
d T i2- i8 as prim er, was carried out as described in section 2B10.2. Single 
stranded DNA samples in 0.2 volumes of formyl dye were analyzed by 
electrophoresis through a 0.7% alkaline agarose gel.
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11.5 Double Stranded cDNA Synthesis
Double stranded cDNA was synthesized from 3ng of polyA+ RNA using 
the cDNA Synthesis System Plus (Amersham), according to the protocol 
supplied. A summary of the steps involved in cDNA synthesis are shown in 
Figure 5. Briefly, 5^g of mRNA was added to a first strand synthesis reaction 
mix containing oligo dT12_i8 and 2 0  units of reverse transcriptase in a volume 
of 50jil. The reaction was incubated at 42° for 1 hr and then chilled on ice. 
Second strand reaction buffer containing 4 units of E. coli ribonuclease H and 
115 units of E. coli DNA polymerase was added to the chilled sample to a final 
volume of 250|d and the sample was incubated sequentially at 12° for 60 min 
and 22° for 60 min. E. coli RNAse H was used to nick the RNA in the RNA:DNA 
hybrid. The E. coli DNA polymerase utilises the nicked RNA as a prim er in the 
synthesis of the second DNA strand. The reaction was terminated by heating 
the sample to 70° fo r 10 min and then chilled on ice. T4 DNA polymerase (2 
units per microgram of original mRNA template) was added to the chilled 
sample and incubated at 37° for 10 min to remove any small remaining 3' 
overhangs from the firs t strand cDNA. Finally, EDTA pHS.O was added to the 
sample to a final concentration of lOmM to terminate the reaction. The double 
stranded cDNA was purified through a small Sephadex G50 column.
The success of the first and second cDNA strand synthesis reactions was 
monitored by incorporating 5|iCi of a-[32P]-dCTP into the first and second cDNA 
synthesis steps. Once each incubation step was complete, small aliquots of the 
reactions were removed to assess the efficiency of cDNA synthesis in terms of 
yields of cDNA synthesised and the size of cDNA molecules obtained. The yields 
o f cDNA were determined by calculating the percentage of [32P]-dCTP 
incorporation into DNA and the size of cDNA molecules obtained estimated by 
alkaline agarose gel electrophoresis.
11.6 Ligation Of Synthetic EcoRI Linkers To cDNA
Double stranded cDNA was dissolved in a minimal volume of water. A 
lOOx molar excess of EcoRI synthetic phosphorylated linkers (Pharmacia) 
relative to cDNA was incubated with the cDNA overnight at 14° in a 20^ .1 
reaction containing 1 un it of T4 DNA ligase in ligation buffer. The ligation 
reaction was heated to 70° for 15 min to denature the ligase, cooled to 37° and
Figure  .5 . Diagrammatic Representation Of The Steps Involved In 
The Synthesis Of Double Stranded cDNA
1) The firs t cDNA strand is synthesized by reverse transcriptase using the 
polyA+ RNA as a template and an oligo dT primer.
2) E. coli RNase H is used to produce nicks and gaps in the RNA strand of the 
RNA:DNA hybrid. The nicked RNA is used as a primer for DNA synthesis and 
repair by R coli DNA polymerase I.
3) The 3 -5 ‘ exonuclease activ ity of T4 DNA polymerase removes any small 
remaining 3' protruding ends from the firs t strand cDNA.
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the cDNA digested with EcoRI in the appropriate buffer. Recombinant cDNA 
molecules were purified from the excess linkers using Geneclean II described 
in section 2B13.4.
11.7 Insertion Of Recombinant cDNA Molecules Into pT7T3 18U 
Phagemid Vector
A 3-fo ld  excess of recombinant cDNA was ligated to the de- 
phosphorylated EcoRI cleaved phagemid vector pT7T3 18U (Pharmacia) in a 
20 jil reaction volume containing 1 unit of T4 DNA ligase and ligation buffer. 
The ligation mix was incubated for 16 hrs at 4°, heated to 70° for 15 min and 
the DNA transfected into competent E. coli.
11.8 Transformation Of Competent E.coli
Competent £  coli (DH5a) were prepared essentially as described in the 
procedure of Hanahan (1983). SOB broth (6.5mls) was inoculated with a single 
bacterial colony and shaken at 37° for 2-3 hrs. The culture was chilled on ice 
fo r 10 min p rio r to centrifugation at 2500rpm at 4° for 12 min. The bacterial 
pellet was vortexed gently in 2ml TFB and placed on ice for 10 min p rio r to 
centrifugation at 2500rpm at 4° fo r 10 min. The pellet was resuspended in 
0.5ml TFB and incubated on ice for 5 min. DMSO (4% v/v) was added to the 
suspension which was incubated on ice for 5 min before addition of DTT 
bu ffer to a fina l concentration of 75mM. The suspension was incubated for a 
fu rth e r 10 min on ice, then DMSO (4% v /v ) was added and incubation 
continued fo r 5 min. The competency of the bacteria in transfection assays 
was tested using uncleaved pUC18 DNA. A 50}il volume of competent cell 
suspension was mixed with lOng of pUC18 plasmid DNA and incubated on ice 
fo r 30min. A fter heat shock treatment at 42° for 90 sec, the bacteria were 
added to 4 volumes of SOC and shaken at 37° for 1 hr before being plated onto 
L-bro th  agar containing 1 0 0 ng/m l am pic illin . Plates were incubated 
overnight at 37°. Routinely, lx lO 9 colonies per |ig plasmid DNA were obtained. 
Competent bacteria were stored at -70° in SOB containing DMSO (75|il per ml of 
bacterial suspension).
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11.9 Amplification And Storage Of Phagmid cDNA Library
Transformed bacterial colonies, grown on L-broth agar plates, were 
picked ind iv idua lly  w ith sterile toothpicks into 200pl L-broth containing 
100|ig /m l am picillin  in 96-well m icrotitre plate. The m icrotitre plate was 
covered with Titertek plate sealers (Flow) to prevent cross contamination, and 
incubated overnight at 37°. Following incubation, a duplicate plate was seeded 
and incubated overnight at 37°. Sterile glycerol was added to the wells of the 
orig inal m icrotitre plate to a final concentration of 15% (v/v). The plate was 
sealed, shaken vigorously then frozen at -70°. The duplicate m icrotitre plate 
was stored at 4° un til recombinant clones were screened according to the 
protocol described in section 2B13.1c and 2B13.3. This procedure generally 
produces a m illion fold amplification of the library.
11.10 Coupled In Vitro Transcription And Translation System
The cDNA molecules, cloned downstream from  the T7 or T3 RNA 
polymerase promoter in pT7T3 18U m ultifunctional phagemid (Pharmacia), 
were transcribed and translated in vitro as previously described by Krieg et 
ah, (1984), using the TNT Coupled Reticulocyte Lysate System (Promega) 
according to the protocol supplied. Briefly, circular recombinant pT7T3 18U 
DNA ( l^ g  per reaction) was added to a total reaction volume of 50[il containing 
50% TNT rabbit reticulocyte lysate, 40 units of T7 or T3 RNA polymerase, 20mM 
of each amino acid except methionine and 0.8mCi/ml of [35S]-methionine and 
incubated at 30° for 2 hrs. The protein products were analysed by SDS-PAGE 
and autoradiography.
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12. N u c le ic  A c id  F ilte r  Hybridisation
12.1 Transfer Of DMA
a) Southern Transfer
The procedure followed was essentially that of Southern (1975) in which 
single stranded DNA was mobilised onto Genescreen Plus nylon membrane 
(DuPont). The agarose gel containing the separated DNA fragments was 
shaken gently in DNA denaturing buffer fo r 30 min at RT and neutralized in 
DNA neutralizing buffer for 30 min at RT with gentle agitation. The gel was 
then transferred onto 2 sheets of Whatman 3mm filte r paper which were in 
contact with, but not covered by, lOx SSC buffer. A sheet of Genescreen Plus 
nylon membrane, the exact size of the gel, was moistened with deionized 
water, soaked in lOx SSC for 15 min, and then placed on top of the gel. Two 
sheets of 3mm paper, cut 2mm smaller than the gel, were placed on top of the 
membrane. Finally, a weighted stack of cut paper towels, approximately 5cm 
deep, was laid on top of the Whatman paper. At least 12 hrs later, the 
membrane was removed, rinsed in 2x SSC and air dried. Efficient transfer of 
DNA fragments from the gel was monitored by visualising the ethidium  
bromide restained blotted gel under UV light. The DNA immobilized on the 
membrane was then hybridized to the appropriate 32P-labelled DNA probe.
b) Dot Blot Transfer of DNA
A piece of Genescreen Plus nylon membrane and filte r paper pad were 
cut to f it  either a dot or slot blot manifold. The membrane and filte r pad were 
soaked in 0.4M Tris-HCl pH7.5 for 30 min at RT. Meanwhile, the DNA was 
denatured in 0.25N NaOH for 10 min at RT, chilled on ice, then diluted to the 
desired concentration in 0.125N NaOH, 0.125x SSC. The pre-soaked membrane 
and f ilte r  pad were fitted into the manifold and the DNA added to the 
appropriate wells. The DNA solution was left in the wells fo r 30 min, after 
which time a gentle suction was applied to the m anifold fo r 30 sec. The 
membrane was removed from the manifold and a ir dried. The filters were 
hybridized to the appropriate 32P-labelled DNA probe.
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c) Lysis of Bacteria and Binding of Bacterial DNA to Nylon Membranes.
A piece of Genescreen Plus nylon membrane and filte r pad were cut to 
f i t  a 96 well dot blot manifold (Schleicher and Schnell) and moistened with 
water. The membrane and filte r pad were placed in the manifold. A volume of 
50 fil of bacterial suspension was added to each well of the manifold. The 
bacterial suspension was allowed to remain in the wells w ithout suction for 30 
min, after which time a gentle suction was applied for 1 min. The membrane 
was removed from the manifold and placed colony side up for 3 min on a stack 
o f 3mm paper impregnated with 10% SDS (w /v). This treatment lim ited the 
diffusion of the DNA during denaturation and neutralisation steps, resulting 
in a sharper hybridization signal. The membrane was placed onto 3mm paper 
saturated with denaturing solution and the bacteria allowed to lyse for 5 min. 
The membrane was then transferred colony side up to 3mm paper soaked in 
neutralising solution fo r 5 min. Finally, the membrane was placed on 3mm 
paper saturated w ith 2 x SSC and left for a fu rthe r 5 min. The air dried 
membrane was washed brie fly  in chloroform to remove bacterial debris, 
rinsed in 2 x SSC and air dried again. The membranes were then hybridized to 
the appropriate 32P-labelled DNA probe.
12.2 Transfer Of RNA
A piece of Genescreen Plus nylon membrane and f ilte r  pad of 
appropriate size for a slot blot manifold (Schleicher and Schnell) were soaked 
in deionized water for 15 min. RNA was dissolved in 50% deionized formamide, 
6 % formaldehyde, and incubated at 50° for 1 hr to denature the RNA. The RNA 
was chilled on ice, diluted in deionized water to the desired concentration and 
added to the wells of the RNA slot blot manifold, containing the pre-soaked 
membrane and filte r pad. The RNA was allowed to to remain on the membrane 
fo r 30 min before a gentle suction was applied. After 30 sec the membrane was 
removed from the manifold, air dried and baked at 80° for 2 hrs to remove the 
formaldehyde. Hybridisation with an appropriate 32P-labelled probe was then 
performed.
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12.3 DNA:DNA Hybrid iza tion
DNA:DNA hybridizations were carried out in sealed plastic bags 
submerged in a shaking water bath. The membranes were incubated in pre­
hybridisation buffer (0.5M sodium phosphate buffer, 7% SDS (w /v)) for 2 hrs 
at 65°. The 32P-labelled DNA probe was boiled for 5 min to denature the DNA, 
then chilled rapidly on ice. The denatured DNA probe was added directly to the 
pre-hybridisation buffer. The membranes were incubated overnight at 65° 
w ith continuous shaking. Between 2 x l0 5 and lx lO 6 cpm of 32P-labelled probe 
(specific activity >5x l07 cpm/^ig DNA) was used per ml of hybridisation buffer. 
Following hybridisation, the membranes were removed from the plastic bags 
and washed 3x in 0.01M sodium phosphate buffer containing 0.1% SDS (w/v) at 
65° for 45 min each wash. After the final wash the membranes were rinsed 
brie fly  in deionized water then air dried. Membranes, covered with cling film , 
were placed in contact w ith Xomat XS-1 film  (Kodak) in conjunction w ith a 
DuPont phosphotungstate intensifying screen at -70°.
12.4 DNA'.RNA Hybridisation
RNA, transferred to nylon membranes, was hybridized to the desired 
32P-labelled DNA probe. Membranes were incubated for 2 hrs at 6 8 ° in pre­
hybridisation buffer (6 X SSC containing 2X Denhardts buffer, 0.1% SDS (w /v)) 
in sealed plastic bags submerged in a shaking water bath. 32P-labelled double 
stranded DNA probes were boiled fo r 5 min, cooled rapidly on ice, and added 
d irectly to the pre-hybridisation buffer. After an overnight hybridisation at 
6 8 °, membranes were removed from the bags and washed once in lx  SSC for 20 
min at RT, then washed three times in 0.2x SSC for 20 min at 6 8 °. All washes 
contained 0.1% SDS (w/v). Membranes were rinsed briefly in deionized water, 
air dried and placed in contact w ith Kodak X-omat XS-1 film  in conjunction 
with a DuPont phosphotungstate intensifying screen at -70°.
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13. R eco m b in an t DNA Technique
13.1 Restriction Enzyme Digestion Of DNA
Restriction endonuclease digestions were carried out under the 
conditions specified by the suppliers for each enzyme.
13.2 Deph osph oryla tion Of Lin earised Vector DNA
Vector DNA was linearized with the appropriate restriction enzyme and 
treated w ith calf intestinal phosphatase at a concentration of 5units/ fig DNA 
in the presence of 20mM Tris.HCl pH8.0 and 40mM NaCl. The reaction was 
incubated at 37° for 1 hr. Linear, dephosphorylated vector DNA was purified 
using Geneclean II.
13.3 Construction Of Recombinant Phagemids
Linear, dephosphorylated vector DNA was incubated with a 3-fold molar 
excess of the required DNA fragment overnight at 14° in a 20|il ligation 
reaction containing 1 un it o f T4 DNA ligase in ligase buffer. Blunt ended 
ligations were performed in a sim ilar manner except that a 2-4 fo ld molar 
excess of linear vector relative to the purified insert was used and incubations 
were performed for 4 hrs at RT.
13.4 Purification Of DNA Using Geneclean II K it
The Geneclean II k it was used to purify "miniprep" plasmid DNA prio r to 
sequencing and to elute DNA fragments from agarose gel slices. Briefly, three 
volumes of sodium iodide solution supplied with the kit was added to the DNA 
preparation. A volume of 5|il of glass bead matrix ("Glassmilk") per fig of DNA 
was added to the DNA in solution and the sample incubated on ice fo r 5 min. 
The glass bead m atrix binds to single stranded and double stranded DNA
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without binding DNA contaminants. The bound DNA was washed 3x with wash 
buffer, then eluted in TE by heating to 55° for 5 min.
13.5 Partial Digestion Of 32P End-Labelled DNA
Approximately lx lO 5 cpm of 32P-labelled DNA fragment was digested 
w ith decreasing concentrations of the desired enzyme (10-0.25 units) in a 
fina l reaction volume of 20^1. The digests were incubated at 37° fo r 15 min, 
pooled and analyzed on a 5% non-denaturing polyacrylam ide gel. A fter 
electrophoresis, the gel was dried under vacuum and placed in contact w ith 
Kodak X-omat XS-1 film  at -70° to obtain an autoradiographic image of the 
digest.
13.6 Small Scale Preparation Of Plasmid DNA
Small amounts of plasmid DNA were prepared using the method of 
Chowdhury (1991). Single bacterial colonies were inoculated into 2ml L-broth 
containing 35-50pg/ml ampicillin and incubated in an orbital shaker at 37° 
fo r 16-18 hrs. A volume of 500|il of bacterial suspension was vortexed 
v ig o ro u s ly  w ith  an equa l vo lu m e  o f a m ix tu re  o f 
phenol:chloroform:isoamylalcohol (25:24:1) and the aqueous phase separated 
from  the phenol phase by centrifugation in a microfuge. The phenol was 
saturated w ith  TE p rio r to mixing w ith chloroform  and isoamylalcohol. 
Plasmid DNA was precipitated with isopropanol, lyophilized and resuspended 
in TE pH8.0 containing 20^g/ml RNAse A. About 5-10 jal of the DNA solution was 
cleaved with the appropriate restriction enzyme.
13.7 Large Scale Preparation Of Plasmid DNA
A single bacterial colony was inoculated into 5ml L-broth, containing 
100ng/m l am picillin, and grown overnight at 37° in an orb ita l shaker. The 
overnight culture was added to 350ml L-broth containing am picillin in 2 litre  
flasks and the culture shaken at 37°. When the culture had reached an OD650 of
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approximately 0 .8 , chloramphenicol was added to a final concentration of 
lOOpg/ml and incubation continued overnight. Plasmid DNA was prepared by 
the "maxi-boiling" technique of Holmes and Quigley (1981). Cells were pelleted 
at 7000 rpm for 3 min (Sorvall GS3 rotor) and resuspended in 20ml STET buffer. 
Lysozyme, at a fina l concentration of 1 mg/m l, was added and the sample 
incubated at RT for 30 sec prior to boiling for 45 sec. The lysate was clarified 
by centrifugation at 18000 rpm at 4° fo r 1 h r in a Sorvall SS34 rotor. 
Isopropanol (0.9 volumes) was added to the supernatant and the DNA pelleted 
at 2500 rpm at 4° for 10 min. The drained pellet was resuspended in 5ml TE and 
caesium chloride added to a final density of 1 .6 mg/ml and ethidium bromide to 
0.5mg/ml. The solution was left on ice for 1 hr, spun at 2500 rpm for 10 min to 
remove debris and transferred to plastic TV865 ultracentrifuge tubes. The 
tubes were sealed and centrifuged on a vertical TV865 rotor at 40000 rpm at 15° 
fo r 16 hr. The DNA was visualised by daylight or long wave UV illum ination 
and the lower supercoiled plasmid DNA band removed with a large bore needle 
and syringe. The DNA was extracted twice with bu tan-l-o l (TE saturated), and 
dialyzed against TE at RT for 2 hrs before being treated w ith 50ng/ml RNAse 
fo r 1 hr at 65°, followed by 50(ig/ml proteinase K for 1 hr at 37°. DNA was 
extracted w ith an equal volume of phenohchloroform, then chloroform and 
precipitated twice w ith ethanol. The DNA was pelleted, washed w ith 70% 
ethanol, then lyophilized before being resuspended in TE.
14. D N A  Sequencing
14.1 Double Stranded DNA Sequencing
Double stranded DNA was sequenced using "Sequenase" T7 DNA 
polymerase, a genetic variant of bacteriophage T7 DNA polymerase, (Tabor 
and Richardson, 1989) and the sequencing solutions supplied w ith  the 
Sequenase Version 2 Sequencing Kit (United States Biochemical). Double 
stranded template DNA (3-5*ig) was added to 5ng of sequencing prim er in 
sterile water to a final volume of 8p.l and heated to 95° fo r 4 min to denature 
the template DNA. The sample was cooled to 37° fo r 15 min to allow the primer 
to anneal to the template DNA and then chilled on ice. The labelling step was 
performed by adding diluted labelling mix containing 2 units o f Sequenase T7
*(M 13 universal and reverse sequencing primers)
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DNA polymerase and 50gCi/ml of [35S]-dATP, to the chilled DNA sample to a 
final volume of 15.5|il, and the reaction incubated for 2-5 min at RT. Following 
incubation at RT, 3.5pl volumes of the labelled DNA mixture were added to 
tubes containing ddATP, ddTTP, ddCTP or ddGTP termination mix. The samples 
were incubated at 37° for 5 min after which time, stop solution was added to 
each of the term ination mixtures to stop the reaction. The sequencing 
products were analysed by denaturing polyacrylamide gel electrophoresis 
(see section 2B15.4)
15. Gel A n a lys is  O f DNA
15.1 Non-Denaturing Agarose Gels
Concentrations of agarose between 0.7% to 1.4% (w /v) in TAE buffer 
con ta in ing  0 .5 |ig /m l eth idium  bromide were used in horizonta l gels, 
depending on the size of the DNA fragments to be resolved. DNA samples in 0.2 
volumes of formyl dye were electrophoresed at lOV/cm 2 for 3 hrs or un til the 
dye fron t had migrated 2/3 the length of the gel. DNA fragments were 
visualised under short wave UV light. Long wave UV light was used to reduce 
DNA damage when preparative gels were being analysed.
15.2 Alkaline Agarose Gels
Alkaline agarose gels (McDonnell et al ., 1977) were used to analyze 
single stranded DNA. 0.7% agarose horizontal gels were prepared in 50mM 
NaOH and Im M  EDTA pH8.0. DNA samples were dissolved in 50mN^NaOH, Im M  
EDTA and 0.2 volumes of 6 x alkaline loading buffer and electrophoresed at 
0.25V/cm for 2-3hr using alkaline electrophoresis buffer. Electrophoresis was 
carried out un til the dye had migrated 2/3 the length of the gel. At the end of 
the run, the gel was soaked in 7% TCA for 30 min at RT, covered w ith cling 
film  and exposed to Kodak X-omat XS-1 film at RT.
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15.3 Non-Denaturing Polyacrylamide Gels
DNA fragments (7000-100bp in size) were separated on vertical 
polyacrylamide gels containing 5% acrylamide cross-linked w ith 1 part in 30 
w /w  of N-N’methylene bisacrylamide in TAE buffer. Polymerisation was 
achieved by the addition of ammonium persulphate (0.006% w/v) and TEMED 
(0.004%) to the gel solution just before pouring. Wells were formed w ith 
Teflon combs. DNA fragments were separated in 0.2 volumes formyl dye by 
electrophoresis at 3V/cm fo r 18 hrs, using TAE buffer. Separated DNA 
fragments were visualised by e ither e th id ium  brom ide stain ing or 
autoradiography.
15 4 Denaturing Polyacrylamide Gels
Denaturing polyacrylamide gels (0.35mm thick) were used to analyze 
the products of DNA sequencing reactions. Glass sequencing gel plates were 
washed in ethanol p rio r to treatment w ith Replecote (BDH). Plates were 
washed again in ethanol and polished thoroughly. The glass plates were taped 
together and 60ml of single concentration gel mix was poured into the glass 
plate sandwich using a syringe. Gels were left to polymerise fo r 1 hr before 
use. Wells were formed with sharks tooth combs. Boiled sequencing reactions 
were electrophoresed at 70 Watts for 1/2-4 hrs in TBE tank buffer. A fter 
electrophoresis the gel was transferred to 3mm Whatman filte r paper and 
dried under vacuum at 80° fo r 2 hrs. Gels were placed in contact w ith X-omat 
XS-1 film.
16. E le c tro n  M ic ro s c o p y
16.1 Preparation Of Samples In Epon Resin
The growth medium was removed from mock and virus-infected HFL cell 
monolayers in 50mm dishes at 3 hrs post-infection at NPT. The monolayers 
were washed 3x in ice cold PBS then scraped into 0.5ml PBS, transferred to
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beem capsules and pelleted at 3000 rpm for 10 min at 4°. fclutaraldehyde (2.5% 
in PBS) was added to the pellets and the samples incubated at 4 ° for 1 hr. The 
pellets were washed 3x in PBS and fixed w ith 1% (w/v) 0 S0 4 for 1 hr. After 
fixation, the pellets were again washed 3x in PBS and then subsequently 
dehydrated through a series of increasing ethanol concentrations (30, 50, 70, 
90, 100% v /v  in PBS). The pellets were in filtra ted  w ith epon resin and 
incubated overnight at room temperature. Following overnight incubation, 
the resin was removed from the samples and replaced w ith fresh epon resin. 
Polymerization of the resin was achieved by incubating the samples at 65° for 
3 days.
16.2 Thin Sectioning
Pelleted cells, embedded in polymerized epon resin, were cut w ith a 
diamond knife on an Ultra-microtome (Ultracut E, Reichert-Jung), and thin 
sections were collected on parlodium-coated copper grids. Sections were 
stained w ith saturated uranyl acetate in 50% ethanol fo r 1 hr, rinsed with 
deionized water and counter-stained with lead citrate fo r 15 min. The stained 
thin sections were examined at 80KV in a Jeol 100S electron microscope.
17. C o m p u tin g  and  A n a lys is  o f  Sequence Data
Sequence handling was carried out on a DEC VAX computer. The genetic 
computer group (GCG) sequence analysis software package version 5.0 and 6.0 
was used ( Devereux et al, 1984; Devereux, 1989).
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3.Results
Section 3.A Characterization
UL25 Gene Product
1. In tro d u c t io n
From nucleotide sequence analysis of the HSV-1 strain 17 genome, the 
HSV-1 UL25 gene was predicted to encode a protein of 62,666MW (McGeoch et al.y 
1988b). Studies carried out on the HSV-1 ts mutants ts l204 and rsl208, which 
both have lesions in the UL25 gene, suggested that the gene product was a 
v irion  protein required at early and late times in infection (Addison et al., 
1984). These conclusions were based upon observations that fs l204 bound to the 
cell surface at the NPT but was unable to penetrate the cell membrane, whilst 
ts l208, although able to enter the cell, was unable to assemble functional 
capsids. Provided tsl204 was allowed to enter cells by brief incubation at the PT 
prio r to growth at the restrictive temperature, the phenotype of the mutant was 
similar to that of tsl208, inasmuch as few capsids, all of which lacked viral DNA, 
were formed. Since few nuclear capsids were found in rsl204- and rs l2 0 8 - 
infected cells when compared to wt virus-infected cells, it was thought that the 
UL25 gene product may be involved in capsid stabilisation.
Sequence data analysis has indicated that UL25 is un like ly to be in the 
virus envelope, since it does not have any characteristics of membrane-bound 
proteins (McGeoch et al., 1988b). Moreover, it is not a known capsid protein. For 
these reasons, the UL25 protein was thought to be in the tegument.
An antiserum was raised in a rabbit against a synthetic oligopeptide of 15 
amino acid residues, termed p i06, corresponding to amino acids 135 to 150 of the 
predicted UL25 ORF. Figure 6 shows a schematic representation o f the predicted 
amino acid sequence of the UL25 protein and the oligopeptide used to make the
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Figure 6. A Schematic Representation Of The HSV-1 Genome And 
The Location Of The UL25 Gene.
The predicted amino acid sequence of the UL25 polypeptide and the location 
of the oligopeptide p i 06 (boxed), against which an antiserum was raised, are 
indicated.
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antiserum.Antibodies in the antiserum recognized a virus-specific polypeptide 
in an immunoprecipitation assay but did not bind to antigen in a western blot 
analysis (D.Smith unpublished observations).
The studies reported here represent in itia l efforts to understand the 
function of the UL25 protein. W ith the aid of the oligopeptide polyclonal 
antibody directed against amino acid sequences present in the UL25 gene 
product, the synthesis, processing and location of the UL25 polypeptide have 
been examined.
2. Id e n tif ic a tio n  O f The UL25 Gene P roduct
BHK cells were infected w ith HSV-1 and radiolabelled w ith [35S]- 
methionine at 4 hrs post-infection. After a 30 min incubation, cells were 
harvested and immunoprecipitation reactions were carried out w ith the serum 
obtained from  the pre-immune rabbit and the anti-UL25 oligopeptide 
antiserum. The immunoprecipitated proteins were separated on a SDS 9%- 
polyacrylamide gel and visualized by fluorography (Figure 7). The antiserum 
recognised a polypeptide of apparent Mr 67000 which was not detected in 
immunoprecipitations using pre-immune serum. Two other polypeptides with 
MW of approximately llO kDa and 150kDa, which probably correspond to 
glycoprotein B and the major capsid protein VP5 respectively, were also present 
in the immune precipitate. Since similar sized proteins were precipitated from 
virus-infected cell extracts incubated with the pre-immune sera, the presence 
of gB and VP5 in the immune precipitates is not due to the specific interaction 
of VP5 or gB with either the antiserum or the putative UL25 protein.
The specific ity o f the UL25 antiserum was assessed by perform ing 
immunoprecipitations in the absence or presence of 1 0 0 |ag/ml of oligopeptide 
p l0 6  (Figure 8 lanes 3 and 4 respectively). The results show that the 
precipitation of the 67,000MW protein was greatly inhibited in the presence of 
100jig/m l of oligopeptide p l06. Thus, oligopeptide concentrations of 100|ig/ml 
were used in fu rth e r imm unoprecip itation experiments w ith  the UL25 
antiserum. A number of polypeptides with molecular weights o f approximately 
67 kDa were observed in immunoprecipitations performed in the presence of 
oligopeptide p i 06. It is likely that these similar sized polypeptides are distinct 
from the UL25 gene product, since they appear to be s ligh tly  larger than
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Figure 7 . Identification Of The UL25 Gene Product.
BHK cells were infected with wt virus at 37° and labelled at 4 hrs post-infection 
w ith 100p.Ci/ml of [35S]-methionine. After 30 min the cells were harvested and 
cell lysates prepared. Immunoprecipitation reactions were carried out using 
the UL25 specific antiserum (UL25) or pre-immune serum (Pre-immune). The 
precipitated proteins were separated on a SDS-9% polyacrylam ide gel and 
visualized by fluorography. HSV-1 wt virus-infected cell extracts are indicated.
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Figure 8. Specificity Of The UL25 Antiserum
Cells were infected with wt virus and were labelled at 4 hrs post-infection at 
3 7° fo r 30 min w ith 100pCi/m l o f [3 5 S]-m ethionine and used in 
immunoprecipitation reactions with the UL25 antiserum in the absence and 
presence of 100pg/ml of oligopeptide p i 06 (Lanes 3 and 4 respectively). The 
precipitated polypeptides were resolved by electrophoresis through a SDS 
9%-polyacrylamide gel and visualized by fluorography. Lanes 1 and 2 
represent mock-infected and wt HSV-1 infected cell lysates respectively. The 
polypeptides w ith MWs of approximately 67 kDa that were observed in 
immunoprecipitations performed in the presence of oligopeptide p i 06 are 
indicated by a filled arrow.
% A dditional m inor polypeptide bands also appeardl to be recognized by the UL25- 
specific antiserum as indicated in Figure 9, which may be due to  internal 
in itia tion of translation of the UL25 polyA+ RNA.
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polypeptide that was immunoprecipitated w ith the anti-UL25 oligopeptide 
antiserum.
The 67,000 virus-specific polypeptide recognized by the UL25 antiserum 
is sim ilar to the size of the UL25 gene product predicted from the analysis of the 
HSV-1 genome, and therefore is likely to be the UL25 gene product.
3. Regulation Of Expression Of The
To fu rthe r characterize the UL25 gene product, the kinetics of UL25 
protein synthesis were analyzed. BHK cell monolayers were infected with wt 
HSV-1 at 37°, and pulse labelled for 30 min w ith [35S]-methionine at various 
times post-infection. The cells were harvested after radiolabelling and the cell 
lysates used in immunoprecipitation reactions with the UL25 antiserum in the 
presence or absence of oligopeptide p l06 . The immunoprecipitated proteins 
were analyzed by SDS-PAGE and visualized by fluorography (Figure 9). The 
UL25 protein was detected at 1 hr post-infection and reached a peak of synthesis 
at 4-5 hrs post-infection. The levels of UL25 protein immunoprecipitated from 
infected cells appeared to decline slowly thereafter. These results are consistant 
w ith UL25 being regulated as a late gene product. Two classes of late gene 
product, leaky late (yi) and true late (72), have been defined, according to their 
ab ility  to be expressed in the absence of viral DNA replication. Leaky late genes 
are transcribed in the absence of v ira l DNA replication. Maximal levels of 
mRNA synthesis, however, occur only after replication of the v ira l genome. 
Transcription of true late genes is more dependent on viral DNA synthesis and 
less than 5% of mRNA from true late genes in wt virus-infected cells is detected 
under conditions which severely inh ib it viral DNA synthesis.
To determine which class of late gene UL25 belonged to, the synthesis of 
the UL25 protein was analysed in the presence of phosphonoacetic acid (PAA), a 
viral DNA polymerase inhib itor. Previous studies indicated that 300jig/m l of 
PAA was sufficient to severely inh ib it expression of glycoprotein C, a true late 
gene product, to less than 5% of levels expressed in untreated cells (Homa et ai., 
1986). Therefore, BHK cells were infected at 37° with HSV-1 in the presence and 
absence of 100ng/ml and 300ng/ml of PAA. At 4 hrs post-infection the cells were 
Pulse labelled fo r 30 min w ith 100nCi/ml of [35S]-m ethionine and then 
harvested. The cell lysates were incubated w ith the UL25 antiserum and
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immunoprecipitation reactions carried out. The immunoprecipitated proteins 
were analysed by SDS-PAGE and fluorography (Figure 10).
In the absence of PAA, the UL25 polypeptide was detectable at 4 hrs post­
infection (lane 3), whilst in virus-infected cells treated w ith 100|ig/ml of PAA 
the level of precipitable UL25 polypeptide was reduced 5-fold as determined by 
densitometric analysis of the autoradiograph (lane 5). Similarly, the level of the 
UL25 gene product was reduced 12-fold in HSV-1 infected cells incubated in the 
presence of 300pg/ml of PAA. These results indicate that UL25 is regulated as a 
leaky late vira l gene.
Control samples were incubated w ith monoclonal antibodies specific for 
the DBP, an early protein, or glycoprotein C (a true late gene). As expected, the 
synthesis of gC in infected cells incubated in the presence of 300|ig/ml of PAA 
was severely reduced compared to that in untreated cells (lanes 9 and 10 
respectively). In contrast synthesis of DBP was not affected in cells treated with 
300ng/ml of PAA (lanes 11 and 12).
4. Pulse-Cha.se A na lys is  O f The
The UL25 gene is predicted to encode a protein of molecular weight 62,666 
(McGeoch et al., 1988b), which is sim ilar to the apparent size of 67,000kDa 
observed by SDS-PAGE. The slight discrepancy between the apparent and 
predicted size of the UL25 polypeptide may be due to the inaccuracy of 
predicting protein size by SDS-PAGE. A lternatively, the UL25 protein may 
undergo processing follow ing synthesis to give rise to the 67kDa protein 
observed by SDS-PAGE.
To determine whether processing of the UL25 polypeptide occurs, BHK 
cells were infected with wt HSV-1 at 37° and at 4 hrs post-infection were pulse 
labelled fo r 15 min with lOOpCi/ml of [35S]-methionine. After labelling, the cells 
were either harvested immediately or incubated in the absence of radiolabel for 
various time intervals. Cell lysates were prepared and im m unoprecipitation 
reactions were performed with UL25 antiserum. The precipitated proteins were 
separated by SDS-PAGE and visualized by fluorography (Figure 11). No 
difference was detected in the mobility of the UL25 polypeptide, suggesting that 
either post-translational modification does not occur, or the UL25 polypeptide
lOOug/ml PAA 300ug/ml PAA
300ug/ml 
gC PAA no PAA
9 10
300ug/ml 
DBP PAA no PAA
11 12
Figure 10. Expression Of UL25 Polypeptide In The Presence And 
Absence Of HSV-1 DNA Replication.
BHK cells were infected with wt virus in the presence and absence of 100(ig/ml 
or 300[ig/m l of PAA. At 4 hrs post-infection the cells were pulse-labelleled fo r 
30 min w ith lOOpCi/ml of [35S]-methionine, harvested and the cell lysates used 
in imm unoprecipitation reactions with antiserum directed against the UL25 
prote in (lanes 3-8). Parallel samples were prepared at 4 and 12 hrs post­
infection and used in immunoprecipitations with antisera directed against DBP 
and gC respectively (lanes 9, 10 and lanes 11, 12). A ll immunoprecipitation 
reactions were performed in parallel. The precipitated proteins were analyzed 
by 9% SDS-PAGE and fluorography. Immunoprecipitations in the presence of 
lOOjig/m l o f oligopeptide p i06 are indicated by +. Lanes 1 and 2 are purified 
HSV-1 virions and L-particles respectively.
Virus Pulse Pulse+ 1 3 9 24
<UL25 polypeptide
Figure 11. Pulse-Cha.se Analysis Of UL25 Polypeptide Synthesis.
BHK cells were infected with wt virus at 37° and at 4 hrs post-infection the cells 
were pulse-labelled with lOOfiCi/ml of [35S]-methionine for 15 min. The labelled 
cells were harvested immediately or incubated for various times post-infection 
in the absence of radioactive medium. The harvested cell lysates were incubated 
w ith  antiserum against the UL25 protein. The immunoprecipitated proteins 
were separated by 9% SDS-PAGE and visualized by fluorography. The pulse and 
the various times of chase (in hours) are indicated above the lanes. The lane 
marked V irus, represents pu rified  HSV-1 v irions. Im m unoprec ip ita tion  
performed in the presence of lOOpg/ml of oligopeptide p i 06 is indicated by +.
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undergoes a form of processing which does not alter its apparent molecular 
weight.
A lte rna tive ly , it  is possible tha t processing is occurring on the nascent 
polypeptide.
5. Loca lisa tion  O f The UL25 W ith in  The V irio n  Partic le
To determine the location of the UL25 protein w ith in  the virion , virus- 
infected cells were labelled w ith [35S]-methionine, and the radiolabelled 
virions, purified by density gradient centrifugation, were treated w ith NP-40 to 
remove the envelope proteins. The soluble and insoluble protein fractions were 
separated and prepared for immunoprecipitation with the UL25 antiserum. The 
p rec ip ita ted  proteins were analysed by SDS-PAGE and visualized by 
fluorography (Figure 12).
Treatment of virions with NP-40 was effective in removing a significant 
proportion of the envelope proteins and Vmw65 (lane %). In contrast, the capsid 
prote in  VP5, was not solubilized, suggesting that the capsid remained intact 
fo llow ing NP-40 treatment (lane 7 ). Furthermore, the predominant association 
of many tegument proteins including the UL25 polypeptide (lanel^) w ith the 
capsid fo llow ing removal of the envelope is consistent w ith  previously 
published data, suggesting that the extraction procedure was satisfactory 
(Roizman and Furlong, 1974).
In conclusion, the data indicate that the UL25 polypeptide is a structural 
component of the virion and forms a tight association with the tegument/capsid 
structure, inasmuch as removal of the viral envelope does not result in the loss 
of a significant amount of the UL25 polypeptide from the virion.
6. Loca tion  O f The UL25 Polypeptide
The previous data suggested that the UL25 protein might be important for 
capsid s tab ility  and form a tight interaction w ith one or more capsid or 
tegument components. This being so, the UL25 protein might not be expected to 
be an integral component of L-particles since they lack the capsid structure. To 
address this possibility, equivalent numbers of 3:>S-labelled virions and L- 
partic les, were solubilized and incubated w ith  UL25 antiserum . The
Figure 12. Localisation O f The UL25 Polypeptide Within The HSV-1 
Virion.
HSV-1 virions were labelled with [35S]-methionine and purified  by density 
gradient centrifugation. Purified virions were treated with 1% NP-40 and the 
soluble and insoluble proteins were separated by cen trifugation  in to  
supernatant (SN) and pelleted (P) fractions respectively. Equivalent amounts of 
each fraction were immunoprecipitated with antiserum specific for UL25 in the 
presence ( + ) and absence of lOOpg/m l o f o ligopeptide  p l0 6 . The 
immunoprecipitated proteins were separated on a SDS 9%-polyacrylamide gel 
and visualized by fluorography. The UL25 polypeptide is indicated by the arrow 
head. The viral envelope proteins gB and VP5and the tegument protein Vmw65 
are indicated. The radiolabelled pelleted and supernatant fractions are 
indicated.
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immunoprecipitated proteins were separated by SDS-PAGE and visualized by 
flu o ro g ra p h y  (F igure 13). S u p ris in g ly , the UL25 p ro te in  was 
immunoprecipitated from both v irion  and L-particle preparations. The above 
experiment was repeated several times and the UL2 5 polypeptide was 
consistently found in L-particles.
1 2 3 4 5 6
<UL25
polypeptide
Figure 13. Localisation OfUL25 Polypeptide In L-Particles.
35S-labelled HSV-1 virions and L-particles were purified by density gradient 
centrifugation. Equivalent numbers of virions and L-particles were solubilized 
and used in immunoprecipitation reactions with antiserum directed against the 
UL25 protein in the presence (+) and absence (-) of lOOpg/ml o f oligopeptide 
p i06. Precipitated proteins were resolved by electrophoresis through a SDS-9% 
polyacrylam ide gel and visualized by fluorography. Purified virions and L- 
partic les are shown in lanes marked 1 and 2 respective ly, w h ils t 
immunoprecipitated polypeptides are shown in lanes 3,4,5 and 6.
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Section 3£ Characterisation
Mutant tsl204
1. In tro d u c t io n
The HSV-1 mutant tsl204 was previously shown to carry a mutation in the 
UL25 gene and as a result was unable to penetrate the cell membrane at the NPT 
(Addison et al., 1984). This conclusion was based prim arily on EM examination of 
th in sections of tsl204 infected cells and the observation that the tsl204 defect 
could be overcome by treatment of infected cells w ith  a compound which 
promotes membrane fusion (ie. PEG)
Recently, there has been some doubt as to whether the inability of ts l204 
to infect cells at the NPT resulted from a defect in cell entry. The aim of the 
present study was to re-examine the phenotype of rs l204 at the NPT and to 
further characterize the tsl204 defect.
2. A n a lys is  O f ts1204-In fected  C
To determine the nature of the tsl204 defect, HFL cells were either mock- 
infected or infected with wt HSV-1 or tsl204 and incubated at 38.5°. At 7 hrs 
post-infection the cells were pulse-labelled for 30 min w ith lOOpCi/ml of [35S]- 
methionine and the cell lysates analyzed by SDS-PAGE and autoradiography 
(Figure 14). In contrast to wt HSV-1, ts l204  was unable to induce v ira l 
polypeptides at the NPT. Indeed, tsl204-infected cells showed a sim ilar protein 
profile  to that of mock-infected cells. Furthermore, ts l204  did not appear to 
induce host cell shut-off o f protein synthesis. Consistent w ith  previous 
findings, fs l204 infection of HFL cells at the NPT resulted in the accumulation of 
a 56,000 MW cellular protein, which was not induced in mock-infected or wt- 
infected cells.
In conclusion, these data clearly support previous findings that ts l204 is 
defective at a step prio r to the onset of viral protein synthesis, at the stage of 
v irion adsorption, penetration or uncoating of the vira l genome.
Figure 14. Induction Of Viral Polypeptides By ts l204 A t The NPT
H
HFL cells were mock-infected or infected with tsl204 or wt virus and incubated 
at the NPT. At 7 hrs post-infection, the cells were pulse-labelled w ith 100|iC i/m l 
of [35S]-methionine fo r 30 min before being harvested and the cell lysates 
analyzed by SDS-PAGE and autoradiography. The cellular polypeptide induced 
in tsl204-infected cells is indicated by the arrow head.
*(m o i of 20pfu per cell)
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3. EM  A na lys is  O f Thin  Sections
Addison et al. (1984) demonstrated previously that rs l204  was not 
defective in adsorption at the NPT, since tsl204 and wt HSV-1 exhibited very 
sim ilar adsorption kinetics. It is therefore likely that the failure of ts l204 to 
infect cells is a result of a defect in either cell penetration, uncoating or both of 
these processes. To address these possibilities, th in section preparations of HFL 
cells infected with a high moi ( about 200pfu/cell) of purified rsl204 virus at 
39.5°, were examined by EM. Infected cells were harvested at 3 hrs post­
infection and prepared for EM as described in section 2B16. As controls, cells 
were infected with purified tsl213 or wt HSV-1 virions and these samples were 
s im ilarly treated and observed in parallel. The HSV-1 mutant tsl213 carries a 
m utation in the gene encoding the large tegument protein Vmw273 and is 
believed to be defective in uncoating of the v ira l genome. The results are 
indicated in Figure 15 and Table 2.
In contrast to wt virus-infected cells, capsids were not observed w ith in 
nuclei of cells infected with tsl204 or tsl213. Indeed, these cells showed little  
sign of infection such as margination of host-cell chromatin. Further analysis 
of ts l204- and tsl213-infected cells revealed the presence of capsids in the 
cytoplasm, some of which were found juxtaposed to the nuclear membrane 
(Figures 15c and 15d). All of the capsids observed in the 100 th in sections of 
ts l204- and tsl213-infected cell cytoplasm, contained v ira l DNA. In contrast, 
cytoplasmic capsids juxtaposed to the nuclear membrane were not observed in 
wt virus-infected cells at 3 hrs post-infection. These observations demonstrate 
that both ts l204 and rs 1213 are unable to uncoat the v ira l genome at the NPT. 
These results are consistant w ith  previous data suggesting that functional 
Vmw273 is required for the release of the vira l genome from the nucleocapsid 
(Batterson et al., 1983).
The present study failed to confirm that tsl204 has a defect in membrane 
penetration, inasmuch as capsids could be detected w ith in  the infected cell 
cytoplasm at the NPT. Although EM examination of th in  sections o f ts l2 0 4 - 
infected cells at the NPT revealed numerous enveloped virions attached to the 
cell membrane, a sim ilar phenomenon was observed in both ts l213- and wt 
virus-infected cells.
Figure 15. Electron Micrographs O f Mock, tsl204, ts l213  And wt- 
Infected HFL Cells A t 39.5° A t 3 Hrs Post-Infection.
HFL cells were infected w ith  a high moi (200pfu per cell) o f v irus and 
incubated at 39.5°. At 3 hrs post-infection the cells were harvested and 
prepared fo r electron microscopy as described in section 2B.16.
(C) cytoplasm 
(CM) cell membrane 
(N) nucleus
The bar represents O.SfiM.
Figure iSa) Mock-In
V
i) 
lim
pl
y 
an
d 
fu
ll 
ca
ps
ids
 
in 
the
 
nu
cle
us
 
of 
inf
ec
te
d 
ce
ll. 
Fil
led
 
ar
ro
ws
 
in
di
ca
te
 
fu
ll 
ca
ps
id
s,
 w
hi
lst
 
em
pt
y 
ca
ps
ids
 
are
 
in
di
ca
te
d 
by 
em
pt
y 
ar
ro
ws
: 
(ii
) 
Cl
us
te
r 
of 
ca
ps
ids
 
in 
the
 
nu
cle
us
; 
(ii
i) 
En
ve
lop
ed
 
wt
 v
iru
s 
on 
the
 
su
rfa
ce
 
of 
the
 
ce
ll.
1(i)
 a
nd
 
(ii)
 C
yt
op
la
sm
ic 
ca
ps
ids
 j
ux
ta
po
se
d 
to 
the
 
nu
cle
ar
 
m
em
br
an
e;
 (
iii)
 E
nv
elo
pe
d 
ts!
20
4 
vir
io
ns
 
on 
the
 
su
rfa
ce
 
of 
the
 
ce
ll.
(i)
 C
lu
st
er
 
of 
cy
to
pl
as
m
ic
 
ca
ps
id
s 
co
nt
ai
ni
ng
 
DN
A;
 (
ii)
 E
nv
el
op
ed
 
ts
!2
13
 
vi
rio
ns
 
on 
the
 
su
rfa
ce
 
of 
the
 
ce
ll.
o  a
o o
ro
S t/5n.
u °  3 °
u
c U
1 ►—42 pu,
CO
§
1
T30)
■ *o<J
ICO
2 
2
S5
i
QJ•O
g
<N
QJ
s
£ HF
L 
ce
lls
 
we
re 
inf
ec
te
d 
wi
th 
a 
hig
h 
m
oi 
(20
0 
pfu
 
pe
r 
ce
ll) 
of 
wt
 v
iru
s,
 t
sl2
04
 
or 
ts
l2
13
 
an
d 
in
cu
ba
te
d 
at 
39
.5
°. 
At 
3 
hrs
 
po
st
-in
fe
ct
io
n 
th
e 
ce
lls
 
we
re 
ha
rv
es
te
d 
an
d 
pr
ep
ar
ed
 
for
 
EM 
as 
de
sc
rib
ed
 
in 
se
cti
on
 
2B
.1
6.
 T
he
 
nu
m
be
r 
of 
cy
to
pl
as
m
ic 
an
d 
nu
cle
ar
 
ca
ps
ids
 
we
re 
co
un
te
d 
in
 
100
 
thi
n 
se
cti
on
s 
of 
ea
ch
 
vir
us
-in
fe
ct
ed
 
ce
ll 
pr
ep
ar
at
io
n.
73 Chapter 3: Results
4. PEG T re a tm e n t O f ts1204-In fected  Cells
To confirm that the inab ility  of rsl204 to establish a ly tic  infection 
resulted from a failure to release the vira l genome from the capsid, virus- 
infected cells were treated according to the procedure described by Sarmiento 
et al. (1979). In this experiment, tsl204, tsl213 and wt virus-infected HFL cells 
incubated at 39.5°, were treated w ith PEG, a compound which promotes 
membrane fusion, to allow entry of virus attached to the cell surface. Control 
samples were treated in a sim ilar manner except PEG was om itted from all 
solutions. Following PEG treatment, virus-infected cells were incubated for a 
fu rthe r 4 hrs at the NPT, and either prepared for indirect immunofluorescence 
using DBP antiserum and anti-mouse IgG conjugated to FITC (Figure 16) or 
pulse-labelled with [35S]-methionine and the cell lysates analyzed by SDS-PAGE 
and autoradiography (Figure 17).
Greater than 95% of wt virus-infected cells that were untreated or treated 
w ith PEG showed bright nuclear fluorescence, whilst none of the ts l204- and 
ts 1213-infected cells treated w ith PEG showed b righ t nuclear fluorescence. 
Instead, tsl204-infected cells treated with PEG resembled mock-infected cells or 
untreated tsl2Q4 infected cells at the NPT, suggesting that PEG was not sufficient 
to overcome the tsl204 defect and that rsl204 was defective at a stage subsequent 
to membrane fusion ie. uncoating. In the absence of a positive control, it is 
conceivable that on this occasion PEG treatment was not sufficient to promote 
membrane fusion. However, the results obta ined were consistently  
reproducible, suggesting that the above procedure was satisfactory.
1
SDS-PAGE analysis of PEG treated and untreated cell extracts confirmed 
data from  the immunofluorescence assays, inasmuch as PEG treatment failed to 
overcome the tsl204 defect.
In conclusion, the results presented here indicate that rsl204 is unable to 
uncoat the viral genome at the NPT. These results fail to confirm  data presented 
by Addison et al (1984) who suggested that tsl204 was defective in cell entry. In 
addition, the work also suggests that the HSV-1 mutant tsl213, which contains a 
lesion in the gene encoding the large tegument prote in Vmw273, is also 
defective in uncoating. This finding is in agreement with previous experiments 
showing that Vmw273 is required for the release of v ira l DNA from the capsid 
(Batterson et al, 1983).
Figure 16. Analysis O f The Effects Of PEG Treatment On HSV-1 
Infected Cells Using An Indirect Immunofluorescence Assay.
HFL cells were infected w ith 5pfu per cell of tsl204, tsl213 or wt-HSV-1 at 39.5° 
and treated w ith PEG according to the procedure described in section 2B.4. 
Control samples were treated in a similar manner except PEG was om itted from  
all solutions. Following PEG treatment, the virus-infected cells were incubated 
for a fu rth e r 4 hrs at 39.5° then prepared fo r  im m unofluorescence. 
Immunofluorescence was performed using an antiserum specific for the DBP.
A) Mock-Infected Cells
B) M ock-Infected Cells Treated With PEG.
C) Wt V irus-Infected Cells
D )W t V irus-Infected Cells Treated W ith PEG.
E) ts1204-Infected Cells
F) ts120 4 -In f ected Cells Treated W ith PEG.
G) ts 1213 -In f ected Cells
H) ts l 213-Inf ected Cells
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Figure 1 7. Effect Of PEG Treatment On ts l204 Infection.
HFL cell monolayers were mock-infected or infected with tsl204 or wr virus at a 
moi o f 20pfu per cell at 39.5° ,then treated with PEG as described in section 2B.4. 
A fter a fu rther 6 hrs incubation at 39.5°, the cells were pulse-labelled w ith 
lOOpCi/m l of [35S]-methionine fo r 30 min and then harvested. The cell 
polypeptides were separated by SDS-PAGE and visualized by autoradiography. 
Control samples were prepared in a sim ilar manner except PEG was omitted 
from all solutions. Lanes marked P represent cells treated with PEG.
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Section 3.C Induction
1. In tro d u c t io n
The protein p56 is an example of a cellular protein whose synthesis is 
upregulated during infection w ith an HSV-1 ts mutant (Preston, 1990). This 
protein was observed in HFL cells infected w ith the mutant ts l204 at the NPT. 
At this temperature it was believed that ts 1204 attaches to but fails to 
penetrate the cell membrane (Addison et al., 1984). These studies suggested 
that p56 induction was unlikely to result from  nonspecific binding of large 
numbers of mutant virus particles to the cell surface. On this basis it  was 
concluded that the synthesis of p56 was induced by the specific interaction of 
ts l204  with the cell surface components.
Further experiments to determine the effect o f neutralising gH and gD 
antibodies on the ab ility  of ts l204  to induce p56 were performed by pre­
incubating the infecting virus w ith monoclonal antibody specific fo r gD or 
gH at concentrations which reduced the virus titre  by about 104 (Preston 
unpublished data). The results showed that pre-incubation of the virus with 
antibodies specific fo r gH or gD prevented the induction of p56 by ts l204 . 
Furthermore, treatment of cells p rio r to the addition of virus, w ith purified 
HSV-1 truncated gD, lacking the carboxyterminal transmembrane domain, 
also inhibited p56 induction by fsl204.
2. The Role O f gC In  The Inductio
Previous results have shown that virus neutralised by monoclonal 
antibody specific for gD, could s till attach to cells, presumably via the 
interaction of gC with cell surface HS (Ligas and Johnson, 1988). Thus the 
observation that tsl204, neutralized by monoclonal antibodies specific to gD, 
failed to induce p56 at the NPT, suggested that gC was not im portant fo r the 
induction of p56.
To address this possibility, the E. coli (3- galactosidase gene under the 
control of the SV40 early promoter was inserted in to the unique Xbal site
75 Chapter 3: Results
w ith in  the cloned HSV-1 strain MP BamHI i fragment which contained a 
frame shift mutation in the gC gene (Preston unpublished data). The mutated 
fragment was recombined into rsl204. Two isolates, gC lts l204  which made a 
truncated gC protein and gC2tsl204 which produced no detectable polypeptide 
recognized by the monoclonal antibody specific for gC, were analyzed for 
their ab ility to induce p56.
HFL cell monolayers were mock-infected or infected w ith  e ither 
tsl204, gC lts l204, gC2tsl204 or vvt virus at a moi of 20 pfu per cell. The cells 
were incubated at the NPT for 7 hrs after which time they were pulse- 
labelled w ith lOOuCi/ml of [35S]-methionine for 30 min. Following incubation, 
the cells were harvested and the radiolabelled cell proteins were analyzed by 
SDS-PAGE (Figure 18). The results showed that both gC lts l204 and gC2rsl204 
were able to induce p56 in HFL cells at the NPT and it can be concluded 
therefore, that the interaction between gC and the cell surface is not 
important for the induction of p56.
3. In d u c tio n  O f p 5 6  B y L-Particles
Previous reports suggested that p56 induction resulted from  the 
interaction of ts l204 with the cell membrane. If this is the case then it is 
plausible to argue that the induction of p56 should also be mediated by tsl204 
L-particles. To address this possibility, virions and L-particles were purified 
from  ts l204-in fected HFL cells according to the procedure described in 
section 2B.2.4, except that the infected cells were not incubated w ith [35S]- 
methionine. L-particle preparations are normally contaminated w ith a small 
proportion of virions. To ensure that the extent of p56 induction could be 
attributed to attachment of L-particles and not contaminating virions to the 
cell surface, the percentage of contaminating virions in the L-particle 
preparation was determined by virus partical counting. Approximately 0.3% 
of the v ira l particles in the preparation were virions. In addition , the 
particle to pfu ratio of the purified virions, determined by particle counting 
and plaque assay, was calculated as 1 in 20 (results not shown). According to 
these data, it was assumed that the low numbers of virions contaminating the 
L-particle preparation would not be able to induce detectable levels of p56 at 
particle numbers representing a pfu of 20 or less.
Figure 18. Induction  O f p56  By gC M utan t ts !204 .
HFL cell monolayers were mock-infected or infected with wt-virus, ts l204 , 
gC ltsl204 or gC2tsl204 at a moi of 20 pfu per cell. The isolate, gC lts l204 made 
a truncated gC protein whilst gC2tsl204 produced no detectable gC 
polypeptide that was recognized by a gC-specific monoclonal antibody (See 
text fo r details). The cells were incubated at the NPT for 7 hrs at which time 
the infected-cells were pulse-labelled with 50pCi/ml of [35S]-methionine for 
30 min. Following incubation, the cells were harvested and the radiolabelled 
proteins analyzed by SDS-PAGE and autoradiography.
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HFL cell monolayers were mock-infected or infected w ith purified 
ts l2 0 4  or L-particles at the NPT. The numbers of L-particles used in the 
experiment were 20, 100, 200 and 400 particles per cell which represented a 
moi of 1, 5, 10 and 20 pfu per cell respectively. The cells were incubated at the 
NPT un til 7 hrs post-infection, at which time the cells were pulse-labelled 
w ith 50uCi/ml of [35S]-methionine for 30 min. Following incubation, the cells 
were harvested and the radiolabelled proteins analyzed by SDS-PAGE and 
autoradiography. The results show that the purified virions could induce p56 
at the NPT at a moi of 20 pfu per cell, which is equivalent to approximately 
400 virus particles per cell (Figure 19). In contrast, a sim ilar number of L- 
particles failed to induce p56 at the NPT. This experiment was repeated on a 
fu rthe r three occasions with identical results. Thus it can be concluded from 
this experiment that L-particles purified from  rs l204-in fected cells are 
unable to induce p56 at the NPT.
1 2 3 4 5 6 7
No of L-particles 
wt mi tsl204 20 100 200 400
Figure 19. Induction Of p56 By L-Particles
Virions and L-particles were purified from  ts l204-in fected HFL cells as 
described in section 2B.2.4. HFL cells were mock-infected or infected w ith 
tsl204, wt virus or tsl204 L-particles. The number of L-particles added per 
cell were (lane 4) 20, (lane 5) 100, (lane 6) 200 and (lane 7) 400. The cells 
were incubated at the NPT un til 7 hrs post-infection, at which time the 
infected cells were pulse-labelled with 50uCi/ml of [35S]-methionine for 30 
min. Following incubation the cells were harvested and the radiolabelled 
proteins were analyzed by SDS-PAGE and autoradiography. The cell protein 
p56 is indicated in lane 3. Lanes 1 and 2 represent wt v irus- and mock- 
infected cell proteins respectively.
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Section 3.D Identification Of PolyA+ RNAs 
That Accumulate In HSV-1 Infected Cells.
1. In tro d u c t io n
In general, HSV infection leads to a decrease in host cell protein synthesis 
(Fenwick and Walker, 1978). However, the converse is true fo r a m inority  of 
ce llu la r proteins, whose expression is upregulated in HSV-infected cells 
(LaThangue et al., 1984; Macnab et al., 1985; Kemp et al., 1986a,b; Patel et al., 
1986; LaThangue and Latchman, 1988; Kennedy et al., 1990; Hewitt eta/., 1991; 
Wakakura et al., Although the expression of many HSV-induced cellular
genes is dependent on v ira l protein synthesis, a m ino rity  of cell proteins 
appear to accumulate in conditions that restrict the induction  of HSV 
polypeptides. Thus, it can be assumed that these cellular proteins are induced by 
events occuring p rio r to the onset of v ira l prote in  synthesis, such as 
attachment of the v irion to the cell surface or entry of the nucleocapsid into 
the cell cytoplasm. The HSV-induced host cell protein p56 is an example of a 
cellular protein that is induced by events occuring p rio r to the onset o f viral 
protein synthesis (Preston, 1990).
The aim of this investigation was to isolate cDNAs representing polyA+ 
RNAs that accumulate in tsl204-infected HFL cells.
To isolate the fu ll length cDNA clone encoding p56, a phagemid cDNA 
lib ra ry was prepared from polyA+ RNA purified from tsl204-infected cells. The 
cDNA lib ra ry  was screened by differentia l hybridization. Clones that showed 
preferential hybridization to the cDNA probe synthesized from  polyA4* RNA 
purified from tsl204-infected HFL cells rather than a similar probe synthesized 
from mock-infected cell polyA+ RNA, were selected for further analysis.
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2. Construction Of The cDNA L
The polyA+ RNA used as a template for cDNA synthesis was prepared from 
tsl204-infected cells at 7 hrs post-infection, at which time maximal levels of p56 
synthesis occured (Preston, 1990). HFL cell monolayers on 90mm petri dishes 
were infected w ith tsl204 at a moi of 20 pfu per cell at the NPT. At 7 hrs post­
infection, the cells were washed twice in ice cold PBS and scraped from  the 
dishes using rubber policemen. The harvested cells were pelle ted by 
centrifugation and polyA+ RNA was extracted from the pelleted cells according 
to the procedures described in sections 2B.11.1 and 2B.11.2.
The success of cDNA cloning is determined largely by the quality of the 
polyA+ RNA used as a template for first strand cDNA synthesis. It was therefore 
important to check the integrity of the polyA+ RNA preparation. This was done 
using the following tests:
a) The Ability of the Bulk mRNA Preparation to Direct the Synthesis of Long 
Molecules of First Strand cDNA.
This was determined by synthesizing first strand cDNA using the polyA+ 
RNA as a template and oligo d T i2- i8 as a primer according to the procedure 
described in section 2B.11.4. The radiolabelled cDNA was analyzed on a 1% 
alkaline agarose gel and visualized by autoradiography (Figure 20). 32P end- 
labelled H ind lll fragments of X DNA were used as MW markers. The single 
stranded cDNA appeared on the gel as a continuous smear from less than 300b to 
more than 5kb. I f  the polyA+ RNA is high quality then ideally, the m ajority of 
the cDNA molecules should be l-2kb  in length. However, the results shown in 
Figure 20 showed that the the bulk of the cDNA was approximately 500b in 
length, which suggests that the polyA+ RNA had undergone some degradation. 
Nonetheless, the ability of the polyA+ RNA to direct the synthesis o f significant 
amounts of long cDNA molecules (5kb) suggested that degradation of the polyA+ 
RNA preparation was not extensive.
Markers 1st strand 
cDNA
Figure 20. First Strand cDNA Synthesis.
HFL cells were infected with tsl204 at a moi of 20pfu per cell and incubated at 
the NPT for 7 hrs post-infection. The cells were harvested and the total polyA+ 
RNA was prepared from the infected cells as previously described in sections 
2B.11.1 and 2B.11.2. Poly A+ RNA (0.5|ig) was used as a template for the synthesis 
of single stranded cDNA according to the procedure described in section 2B.11.4. 
The 32P-labelled first strand DNA was analyzed by electrophoresis through an 
alkaline 1% agarose gel using as markers 32P end-labelled Hindlll fragments of 
bacteriophage X DNA.
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b) The Ability of the PolyA+ RNA Preparation to Direct the Synthesis of High 
Molecular Weight Polypeptides in a Reticulocyte In Vitro Translation System.
The integrity of the polyA+ RNA was assessed by translating 0.5fj.g of the 
p o ly A + RNA preparation in a cell free rabbit reticulocyte lysate system 
(Promega) in the presence of 0.8mCi/ml of [35S]-methionine. The radiolabelled 
proteins were separated on a SDS 9%-polyacrylamide gel and detected by 
placing the gel in contact with pre-flashed Kodak Xomat XS-1 film  (Figure 21). A 
large number of proteins ranging in size from less than 10 kDa to greater than 
100 kDa were synthesized from the polyA+ RNA, confirm ing that the polyA+ 
RNA was not appreciably degraded. In addition, the abundance of the polyA+ 
RNA encoding p56, the protein of interest, was checked by in vitro translation 
of this polyA+ RNA. The synthesis of cDNA was performed using a polyA+ RNA 
preparation in which the in vitro synthesis of p56 appeared as a prominent 
band on a SDS polyacrylamide gel (Figure 21). A crude estimation of the 
frequency w ith which the p56 polyA+ RNA occured in the total polyA+ RNA 
population was made by comparing the intensity of the p56 polypeptide band 
shown in the autoradiograph of tsl204-infected cell proteins (Figure 21) with 
that o f actin, another abundant cellu lar p ro te in  by densitom etry. The 
frequency of actin cDNA clones in a fibroblastoid cell line cDNA lib ra ry  is 
approximately 1-4% (Current Protocols in Molecular Biology, 1987). Thus, 
assuming that actin and p56 each have an equal number of methionine 
residues, it was concluded that the p56 protein comprised between 1 and 5% of 
the total cell protein in tsl204-infected cells.
2.1 Strategy For cDNA Cloning
Previous studies have reported that about 2 x l0 5 recombinants must be 
screened (using nucleic acid probes) to detect a low abundance polyA+ RNA 
(Sambrook et al., 1989). In this study it was estimated that the polyA+ RNA 
encoding p56 is relatively abundant, comprising at least 1% of the total polyA+ 
RNA population used to construct the cDNA library. Thus, on this basis it is 
conceivable that for every 100 recombinants generated by cDNA cloning, at 
least one of these w ill represent the polyA+ RNA encoding p56. However, it is 
usually regarded as sensible to aim for a library that contains at least 5 times 
more recombinants than the total indicated by the lowest abundance estimate.
1 2 3
Actin >
Figure 21. Translation OfPolyA+ RNA In Reticulocyte Lysates.
HFL cells were mock-infected or infected with ts l204 at a moi of 20pfu per 
cell and incubated at the NPT. At 7 hrs post-infection, the cells were 
harvested and cytoplasmic RNA was extracted from the infected cells 
essentially as described by Preston et al., (1979) (refer to section 2B.11.1). 
PolyA+ RNA was selected from the cytoplasmic RNA using Hybond-mAP 
Messenger A ffin ity  Paper. The polyA+ RNA was translated in vitro as 
described in section 2B.11.3. The translated proteins were separated on a 
SDS-9% polyacrylam ide gel and visualized by autoradiography. In the 
ts 1204-infected cell track the position of the ce llu la r p ro te in  p56 is 
indicated by the arrow head. Lane 1 represents a negative RNA control, 
w h ils t lanes 2 and 3 show the in vitro tra n s la tio n  products o f 
ts1204-infected cell RNA and mock-infected cell RNA respectively.
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Considering the relative abundance of the p56 polyA+ RNA, a high cloning 
efficiency was not regarded to be of central importance in the isolation o f the 
corresponding cDNA. Although the cloning efficiencies of phagemid vectors 
are usually 10 to 50-fold lower than that of A. vectors, the resulting cDNAs are 
considered simpler to isolate and manipulate than A. recombinants. Thus fo r the 
purpose of isolating the p56 cDNA the phagmid vector pT7T3 18U (Pharmacia) 
was chosen for cDNA cloning. This phagemid was selected as a cloning vector 
fo r a number of reasons. Firstly, pT7T3 18U contains both the T7 and T3 RNA 
promoters which flank the multiple cloning site. The arrangement o f the RNA 
promoters allows the selective transcription of either cDNA strand to produce 
RNA in vitro and provides a means of identifying the protein product encoded 
by the cDNA insert. Secondly, both strands of the cDNA insert can be sequenced 
d irectly  using the M l3 universal prim er or the M l3 reverse sequencing 
primer, thus, avoiding the need for further cloning procedures. A diagram of 
the pT7T3U 18U phagemid is shown in Figure 22.
2.2 Synthesis Of Double Stranded cDNA.
The polyA+ RNA, having satisfied the above requirements, was used as a 
template for the synthesis of double stranded cDNA using the Amersham cDNA 
synthesis system (see section 2B.11.5 and Figure 5). The incorporation of [oc32P]- 
dCTP into the cDNA synthesis reactions allowed the monitoring of the efficiency 
of cDNA synthesis in terms of yields of cDNA synthesized, and the size of the 
cDNA molecules obtained. The yields of cDNA synthesized were determined by 
calculating the percentage of [a32P]-dCTP incorporation into DNA (results not 
shown). To determine the size of the cDNA molecules produced during cDNA 
synthesis, small aliquots of the firs t and second cDNA reaction mixtures were 
analyzed by electrophoresis through a 1% alkaline agarose gel using as 
markers 32P end-labelled H ind lll fragments of A. The radiolabelled cDNA 
molecules were visualized by autoradiography (Figure 23). The results indicated 
that synthesis o f firs t strand cDNA using oligo dT12-i8 and the polyA+ RNA 
preparation as a template had occured, shown by the smear of radiolabelled 
firs t strand cDNA which ranged in size from less than 300bp to more than 2.5kb 
in length. Sim ilarly, second strand cDNA synthesis made by self prim ing, 
appeared as a smear of radiolabelled cDNA from  less than 500bp to 
approximately 6kbp in length.
Universal
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Figure 22. A Diagrammatic Representation Of The pT/T3 18U Cloning 
Vector.
The pT7T3 18U multifunctional phagemid is shown containing the T7 and T3 
RNA promoters flanking the pUC18 m u ltip le  clon ing site in  opposite 
orientation. This arrangement allows transcripts to be generated from either 
strand of cDNA in vitro translation experiments. The multiple cloning site is 
located w ithin the ia.cZ’ gene. The position of the Ampr  gene and the origins of 
replication are indicated.
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Figure 23. First And Second Strand cDNA Synthesis.
Poly A+ RNA (3jj.g), extracted from tsl204-infected HFL cells as previously 
described, was used to synthesize 32P-labelled double stranded cDNA molecules 
using the Amersham cDNA Synthesis System according to the protocol described 
in section 2B.11.5. The products of the first and second cDNA synthesis reactions 
were analyzed by electrophoresis through a 1% alkaline agarose gel and 
visua lized by autoradiography. 32P end-labelled H in d l l l  fragments of 
bacteriophage \  DNA were used as molecular weight markers.
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Following cDNA synthesis, the blunt-ended, double stranded cDNA 
molecules were purified on a small Sephadex G50 column and then ligated to a 
100-fold excess of oligonucleotide linkers containing phosphorylated EcoRl 
ends. Finally, the cDNA was inserted into the EcoRl site w ith in  the m ultip le 
cloning site of the pT7T3 18U phagemid (Pharmacia).
Following ligation of the cDNA inserts into pT7T3 18U, the recombinant 
molecules were introduced into competent E. coli (DH5a). The cDNA lib ra ry  was 
amplified as described in section 2B.11.9.
2.3 Evaluation Of The cDNA Library
Prior to differential screening, the lib ra ry  was evaluated to determine 
whether it  was representitive of the total polyA+ RNA population in ts l2 0 4 - 
infected cells. Evaluation of the cDNA library was done in two ways.
a) Examination of the Inserts of 24 Randomly Chosen Clones.
To confirm  that the bacteria contained recombinant cDNA rather than 
recircularized vector DNA, "m iniprep" DNA was prepared from  24 randomly 
chosen independent bacterial clones picked from the prim ary transformation 
plate. The plasmid DNAs were cleaved w ith EcoRl and analysed by agarose gel 
electrophoresis. All of the 24 clones contained cDNA inserts, however, only 11 
contained an insert of greater than lkbp . Ideally, i f  the polyA+ RNA 
preparation is o f high quality, then at least 20 of the 24 recombinant clones 
should have inserts w ith an average size of lk b  or more. The fact that the 
m a jo rity  of the cDNA inserts were less than lk b  in length was not suprising 
since previous data suggested that the polyA+ RNA preparation used fo r cDNA 
synthesis had undergone some degradation.
From the analysis of the above clones, the number of transformants per 
microgram of polyA+ RNA template was calculated as 1X105.
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b) Screening for the Actin cDNA
Since actin comprises approximately 1-4% of the tota l prote in  in a 
fibroblastoid cell line, a sim ilar proportion of recombinant bacterial clones 
m ight be expected to hybridize to an actin hybrid ization probe. Bacterial 
plasmid DNAs were immobilized onto a nylon membrane and hybridized to a 32P- 
labelled actin DNA probe. Of the 480 clones screened in this manner, 21 of these 
hybridized to the radiolabelled actin probe (results not shown). Thus the 
freqency w ith which the actin cDNA occurs w ith in  the cDNA lib ra ry  is 
approximately 4.4%.
Clearly, degradation of the polyA+ RNA preparation may result in a 
reduction in the probability of isolating a fu ll length p56 cDNA. However, since 
in vitro translation of the p56 polyA+ RNA resulted in a major band on an SDS- 
polyacrylamide gel, it is likely that there is an abundance of the fu ll length p56 
polyA+ RNA in the total RNA preparation used for cDNA synthesis.
3. Id e n tif ic a t io n  O f cDNA Clones
The differential filte r hybridization method was used to screen the cDNA 
lib ra ry because it lended itself perfectly to the isolation of cDNAs representing 
polyA+ RNAs which accumulate in tsl204-infected cells. Usually, the use of this 
screening method is lim ited by the abundance of the cDNA of interest w ith in 
the lib ra ry . Previous differentia l screening studies have been successful in 
detecting cDNAs representing polyA+ RNAs comprising not less than 0.5% of 
the total polyA+ RNA population (Foster et al., 1982; Schutzbank et ah, 1982; 
Linzer and Nathans, 1983). Since the p56 polyA+ RNA was estimated to occur at a 
frequency of at least 1% in the total polyA+ RNA population, it was hoped that 
th is  screening method would be su ffic ien t fo r the iso la tion  o f the 
corresponding p56 cDNA.
A summary of the principles of differential hybridization are given below 
and illustrated in Figure 24. Briefly, 32P-labelled firs t strand cDNAs were 
synthesized using polyA+ RNA extracted from mock- and ts l204-in fected HFL 
cells as templates. The majority of the cDNA molecules should corresponded to 
ce llu lar polyA+ RNAs whose concentrations were not appreciably altered by 
ts l 204-infection. However, a m inority of cDNAs should be copied from  polyA+
Figure 24. Differential Screening
ts1204-infected 
HFL cells
mock-infected 
HFL cells
Poly A+ 
RNA
First strand cDNA synthesis 
using polyA-h RNA as a 
template and oligo dT.
polyA-h
RNA
PolyA-h
RNA
t
single stranded 
cDNA probes
Each probe is independantly 
hybridized to duplicate copies 
of a cDNA library constructed 
from polyA+ RNA extracted 
from ts1204-infected HFL cells.
clone of 
interest
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RNAs whose concentrations were significantly increased in tsl204-infected HFL 
cells, eg. p56 polyA+ RNA. To minimize variations between the two polyA+ RNA 
populations, the tsl204-infected and mock-infected polyA+ RNA preparations 
used fo r the synthesis of each cDNA probe were prepared in parallel from HFL 
cells w ith  the same passage number. In addition, the in tegrity  of the polyA+ 
RNA was determined as described in sections 2B.11.3 and 2B.11.4 prio r to use as a 
template for cDNA probe synthesis. In addition, only polyA+ RNA preparations 
which had abundant amounts of the p56 polyA+ RNA were used. Finally, the 
radiolabelled cDNA probes (specific activ ity  > l x l 0 7c p m /jig  DNA) were 
hybridized separately to duplicate nylon membranes onto which recombinant 
bacterial DNA had been immobilized according to the procedure described in 
section 2B. 13.1c. Following hybrid ization, the membranes were washed 
thoroughly and the degree of hybridization determined by autoradiography 
(Figure 25). The film  was pre-flashed w ith a photographic flash un it before 
being placed in contact w ith the membrane to allow the in tensity o f the 
autoradiographic image on the film  to be quantitated by densitometry.
Some 3,000 recombinant bacterial clones were screened in this manner 
during two rounds of screening using cDNA probes synthesized from two 
separate polyA+ RNA extractions. Twenty three of the clones that were screened 
appeared to hybridize preferentially to the tsl204-infected cDNA probe, some of 
which are shown in Figure 25. The clones were named according to the number 
and position o f the clone on the m icrotitre  plate. These selected clones 
represented approximately 0.8% of the members o f the lib ra ry  that were 
in itia lly  screened. Although some clones showed an increased hybridization 
signal to the mock-infected cDNA probe (eg 217F), on ly  clones which 
hybridized preferentially to the cDNA probe prepared from tsl204-infected cell
polyA+ RNA were selected for further analysis.
' ; . ^
The relative increase in the hybridization signal to the ts l204 cDNA probe 
compared to the signal from the mock-infected cell cDNA probe was estimated 
fo r each of the selected clones by densitometric analysis. (Table 3). In addition, 
the size of each of the cDNA inserts was determined by digesting each 
recombinant cDNA clone w ith EcoRl and analysing the cleaved DNA by 
electrophoresis through a 1% agarose gel. The size of each cDNA insert was 
calculated by comparing the mobility of the insert DNA to a set of standard DNA 
fragments.
Figure 25. Screening O f The cDNA Library
Ind ividual bacterial clones were grown at 37° in  m icro titre  wells containing L- 
bro th  supplemented w ith  100^g/m l o f am picillin . A volume of 50^1 o f each 
bacterial suspension was spotted onto nylon membranes using a dot b lo t 
apparatus. The bacteria were lysed and the plasmid DNA denatured and fixed to 
the membrane. Recombinant plasmid DNAs from  the lysed bacteria were 
hybrid ized to 32P-labelled single stranded cDNA probes synthesized from  
cytoplasmic polyA+ RNA extracted from  tsl204-infected (+) or mock-infected (-) 
HFL cells. The clones were named according to the number and position o f the 
clone on the membrane. The arrows ind ica te a p a rticu la r clone tha t 
dem onstrated d iffe re n tia l hyb rid iza tio n . Clone 217F w hich hyb rid ized  
preferentia lly to the mock-infected cDNA probe is indicated by the filled  arrow.
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The relative hybridization of each of the 23 selected clones to the ts l204  
cDNA probe as well as the size of each cDNA insert are summarized in Table 3.
The majority of the selected clones showed only a marginal increase in the 
hybridization signal to the tsl204-infected cDNA probe. Futhermore, these 
clones hybridized weakly to the tsl204 cDNA probe, which suggests that they 
represent m inor messages within the total cytoplasmic polyA+ RNA population. 
Interestingly, recombinants that hybridized almost exclusively to the ts l2 0 4  
cDNA probe appeared to represent abundant messages w ith in  the polyA+ RNA 
population.
In the present study, only cDNA clones which hybridized to abundant polyA+ 
RNAs were analyzed further.
4. Identification O f Homologous
The polyA+ RNA encoding p56 is believed to be an abundant species w ithin 
the total rsl204-infected HFL cell polyA+ RNA population (1-5%). Therefore, the 
cDNA encoding p56 might be expected to occur at a sim ilar frequency in the 
cDNA library. Consequently, of the 3000 recombinant bacterial clones that were 
screened, a conservative estimate for the number of recombinant cDNA clones 
encoding p56 would be approximately 30. Furthermore, it  is feasible that a 
proportion of the 23 clones that show preferential hybridization to the ts l204- 
cDNA probe may represent identical polyA+ RNAs. To address this possibility, 
DNA cross-hybridization analysis of each of the 23 selected clones was 
performed.
Recombinant phagemid DNA was prepared from each of the 23 bacterial 
clones showing preferential hybridization to the tsl204-cDNA probe according 
to the protocol described in section 2B.13.7. The insert DNA from  each 
recombinant was purified from the vector DNA by cleaving the DNA w ith EcoRl 
and separating the cleaved DNA fragments by electrophoresis through a 0.7% 
agarose gel. Following electrophoresis, the cDNA inserts were purified from  the 
agarose gel using Geneclene II (described in section 2B.13.4). Finally, the 
pu rified  cDNA inserts were used as templates to synthesize ind iv idua l 32P- 
labelled single stranded DNA probes by primer extension (section 2B.10.1). Each 
radiolabelled probe was hybridized to 200ng of each of the 23 recombinant 
phagemid DNAs immobilized on nylon membranes. Following hybridization, the 
filters were washed thoroughly and the extent of hybridization was determined 
by autoradiography.
Clone Insert size (kbp)
Relative
hybridisation
34H 0.7 3.4
32F 0.12 2.8
35H 0.11 1.5
84D 1.2 13.6
13 IE 2.2 11.4
131H 2.5 15.8
1310H 0.075 17.6
162F 0.2 1.75
168C 1.6 3.2
169A 0.3 4.0
177E 0.6 3.75
1711G 1.1 3.3
191D 0.8 3.1
194D 1.6 4.5
208E 0.4 2.0
2012D 1.6 3.2
218E 1.6 5.1
2212H 1.6 6.0
339E 1.6 5.74
633H 0.8 15.2
634C 0.55 12.3
634E 0.4 10.7
637H 0.325 14.0
Table 3. Summary Of ts1204-Inducible cDNA Clones
Insert sizes were measured on 1% agarose gels by comparing the relative 
m ob ilities o f DNA fragments generated by EcoRl cleavage o f the 
recom binant cDNAs, w ith  a set o f standard fragments. The re lative 
hybridisation signal of each clone to the cDNA probe prepared from rsl204- 
infected HFL cell PolyA+ RNA compared to that synthesized from  mock- 
infected polyA+ RNA was estimated by densitometric analysis.
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The m ajority o f the recombinant cDNA clones appeared to be unique, 
inasmuch as they did not cross-hybridize w ith any o f the remaining 22 
recombinants (results not shown). Nonetheless, DNA cross-hybridization 
analysis allowed the identification of two distinct groups of cDNA molecules that 
represented polyA+ RNAs which appeared to accumulate in tsl204-infected HFL 
cells. According to the number of bacterial clones in each group, the groups 
were designated C4 and C6 respectively. The degree of cross hybridization 
between the the C4 and C6 cDNA clones is illustra ted in Figures 26 and 27 
respectively.
The group of cDNA clones designated C6 consisted o f six members, 194D, 
168C, 2012D, 2212H, 218E and 339E. With the exception of 339E, all of the clones 
were isolated during the firs t round of screening. The ind iv idua l 32P- 
radiolabelled probes cross-hybridized with equal intensity to each member of 
C6, which suggested that the C6 clones shared an identical proportion of 
homologous sequences in the cDNA. Indeed, digestion of the C6 recombinant 
cDNAs w ith EcoRl and analysis of the cleaved DNA by electrophoresis through a 
1% agarose gel revealed that each of the C6 recombinants contained cDNA 
insert of approximately 1.5kb in size (Table 3).
Confirmation that each of the above recombinants had homologous cDNA 
inserts was obtained from sequence data analysis o f each clone by the dideoxy 
chain term ination method using M13 universal and reverse primers. The 
sequencing products were analyzed by denaturing po lyacrylam ide gel 
electrophoresis and visualized by placing the dried gel in contact w ith X-Omat 
XS-1 film  (Figure 28). Figure shows an autoradiograph of the 3’ term ini DNA 
sequences of the C6 cDNA clones. The sequence lying upstream of the A-rich 
region, which probably represents the polyA+ tail, is identical in each of the 
clones. This find ing confirms that the C6 cDNA clones represent identical 
polyA+ RNAs.
Sk*>vOir\ 28
Comparison of the 13o bp of the 3’ terminus of the C6 cDNA^with existing 
sequences stored in the GenEMBL Database using the FASTA program of the GCG 
sequence analysis software, failed to establish the ide n tity  of the protein 
encoded by the C6 cDNA. Similarly, the amino acid sequence predicted from 
translation of the 200bp DNA sequence in all three ORFs d id not show any 
significant homology to sequences stored in the Swiss-Prot Protein Sequence
634C
634(
•  *
A  63711 634C j g A  ^ J6 3 7 H
1311 ^  84C 1311 H P  " 1  84E
Figure 26. DNA Cross-Hybridisation
Recombinant cDNA was prepared from the C4 bacterial clones as described in 
section 2B.13.7. Approximately 200ng of each of the recombinant cDNAs was 
denatured and immobilized onto a nylon membrane using a dot-blot manifold as 
indicated. Each cDNA on the membrane was hybridized to 32P-labelled clone 
specific DNA probes prepared by primer extension (probes are shown in italics 
above each membrane). Following hybridisation, the membranes were washed 
thoroughly and the degree of hybridisation determined by autoradiography. 
The degree of hybridisation of the 634C- and 13IE-specific DNA probes to each 
of the recombinant C4 cDNAs is shown in this figure.
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194D ^ P  2012D 194D 2012D
168C ^ P  2212H 168C ^ P  P P  2212H
339E 0  £  218E 339E 218E
339E 2012D
194D ^ p  2012D 194D 2012D
168C 2212H 168C ^ p  ^ p  2212H
339E H P  218E 339E ^ P  ^ P  218E
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Figure 27. DNA Cross-Hybridisation Analysis Of The C6 cDNA Clones.
Recombinant cDNA was prepared from the bacterial clones 194D, 2012D, 168C, 
339E, 2212H and 218E as described in section 2B.13.7. Approximately 200ng of 
each of the recombinant cDNAs was denatured and immobilized onto a nylon 
membrane using a dot-blot manifold as indicated. A further 5 membranes were 
prepared in a similar manner. Each cDNA on the membrane was hybridized to 
32P-labelled clone specific DNA probes prepared by prim er extension (probes 
are shown in italics above each membrane). Following hybrid isation, the 
membranes were washed thoroughly and the degree of hybrid isa tion  was 
determined by autoradiography.
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A A G A G T G A C G T C T C G A C T C T A C A G A T C T C T C T A C T C C T T T A G T A G  
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Figure 28. DNA Sequence Of The 3 ’ Terminus O f The C6 cDNA Clones
C6 cDNA clones
194D 168C 2012D 221211 218E 339E
A-rich
Region
A G  C T A G  C T A G  C T A G  C T A G C T A G  C T
Figure 28. Sequence Analysis Of The C6 cDNA Clones.
Plasmid DNA was prepared from the C6 cDNA clones and sequenced by the 
dideoxy-chain termination method using "Sequenase" T7 polymerase and the 
sequencing solutions supplied w ith the Sequenase System Plus k it. The 
sequencing products were analyzed by denaturing po lyacry lam ide gel 
electrophoresis and visualized by autoradiography. The A-rich region of each 
of the cDNA clones is indicated.
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Database. These findings introduce the possibility that the C6 cDNA encodes a 
previously uncharacterized cellular protein.
It is conceivable that the homology observed between the C6 clones may 
have been a consequence of cross-contamination of adjacent colonies w ith a 
single bacterial colony during the isolation of bacterial colonies from  the 
prim ary transformation plate or during subsequent manipulations of the cDNA 
library. Although this possibility cannot be ruled out, it is un like ly since all of 
the C6 bacterial clones were isolated from individual prim ary transformation 
plates and separate m icrotitre plates. Another explanation fo r the observed 
sim ilarity in the size of the C6 cDNA molecules is that the C6 cDNAs represent an 
abundant fu ll length polyA+ RNA whose expression is upregulated in ts l204- 
infected HFL cells. Further analysis of the C6 clones is described in section 3D.5 
and was carried out using clone 194D.
The second group of cDNA clones that appeared to be related according to 
DNA cross-hybridization analysis, consisted of four members, 634C, 637H, 84D 
and 13IE. With the exception of 84D, these clones were isolated during the first 
round of differentia l screening. Unlike the C6 cDNA clones, none of the 32P- 
labelled C4 DNA probes cross-hybridized w ith equal in tensity  to each other 
(Figure 26), which suggested that the C4 cDNA clones shared on ly a proportion 
of homologous DNA sequence. Although it was possible that the C4 cDNAs 
represented related polyA+ RNAs which shared varying degrees o f sequence 
homology, a more like ly explanation for the variations in the intensity o f the 
cross-hybridization signals was that each cDNA insert was o f a d ifferent size. 
Digestion of the C4 recombinant cDNAs with EcoRl and analysis of the cleaved 
DNA by electrophoresis through a 1% agarose gel, revealed that the la tte r 
proposal was more likely, inasmuch as the C4 cDNA clones 634C, 637H, 84D and 
131E contained cDNA inserts sizes of 0.55kbp, 0.325kbp, 1.2kbp and 2.2kbp 
respectively. Unfortunately, the recombinant bacterial clone 13IE which 
contained the plasmid w ith  the largest cDNA insert was found to be 
contaminated w ith  bacteriophage, and as a consequence it  was discarded. 
Further analysis of the C4 group of cDNA clones was carried out using clone 
84D.
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5. Further Analysis Of The C6
5.1 RNA Homologous To The C6 cDNA 
Infected HFL Cells.
The results so far report the isolation of a cDNA (C6) corresponding to a 
polyA+ RNA which accumulates in ts 1204-infected HFL cells. To confirm  this 
finding, the relative abundance of the 194D specific polyA+ RNA in tsl204-, wt 
virus- and mock-infected cells was assessed.
HFL cell monolayers were mock-infected or infected w ith  ts l204  or wt 
virus at a moi of 20pfu per cell and incubated at the NPT. At 7 hrs post-infection 
the cells were harvested and total cytoplasmic RNA was extracted from the cells 
according to the procedure outlined in section 2B.11.1. Each of the total 
cytoplasmic RNA preparations (20^ig) was incubated w ith 50% formamide, 6% 
formaldehyde to denature any RNA secondary structure. The denatured RNA 
was fina lly  immobilized onto a nylon membrane in a slot blot manifold and 
hybridized to a 32P-labelled DNA probe prepared by prim er extension using the 
194D cDNA insert as a template. Following hybridization, the membrane was 
washed thoroughly and placed in contact w ith pre-flashed Xomat XS-1 film  
(Figure 29 lane 1). Since clone 162B demonstrated equal colony hybridization in 
differentia l screening, it was used as a control in the present study. The results 
indicated that the polyA+ RNA represented by the 194D cDNA was detectable in 
mock-infected cells and accumulated in tsl204-infected cells at the NPT, whilst 
it  was barely detectable in cells infected with wt virus. Densitometric analysis 
o f the intensity of the autoradiographic images on the film  showed that ts l 204- 
infection o f HFL cells resulted in a 4 fold accumulation o f the 194D specific 
po lyA+ RNA. Independent total cytoplasmic RNA populations were tested in a 
second experiment w ith identical results (lane C6 2).
5.2 The C6 cDNA Encodes A 40kDa Cell Protein.
The previous data indicated that the C6 cDNA was derived from  a polyA+
RNA that accumulated in tsl204-infected HFL cells at the NPT. As described
10V2LX>
previously, the clones designated 194D, 168C, 2212H, 218E/land 339E, which 
comprise C6, each have cDNA inserts of approximately 1.5kb, suggesting that
Clone specific DNA probe
(16 1 C6 2 1628
mock-infected cell RNA 
tsl204-infected cell RNA 
wt virus-infected cell RNA
Figure 29. Examination Of HFL Cell Total Cytoplasmic RNA For 
Sequences Homologous To The C6 cDNA.
HFL cell monolayers were mock-infected or infected with ts l 204 or wt HSV-1 at 
a moi of 20pfu per cell at the NPT. At 7 hrs post-infection, the cells were 
harvested and total cytoplasmic RNA was extracted from the harvested cells as 
described in section 2B.11.1. Approximately 20|ig of each of the total RNA 
preparations was immobilized onto a nylon membrane using a slot b lo t 
manifold. The immobilized RNA was hybridized to a 32P-labelled C6-specific 
DNA probe prepared by prim er extension. Following hybrid isation, the 
membrane was washed thoroughly and the degree of hybrid isa tion  was 
determined by autoradiography. Lanes marked 1 and 2 represent identical 
experiments performed w ith independent RNA preparations. Clone 162B 
demonstrated equal colony hybridisation in d ifferentia l screening, and is 
presented here as a control.
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they may represent fu ll length polyA+ RNA molecules. On this basis it was 
assumed that the size of the fu ll length C6 protein could be determined by in 
vitro transcription and translation of the C6 cDNA using the TNT Coupled 
Reticulocyte Lysate System (Promega).
Sequence data analysis of the C6 cDNA clones indicated that the cDNA 
insert sequences were orientated so that transcription from the T7 promoter 
would generate mRNA from the correct strand. Recombinant C6 cDNA was 
therefore transcribed by bacteriophage T7 polymerase which was coupled to 
translation in the micrococcal nuclease treated rabbit reticulocyte lysate in a 
single reaction of coupled transcription-translation (see section 2B.11.10).
The protein product encoded by the C6 cDNA was separated by SDS-PAGE 
and visualized by autoradiography. Rainbow molecular weight markers, 
supplied by Amersham, were also run on the gel. The efficiency of the TNT 
coupled Reticulocyte Lysate System in d irecting  the transcrip tion  of 
complementary RNA from DNA as well as the translation of RNA into protein 
was assessed by performing similar reactions w ith the luciferase DNA supplied 
w ith the kit and mock-infected HFL cell polyA+ RNA.
The results are illustrated in Figure 30. An estimation of the molecular 
weight of the polypeptide encoded by the C6 cDNA was obtained by measuring 
the relative m obility of the C6 protein on a 9% SDS-polyacrylamide gel and 
refering to a standard curve that was constructed by plotting the Log10 of the 
molecular weight of each rainbow marker polypeptides against the distance 
that the marker had migrated through the gel. Thus, according to the standard 
curve, the C6 polypeptide was estimated to have a molecular weight of 
approximately 40 kDa. Although a number of lower molecular weight protein 
bands could be seen, in addition to the 40kDa C6 protein in lane 2, these 
probably resulted from the internal initiation of translation.
5.3 C6 cDNA Does Not Encode The Mitochondrial Aspartate Amino- 
Transferase.
Macnab et al., (1985) identified a series of tumour specific cellular proteins 
w ith apparent molecular weights of 200, 90, 40 and 32kDa respectively, that 
were recognized by antisera raised against HSV-2 infected cells and by TBS.
Figure 30. The Gene Product Of The C6 ORF.
The C6 cDNA insert cloned downstream from the T7 RNA polymerase 
promoter in pT7T3 18U were transcribed and translated in vitro using 
the TNT Coupled Reticulocyte Lysate System (Promega). The 
radiolabelled proteins were resolved on a 9% SDS-polyacrylamide gel 
and visualized by autoradiography (lane 2). In vitro tra n s la te d  
mock-infected HFL cell polyA+ RNA and the 62kDa protein product of 
the Luciferase RNA supplied with the kit, are indicated in lanes 1 and 3 
respectively. The position of the Rainbow molecular weight markers 
are indicated by the arrows to the left of the figure.
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Further analysis of the 40kDa cell protein, confirmed that expression of this 
protein was increased in HSV-infection (Macnab et al., 1992). Recently, the 
40kDa protein was identified as the mitochondrial aspartate amino-transferase 
(Lucasson, 1992).
To address the possibility that the 40 kDa C6 protein, which accumulates 
during tel 204-infection, was homologous to the 40 kDa mitochondrial aspartate
tVua.
amino-transferase, recombinant cDNA 194D was used as a template inATNT 
coupled reticulocyte system for the in vitro synthesis of C6 polypeptide. 35S- 
methionine labelled C6 protein, synthesized in vitro, was immunoprecipitated 
with tum our bearing serum (TBS). The precipitated proteins were separated on 
a 9% SDS-polyacrylamide gel and visualized by autoradiography (Figure 31). 
The results show that the TBS immunoprecipitated the [35S]-labelled 40kDa 
cellular protein from tumourogenic Bn5T cells (Lane 3), but failed to interact 
w ith the C6 protein. It is likely therefore that the C6 protein and the aspartate 
amino-transferase are distinct proteins.
To confirm this finding, DNA cross hybridization analysis of the C6 cDNA 
with the cDNA encoding the rat aspartate amino-transferase (MasPAT Huyhn et 
al.. 1981) was performed. The C6 and MasPAT cDNA inserts (200ng) were 
denatured and immobilized onto a nylon membrane using a slot b lot manifold. 
The membrane was hybridized to a 32P-labelled MasPAT DNA probe prepared by 
prim er extension using the MasPAT cDNA insert as a template. Following 
overnight incubation at 65°, the membrane was washed thoroughly and the 
degree of hybridization was determined by autoradiography (Figure 32). The 
MasPAT DNA probe was unable to hybridize to the C6 cDNA, confirming previous 
data that the C6 and MasPAT cDNAs encode distinct proteins.
6. F u r th e r  C ha rac te risa tion  O f The C4 cDNA C lones
6.1 RNA Homologous To The C4 cDNA Clones Accumulates In ts l 204- 
Infected HFL Cells.
The previous section described the isolation of a cDNA (C4) representing a 
polyA+ RNA which accumulated in tel204-infected HFL cells, inasmuch as the C4 
cDNA appeared to show preferential hybridization to the tsl204-cDNA probe
200
Figure 31. Immunoprecipitation Of The C6 Protein Product With TBS.
The 35S-methionine-labelled C6 protein product was synthesized in vitro using 
the TNT Coupled Reticulocyte Lysate System as described in section 2B. 11.10. 
Approximately l x l0 6cpm of the radiolabelled C6 protein was added to 200pl of 
RIPA buffer and used in immunoprecipitations w ith TBS. The precipitated 
proteins were separated on a SDS 9%-polyacrylamide gel and visualized by 
autorad iography. The 200, 90, 40 and 32kDa pro te ins tha t were 
immunoprecipitated from 35S-methionine labelled Bn5T cells w ith TBS (lane 3) 
are indicated by dots. Lanes 1) 35S-methionine labelled Bn5T cell extracts; 2) 
Bn5T cells immunoprecipitated without TBS ;3) Bn5T cells immunoprecipitated 
with TBS; 4) C6 protein product; 5) C6 protein immunoprecipitated w ith TBS; 6) 
C6 protein immunoprecipitated without TBS.
C6 cDNA MasPAT cDNA
Figure 32. DNA Cross-Hybridisation Analysis Of C6 With MasPAT.
C6 and MasPAT insert DNA (200ng) were denatured and immobilized onto a 
nylon membrane. The DNAs were hybridized overnight at 65° to a 32P-labelled 
MasPAT DNA probe prepared by prim er extension using 32[P]-dCTP. Following 
hybrid isation, the membrane was washed thorough ly and the extent o f 
hybridisation determined by autoradiography.
% The DNA sequence o f the 5’ terminal end of clone 84D is shown in Figure 34.b).
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during rounds ot differential screening. To confirm  these findings, attempts 
were made to detect the RNA homologous to the 84D cDNA in rsl204-infected HFL 
cells. For comparison, the relative level of 84D polyA+ RNA in mock- and vvr- 
virus infected HFL cells were determined in parallel.
HFL cell monolayers were mock-infected or infected w ith ts l204  or wt 
virus at a moi of 20pfu per cell and incubated at the NPT. At 7 hrs post-infection 
the cells were harvested and total cytoplasmic RNA was extracted according to 
the procedure outlined in section 2B.11.1. A total of 20ug of each of the total 
cytoplasm ic RNA preparations was incubated w ith  50% form am ide, 6% 
formaldehyde to denature possible RNA secondary structure and the denatured 
RNA was fina lly  immobilized onto a nylon membrane in a slot b lo t manifold. 
The immobilized RNA was hybridized to a 32P-labelled DNA probe prepared by 
prim er extension using the 84D cDNA as a template. Following hybridization, 
the membrane was washed thoroughly and the membrane was placed in contact 
w ith pre-flashed Xomat XS-1 film  (Figure 33). Since clone 638E demonstrated 
equal colony hybrid ization to mock- and ts l20 4 -in fec te d  cell cDNA in 
differential screening, it was used as a control in the present study. The results 
indicate that the polyA+ RNA represented by the 84D cDNA was barely 
detectable in mock- or wt virus-infected cells incubated at the NPT, but 
accumulated in cells infected w ith ts l2 0 4  under the same conditions. 
Densitometric analysis of the intensity of the autoradiographic images on the 
film  indicated that ts l 204-infection of HFL cells resulted in a 16 fo ld increase in 
the concentration of the polyA+ RNA represented by the 84D cDNA clone. 
Independent total cytoplasmic RNA preparations were tested in a second 
experiment (lane C4 2). On this occasion a 5-fold increase in the relative 
concentration of the 84D polyA+ RNA in tsl204-infected cells was apparent. The 
significance in the variation in 84D polyA+ RNA accumulation in ts l 204- 
infected cells is discussed in section 4.
6.2 Identification Of An Aiu Repetitive Sequence In 84D.
Approximately 2.00 bp of the 5’ terminal end of clone 84D was sequenced 
using M l3 reverse prim er according to the procedure described in section 
2B.14^Comparison of this 2oobp region with other known nucleotide sequences 
that comprise the Genbank and EMBL databanks was performed using the GCG 
sequence analysis software package version 5.0 and 6.0 (Devereux, 1989). This
Clone specific DNA probe  
C4 1 C4 2 638E 1 638E 2
mock-infected cell RNA
is1204-infccted cell RNA
\\ l virus-infected cell RNA
Figure 33. Examination Of HFL Cell Total Cytoplasmic RNA For 
Sequences Homologous To The C4 cDNA.
HFL cell monolayers were mock-infected or infected w ith ts l204 or ivt-HSV-1 at 
a moi o f 20pfu per cell at the NPT. At 7 hrs post-infection, the cells were 
harvested and total cytoplasmic RNA was extracted from the harvested cells as 
described in section 2B. 11.1. Approximately 20pg of each o f the total RNA 
preparations was immobilized onto a nylon membrane using a slot b lo t 
manifold. The immobilized RNA was hybridized to a 32P-labelled C4-specific DNA 
probe prepared by primer extension. Following hybridisation, the membrane 
was washed thoroughly and the degree of hybridisation was determined by 
autoradiography. Lanes marked 1 and 2 represent identical experiments 
performed with independent RNA preparations. Clone 63 8E demonstrated equal 
colony hybridisation in differentia l screening and is presented here as a 
control.
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analysis indicated that the 5' end of clone 84D was homologous to an alu 
repetitive sequence.
The alu repeats are a family of short interspersed repeated DNA elements. 
Nearly 500,000 alu repeat copies exist in a haploid genome w ith an average 
spacing of approximately 4kbp (Hwu et al., 1986). They are about 300bp in 
length and are dimeric in structure, comprising a right and a le ft ha lf region 
which are separated by an A-rich region (Figure 34 a). Another A-rich region 
exists at the 3’ end of the alu repeat which is variable in size. A well defined 
RNA polymerase III promoter, which directs the transcrip tion of the entire 
element, is located in the LHS of the repeat. The right and left halves are related 
with the exception that the right hand side does not contain an active RNA pol 
III promoter. Although the members of this fam ily can be divided into sub­
families based on nucleotide sequence divergence, all o f the alu sequences 
identified to date share a recognizable 280bp nucleotide consensus sequence 
(Jurka and Smith, 1988; Figure 34b). The alu repeat sequences contain at least 
one restriction site for the Alu I restriction enzyme.
To confirm the in itia l finding that the 5’ terminus of clone 84D did indeed 
represent an alu repeat element, the degree of sequence homology of the 84D 
sequence to the alu consensus sequence described by Jurka and Smith (1988) 
was performed using the FASTA program of the GCG sequence analysis software. 
The results of the comparison are shown in Figure 43.b and illustrate an 80% 
homology between the 84D putative alu repeat sequence and the alu consensus 
sequence. On this basis it can be concluded that an alu repeat lies at the 5' 
terminal end of the cDNA clone 84D. The significance of this observation w ill be 
discussed in section 4.
The in itia l DNA cross-hybridization studies performed with C4 indicated 
that the C4 clones shared only a proportion of homologous DNA sequences. It 
was concluded from  DNA cross-hybridization studies that the C4 cDNAs 
represented the same polyA+ RNA but that the variation in the degree of C4 
cross-hybridization was due to each of the cDNA clones being a d ifferent size. 
On the basis of the previous data, however, it is possible that the C4 cDNAs do not 
represent sim ilar polyA+ RNAs. Instead, the degree of DNA cross-hybridization 
may have resulted from the presence of a homologous alu repetitive sequence.
To address this possibility, experiments were performed to determine 
whether clones 637H and 634C were homologous to the alu repeat or to other
Figure 34. a) A Schematic Representation Of The Alu Repetitive 
Sequence.
The alu repeat, consisting of a left hand side (LHS) and a right hand side (RHS) 
is shown as a long box w ith the A-rich sequences represented by the shaded 
areas. The functional RNA pol III promoter is indicated in the LHS of the repeat 
and directs the transcrip tion  o f the entire  element. The d irec tion  o f 
transcription is from 5' to 3' as indicated in the diagram.
Figure 34.b) Nucleotide Sequence Comparison Between Clone 84D And 
The Alu Repeat Consensus.
The alu consensus sequence defined by Jurka and Smith (1988) and the 5' 
terminus of clone 84D are aligned to show homologous regions. Homologous 
regions were identified by the FASTA program of the GCG sequence analysis 
software. The positions of the A-rich regions and the RNA pol III promoter are 
shown by arrows. The position at which Alu I restriction enzyme cuts the 
repeat is marked by an asterisk.
Functional 
RNA pol III 
promoter
A
A-rich
region
A
A-rich
region
b)
5 ' RNA pol III
Alu consensus promoter
53 CGGGCGG AT C ACCT G AGGT CAGG AGTT CG AG ACC AGCCT GGCC A AC AT GGT G A AACCCC 112
GAGCGCGT CCTGA GTCA GAGTT GAGACCAGCCTAGCC ACAT GTG ACCCT 
84DcDNA
A-rich region
—“ ” “ “ ★
113 GTCTCTACTAAAAATACAAAAATTAGCCGGGCGTGGTGGCGCGCGCCTGTAATCCCAGC 171
GTCTCTACT AAATTC AAATT GGGCAGGC AT GGTGGCGGGT GCCTGTAGTCCCAGC
172 TACTCGGGAGGCTGAGGCAGGAGAATCGCTTGAACCCGGGAGGCGGAGGTTGCAGTGAG 230 
T ACTT GGG AGGCT G AGGC ACG AG AAT CGCTT G ACCCAAG AG AT GG AG ATT GC AGTG AT
3'
231 CCG AG ATCGCGCCACT GC ACT CC AGCCT GGGC-G ACAGAGCGGG ACT CCGT CT C A A AAA 289 
CT A AG AT CGT GCC ACTGCACT CC AGCCTGGGC A AAC AG AGC ACG ACTCC AT CT CC
A-rich region 
 ►
290 A A A A A A A
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sequences w ithin clone 84D. This involved the separation of the 5' terminal alu 
repeat from the remainder of 84D. To ensure that the entire alu repeat was 
cleaved from the 5' terminus of 84D, an experiment was carried out to identify a 
restriction enzyme that cleaved the 84D cDNA at a single site approximately 300 
bp upstream from the 5’ terminus. Recombinant 84D cDNA was cleaved once 
with BamHl in the appropriate buffer and the DNA term ini were labelled with 
32P according to the protocol described in section 2B.10.3. One of the 32P-labelled 
term ini was removed by digesting the DNA with Hindlll. Approximately 1X105 
cpm of 32P-labelled 84D recombinant DNA was digested w ith  decreasing 
concentrations of each of the enzymes marked in Figure 35 and incubated at 37° 
for 15 min. After incubation, the digests were pooled and the partia lly digested 
DNA was analyzed on a 5% non-denaturing polyacrylam ide gel using as 
markers 32P end-labelled X DNA cleaved with Hindlll. The 32P-labelled cleaved 
DNA was visualized by autoradiography (Figure 35). The size of the radiolabelled 
fragments generated by restriction enzyme digestion of the end-labelled 84D 
cDNA was determined by measuring the relative m obility  o f each fragment on 
the polyacrylamide gel and referring to a standard curve that was constructed 
by plotting the size of each of the marker DNAs (Logio) versus the distance that 
the DNA fragments migrated through the gel. The results show that Taq 1 
cleaved the 84D cDNA at a single site approximately 400kbp upstream of the 5’ 
terminus of the 84D cDNA. It was therefore assumed that cleavage of 84D with 
Taql was sufficient to remove the alu repeat from the 5’ terminus of the 84D 
cDNA.
To determine whether the C4 clones shared sequences distinct from the alu 
repetitive sequence, 84D was digested with Taql and the alu repeat was separated 
from the remainder of the 84D insert DNA. The alu repeat and the remainder of 
84D were radiolabelled by primer extension and hybridized seperately to 637H, 
634C, and 84D cDNAs immobilized onto nylon membranes. Following overnight 
hybrid iza tion  the membranes were washed thoroughly and the degree of 
hybrid ization analyzed by autoradiography (Figure 36). The alu repeat DNA 
probe failed to hybridize to the 637H and 634C cDNAs suggesting that these 
clones share sequences with 84D that are distinct from the alu repeat element.
Thus on this basis, the variation in the degree of DNA cross-hybridization 
observed between the C4 clones was probably due to each of the insert cDNAs 
being a d iffe ren t size and not due to the presence o f non-specific DNA — 
sequences.
Restriction enzyme
Figure 35. Partial Digestion Of 32P End-Labelled 84D cDNA
Approximately lx lO 5 cpm of 32P-labelled 84D cDNA was digested w ith increasing 
concentrations of each of the indicated restriction enzymes (10-0.25 units) and 
incubated at 37° for 15 min. Following incubation, the digests were pooled and 
analyzed on a 5% non-denaturing polyacrylamide gel. 32P end-labelled Hindlll 
fragments of bacteriophage X DNA were used as markers. The 32P-labelled DNA 
fragments were visualized by autoradiography.
84D 634C 637H
Large
84D 634C 637H
Alu
Figure 36. DNA Cross-Hybridization Analysis Of The C4 Clones With 
A 32P-Labelled Alu Probe.
The 84D cDNA was digested w ith Taql and the 5' terminal alu repeat was 
separated from the remainder of the 84D cDNA as described in section 2B.13.4 
and 2B.15.1. The alu repeat {Alu) and the remaining 84D sequences {Large) 
were radiolabelled by prim er extension and hybrid ized seperately to 
duplicate nylon membranes onto which 84D, 634C, and 637H cDNAs (500ng) 
had been immobilized as indicated. The probes are shown in italics to the left 
of each membrane. Following overnight incubation at 65° the membranes 
were washed thoroughly and the degree of hybridization determined by 
autoradiography.
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4. Discussion
1. The UL25 Gene P ro du c t
In this report the synthesis, processing and in trace llu la r localization of 
the UL25 gene product have been examined. To study the UL25 protein, a rabbit 
polyclonal antiserum raised against an oligopeptide for the UL25 protein was 
produced. The antiserum was shown to specifically immunoprecipitate a 67,000 
MW protein present in infected cell extracts and purified virions, suggesting 
that the UL25 protein is a structural component of the virion. The virus specific 
polypeptide recognized by the UL25 antiserum was s im ila r in size to the 
polypeptide predicted from sequence analysis of the IISV-I genome and so it is 
likely that this protein was the UL25 gene product.
Studies of the kinetics of UL25 polypeptide synthesis indicated that the 
protein was in itia lly  detectable at early times during infection, reaching its 
peak rate at 4-5 hrs post-infection. Further studies revealed that the maximal 
expression of the UL25 gene product was dependent upon v ira l DNA synthesis. 
These data suggest that UL25 is regulated as a leaky late v ira l gene. 
Furthermore,the UL25 polypeptide was shown to be stably maintained w ith in  
HSV-infected cells for up to 24 hrs after synthesis, consistent w ith a structural 
role required late in viral infection.
2 . The UL25 P o lyp e p tid e  Is Found
It has been well documented that capsid assembly and packaging of vira l 
DNA occur in the infected cell nucleus. The intracellular location o f the UL25 
polypeptide has yet to be determined. However, it is conceivable that i f  the UL25 
protein were to function in capsid assembly or DNA packaging then it would be 
found predom inantly w ith in  the nucleus. It has been suggested that the 
assembly of the tegument proteins, either around capsids or as independent 
condensations, occurs in the cytoplasm (Rixon et a i, 1992). However, the 
location of the UL25 polypeptide in L-particles suggests that L-particles acquire
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the UL25 polypeptide in the nucleus rather than the cytoplasm and that the 
innitiation of tegumentation occurs in the infected cell nucleus.
3. T s l204  Has A D efect In  U nco a ting  A t  The N P T
Addison et al., (1984), reported that ts l 204 had a penetration defect at the 
NPT. This conclusion was based upon two lines of evidence. Firstly, large 
numbers of membrane bound virions were observed on the surface of ts l 204- 
infected cells at the NPT when compared to cells infected w ith wt virus. 
Secondly, treatment of tsl204-infected cells at the NPT w ith PEG, a compound 
which promotes membrane fusion, was sufficient to restore v ira l in fectivity. In 
the present study, PEG reatment of tsl204-infected cells at the NPT did not lead to 
the production of viral antigens. Furthermore, capsids were observed w ith in  
the cytoplasm of tsl 204-infected cells at the NPT. Considerable numbers o f 
tsl 204 virions were also observed bound to the surface of cells at the restrictive 
temperature, which supports the idea that this mutant is defective in cell 
penetration. However, enveloped virions were also observed on the surface of 
cells infected w ith wt virus. On the basis of the present data it  is more like ly 
that ts l 204 has an uncoating defect at the NPT. However, the possibility exists 
that the t s l204 mutation, in addition to preventing uncoating o f the v ira l 
genome, may affect the rate at which virus enters cells.
The results of EM analysis of thin sections of tsl213-infected cells at the 
NPT support results of previous investigators who showed that the FISV-1 
mutant tsB7, which like ts 1213 carries a lesion in the gene encoding the large 
tegument protein Vmw273, is unable to release the v ira l genome from  the 
nucleocapsid at the NPT (Batterson et al., 1983).
The discrepancies seen between the present data and previous 
observations by Addison et al. (1984) with regard to the t s l204 phenotype are 
d ifficu lt to explain. The idea that t s l204 is blocked at a stage fo llow ing 
attachment of the virus to the high a ffin ity  cellu lar receptor but p r io r to 
membrane fusion, was further supported by the observation that at elevated 
temperatures, cells treated with a high moi o f ts l 204 were resistant to 
subsequent infection with wt HSV-1 but not HSV-2. Subsequent analysis o f HSV- 
l/HSV-2 recombinants revealed that the region o f the genome encoding the
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protein important for entry of superinfecting virus was localized w ith in  the 
same region as the gene required for resistance to the drug neomycin (David 
Smith, unpublished observations). Since the region on the IISV genome 
responsible for neomycin resistance maps to the amino-terminus of gC (Oyan et 
al., 1993), it is likely that the type specific effect seen by Addison et al. (1984) 
was probably at the level of the attachment of gC to cell surface HS.
Consistent w ith the idea that a mutation in the UL25 gene product affects 
uncoating of the viral genome, is the observation that the UL25 protein is 
tightly associated with the capsid.
The mechanisms involved in the release o f the v ira l genome from the 
capsid are poorly understood. It is likely that the uncoating process occurs at 
the nuclear membrane. Early studies using metabolic inhib itors suggested that 
de novo RNA and protein synthesis were not required fo r uncoating of the 
genome, suggesting that a ce llu la r enzyme an d /o r a v ir io n  structura l 
component is required for this event (Ilochberg and Becker, 1969). Analysis of 
the HSV-1 mutant tsB7, which carries a lesion in the large tegument protein 
Vmw273, has implicated this v irion  polypeptide in the uncoating process 
(Batterson et al., 1983). In tsB7-infected cells at the NPT capsids containing viral 
DNA, accumulated at the nuclear pores. Upon downshift to the PT, the viral 
genome was released from the capsid. Although a direct role fo r Vmw273 in 
genome uncoating has been suggested, it is possible that it is only ind irectly 
involved in this process, inasmuch as it must be removed from the capsid before 
release of the v ira l genome can occur. Therefore, the tsB7 m utation may 
prevent the dissasociation of Vmw273 from the capsid and subsequently block 
genome uncoating. The observation that the capsid pentamers were frequently 
absent from preparations of flattened capsid sheets led Vernon et al. (1976) to 
propose that their removal allows the escape of the viral DNA from the capsid 
shell.
4. T ra n s c r ip tio n a l In d u c tio n  O f C e llu la r  Genes D u r in g  HSV-1 
In fe c tio n .
Although the expression of viral genes during HSV-infection coexists w ith 
a generalized shut o ff of host protein synthesis, the expression o f a m inority of
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cellular genes is upregulated (Macnab era/., 1985; Kemp era/., 1986; Patel era/., 
1986; Kemp and Latchman, 1988; LaThangue and Latchman, 1988). The 
mechanism by which the activation of these cellular genes occurs against a 
background of generalized repression is unclear. In the m a jority  o f cases, 
induction ot these genes is dependent upon the synthesis of the v ira l IE 
proteins in the infected cell.
In the present study, two d istinct polyA+ RNAs, C4 and C6, which 
accumulated in tsl204-infected HFL cells at the NPT were isolated. Since ts l 204 is 
unable to synthesize viral polypeptides at the restrictive temperature, it is clear 
that the induction of the C4 and C6 polyA+ RNAs occurs p rio r to the onset of 
v ira l protein synthesis. These observations confirm  previous data which 
showed that the induction of some cellular genes can occur in the absence of 
viral protein synthesis (Patel eta/., 1986; Preston, 1990).
The results of this study indicate that the C6 polyA+ RNA encodes fo r a 
cellular polypeptide with a molecular weight of approximately 40 kDa (p40). A 
number of sim ilar sized proteins have been shown to accumulate during FISV- 
in fection and in transformed cell lines (Macnab et a/., 1985, 1992). 
Immunoprecipitations of p40 with TBS showed that p40 was distinct from the 42 
kDa aspartate amino transferase that was im m unoprecipitated from  HSV-2 
infected cells and transformed cells (Lucasson, 1993). A 40 kDa polypeptide was 
shown to accumulate in IISV-1 infected cells using the monoclonal antibody 
TG7A (LaThangue and Latchman, 1988). Further studies revealed that the 
accumulation of this protein was dependent upon the expression o f the IE 
polypeptide Vmw63. It is unlikely, therefore, that p40 is the same as the protein 
described by LaThangue and Latchman (1988), since the accumulation o f p40 
occurs in the absence of viral protein synthesis. Sequencing of approximately 
150bp downstream of the 3' terminus of the C6 cDNA allowed the prediction of 
the sequence of 50 amino acids at the putative carboxy terminal end of p40. The 
predicted amino acid sequence was compared w ith sequences stored w ith in  the 
Swiss-Prot Database using the FASTA program of the GCG sequence analysis 
software. The p40 amino acid sequence showed no significant homology to any 
previously characterized proteins w ithin the database suggesting that p40 is a 
novel cellular polypeptide. Prediction of the entire amino acid sequence o f the 
polypeptide encoded by the C6 polyA+ RNA would assist in the establishment of 
the identity and possibly the function of this protein in the viral lytic cycle.
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Little information was obtained as to the identity o f the protein encoded by 
the C4 polyA+ RNA. Nonetheless, it is intriguing to speculate that this polyA+ 
RNA encodes the cellular protein p56, since the C4 polyA+ RNA was barely 
detectable in mock and wt virus-infected cells whilst it accumulated 16-fold 
during ts l 204-infection at the NPT. In a second experiment, the C4 polyA+ RNA 
only accumulated 5-fold in tsl204-infected cells. Interestingly the accumulation 
o f the p56 polypeptide was sim ilarly decreased in these cells (results not 
shown). It would appear that the accumulation of the C4 polyA+ RNA mirrors 
that of the p56 polypeptide in ts l 204-infected cells at the NPT. The variable 
accumulation of the p56 polypeptide in ts l 204-infected cells was frequently 
observed. The reduced accumulation of p56 in some cases probably resulted 
from the high passage number of the cells.
5 . M echan ism s O f In d u c tio n  O f
Genes
Preston (1990) was first to observe the transcriptional induction of a 56 
kDa protein (p56) in ts l 204-infected human foetal lung cells at the NPT. The 
original proposal that ts l 204 binds to a high a ffin ity  cellular receptor but fails 
to penetrate the cell membrane at the NPT lead to the idea that the accumulation 
of p56 in ts l 204-infected cells results from the prolonged stim ulation o f the 
cellular HSV-1 receptor. However, the results of the present study introduce the 
possibility that the induction of cellular genes during ts l 204-infection occurs 
as a result of virus binding, membrane fusion or release of the capsid and 
tegument proteins into the cytoplasm.
The p56 polypeptide was also induced in cells infected w ith the mutant 
ts l213 at the NPT, albeit at lower amounts relative to ts l 204-infected cells 
(Preston, 1990). Since tsl213 and ts l204 both appear to have uncoating defects, 
it is d ifficu lt to conceive why there is a greater induction o f p56 in ts l 204- 
infected cells than those infected with ts l213. Interestingly, small amounts of 
p56 were also detected in wt virus-infected cells in the presence o f 
cycloheximide. The accumulation of the p56 polypeptide under these conditions 
may result from an increase in mRNA stab ility  due to the presence o f the 
cyclohexamide.
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Normally, once multivalent attachment between the virus and cell surface 
components has taken place, the virus is rapid ly internalized (DeLuca et al., 
1981; Rosenthal et al., 1984). The belief that t s l204 attaches to but fails to 
penetrate the cell membrane at the NPT lead to the idea that the accumulation of 
p56 in ts l 204-infected cells was caused by the prolonged stim ulation o f a 
cellular receptor to which virus was bound. This idea was supported by the 
observation that ts l 204, grown in the presence o f 2-deoxy-D-glucose, which 
prevents glycosylation of viral glycoproteins, failed to induce p56, although 
attachment of virus to cells was not impaired (Preston, 1990). Furthermore, 
antibodies specific for gD blocked the induction of p56 by t s l204, which 
suggested that the interaction of gD with the cell surface m ight be important 
for the induction of p56 (Preston, unpublished observations). However, these 
results do not preclude the possibility that p56 induction is triggered by 
membrane fusion or capsid entry, since inhib ition of specific v ira l interactions 
with cell surface components would prevent membrane fusion and subsequent 
release of the capsid into the cytoplasm. The present data suggest that ts l 204 
can enter cells at the NPT, which fa il to support the idea that p56 induction 
occurs by the continued stimulation of a cellu lar receptor. However, it  is 
possible that the initia l stimulation of a cellular receptor by one or more vira l 
glycoproteins can continue after membrane fusion has taken place. Indeed 
there is evidence to suggest that gD remains associated with the high a ffin ity  
cellular receptor following membrane fusion, in asmuch as gD present in the 
infecting v irion  is the target of gD mediated restriction to superinfection 
(Campadelli-Fiume eta/., 1990). It is unlikely that gC plays an important role in 
the induction of p56, since p56 accumulation still occurs in HFL cells infected 
with mutant virus lacking gC.
A number of cell proteins with a molecular weight of 56 kDa have been 
shown to be induced in cells treated with interferons. Interferons are produced 
in response to viral infection and it is possible that p56 is a member of a fam ily 
o f interferon induced cell proteins. Rubin et al. (1988), used a monoclonal 
antibody to identify a 56 kDa polypeptide that was induced in cells treated with 
y-interferon. This antibody also recognized a 42 kDa cellular polypeptide which 
also accumulated in y-interferon treated cells, although its accumulation was 
not as marked as that of the 56 kDa polypeptide. Further results indicated that 
the expression of these polypeptides resulted from  the in teraction o f y- 
interferon with the y-interferon receptor on the cell surface. Clearly, it would 
be interesting to determine whether p56 and p42, which accumulate in ts l 204- 
infected cells at the NPT, are the same as the interferon induced polypeptides
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identified by Rubin et al. (1988). However, p56 was shown to accumulate in the 
presence of cycloheximide suggesting that p r io r prote in synthesis is not 
required lo r the induction of p56 in infected cells. Nonetheless, the possibility 
exists that the expression of some cellu lar proteins norm ally induced by 
interferons could be mediated by other factors directly related to viral infection 
In support of this idea is the observation that binding of murine hepatitis virus 
to astrocytes in tissue culture induces the expression o f la antigen, a surface 
antigen which is also expressed on cells following exposure to y -in te rfe ron  
(Wong et al., 1984; Massa et al., 1986). It is possible that the triggering of 
expression o f the la antigen by virus binding results from the stimulation of 
the y-interferon receptor on astrocytes by component of the virus.
The finding that p56 does not accumulate in cells infected with ts l204 L- 
particles at the NPT suggests that interactions between v ira l membrane 
proteins and cell surface components are not important fo r the induction of 
cellu lar genes during ts l 204-infection. A lte rnative ly, L-particles may not 
completely mimic virions in the way they enter cells. McLauchlan et al. (1992) 
investigated the biological properties of L-particles by assaying the functions 
of two tegument proteins which are present in both types of particle, Vmw65 
and the vhs protein. Their results showed that L-particles were as efficient as 
virions in supplying both of these proteins in a biological state, suggesting that 
the attachment, fusion and release of tegument proteins was the same for both 
virions and L-particles. These data suggest that the presence of the capsid 
w ithin the cytoplasm is an important factor in the induction of p56 by ts l204.
6. The UL25 Gene P ro d u c t Is Re
In fe c tio n .
It has been concluded that the UL25 gene product performs an essential 
function at late times in infection (Addison et al., 1984), inasmuch as the 
mutants tsl 204 and tsl 208, produce very few capsids at the NPT which lack DNA. 
The tsl 204 and tsl 208 mutations map to different complementation groups than 
the previously identified DNA positive mutants which fail to encapsidate vira l 
DNA at the NPT. According to these findings it  was concluded that the UL25 gene 
product may be required for capsid stab ility  rather than the cleavage and
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packaging of concatemeric DNA. Many similarities have been observed between 
the mechanisms employed by I ISV-1 and the double stranded DNA 
bacteriophages in capsid assembly and DNA packaging. In recent studies, the 
large tegument protein Vmw273 has been suggested to function  in the 
packaging of v ira l DNA in a manner analogous to the well characterized 
terminases of the bacteriophages (Macnabb and Courtney, 1992c). Another T4 
gene product, gpD, has been shown to stabilize the capsid during DNA 
packaging and it is appealing to speculate that gpD is analogous to the UL25 
protein. However, in mature capsids, gpD is present in a 1:1 ratio w ith the capsid 
shell protein and forms trimers on the capsid surface suggesting that it is more 
homologous to the HSV capsid protein VP26 (Imber ef al., 1980; Newcomb et a/., 
1993). Nonetheless, this does not preclude a sim ilar function fo r the UL25 gene 
product. Another explanation for the low numbers o f capsids found in the 
nuclei of tsT204 and tsT208 infected cells is that the UL25 protein is required for 
the in itiation of capsid assembly, such that a ts defect in this polypeptide affects 
the rate o f initiation, which in turn results in few capsid being formed at the 
NPT. Such a function is performed by the T4 bacteriophage gene product gp20, 
which is involved in the ra te-lim iting in itia tio n  o f capsid assembly by 
anchoring the developing capsid to the bacterial membrane (Onorato et al., 
1978; Showe and Onorato, 1978; Black and Showe, 1983). Although a role fo r the 
UL25 protein in the initiation of capsid assembly is appealing, it has recently 
been shown that coexpression of the capsid proteins in a baculovirus system 
lead to the formation of capsids, suggesting that none of the tegument proteins, 
including the UL25 polypeptide, are required fo r the in itia tio n  of capsid 
assembly (Rixon, personal communication). Thus, all o f the signals that are 
involved in the comencement of capsid assembly are represented by the capsid 
polypeptides.
7. S econdary  S tru c tu re  A n a lys is  O f The UL25 Gene P ro d u c t.
The predicted secondary structure of the IISV-1 UL25 polypeptide was 
determined using the Garnier and Peptidestructure programs (Garnier et al., 
1978). These programs determine the probability of a residue type adopting one 
o f the structural states, a-helices (characterised by intra-m olecular hydrogen 
bonding between peptides on the same polypeptide chain), |l-sheet structures 
(inter-molecular hydrogen bonding), and reverse or (1-turns, which cause the
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pro te in  to fo ld on itse lf by approxim ately 180°. The predictions are 
approximately 40% accurate for small globular proteins but of questionable 
application to larger proteins if  no structural information is known. The output 
of the Garnier prediction for the UL25 gene product is shown in Figure 37. Few 
interesting features were observed by these analyses. P-turns were predicted in
several regions of the protein. These structures have been shown to occur at 
protein surfaces where they assume im portant roles in molecular function 
(Richardson, 1981; Leszczyaski and Rose, 1986). A single region o f prim ary 
sequence which was predicted to have a |i-turn structure (residues 397-412) was 
also observed to be a relatively hydrophilic part o f the protein (Figure 37), 
suggesting that this region may lie on the surface of the UL25 polypeptide. 
Furthermore, this region of the sequence is h igh ly conserved w ith in  the 
alphaherpesviruses (Figure 38). Although speculative, these data im ply that 
this region may be an important determinant for the possible interaction of the 
UL25 protein with other virion structural components.
Recently a region of homology between the UL25 protein o f IISV-1 and the 
reovirus p i protein was identified as shown in Figure 38 (Jayasuriya, personal 
communication). Although the region of homology between the reovirus m l 
and IISV-1 UL25 polypeptides is relatively short (approximately 26 amino acids), 
the location of the sim ilarity is interesting since the site o f p i to p lC  cleavage 
lies between amino acids 42 and 43 in the p i protein sequence (Jayasuriya et al., 
1988). The p i protein is cleaved during virion assembly to form the cleavage 
product, pCl, which is the major outer capsid protein of the reovirus. A sim ilar 
if  not identical cleavage of the plC, yielding the 8 protein, has been suggested to 
be of importance in the early stages of reovirus en try  in to  host cells 
(Sturzenbecker et al., 1987). The observed homology between the reovirus p i to 
p lC  cleavage site and the UL25 polypeptide lead to speculation that the UL25 
polypeptide may undergo a sim ilar cleavage event. However, pulse-chase 
analysis of UL25 polypeptide synthesis performed in this study failed to show 
that it undergoes cleavage. Furthermore the proposed cleavage site was located 
in a region of the protein that is not h ighly conserved throughout the 
alphaherpesviruses as would be expected if the cleavage site were important for 
the function of the UL25 protein in virus growth.
In conclusion of the data presented here and elsewhere, the function of 
the UL25 protein in the virion life cycle remains unknown. Clearly, the UL25 
gene product is not required for the in itia tion  o f capsid assembly as was 
orig inally suggested by Addison et al. (1984). Since a role fo r UL25 protein in
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Figure 37. Predicted Secondary Structure O f The UL25 Po iypeptide
Secondary structure predictions were made using the GCG Peptidestructure 
programme, according to Garnier er ai. (197S). Helices are shown w ith a sine 
wave (y\/v), (3-sheets with a small saw tooth wave (~~~) and turns w ith 180° 
turns. Hydrophilic ity (0) and hydrophobicity (^ ) are superimposed over the 
wave.
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Figure 38. P rim ary Structure O f The UL25 Gene P roduct
The predicted amino-acid sequence (1-580) of the HSV-1 UL25 polypeptide is 
shown in the single letter amino acid code (McGeoch era/., 1988b). Sequence 
analysis has identified proteins homologous to the HSV-1 UL25 gene product 
in VZV and EHV-1 (Davison and Scott, 1986; Telford er al., 1992). Amino acid 
residues that are highly conserved w ith in  this fam ily  of homologous 
alphaherpesviruses proteins are asterisked. The pu ta tive  region of 
homology with the reovirus | i l protein is indicated by the solid line.
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capsid stab ility  has been suggested, it would be interesting to determine 
whether the UL25 protein interacts w ith one or more of the known capsid 
proteins. From analysis of the secondary structure predictions of the UL25 
polypeptide it is likely that some regions of the protein are involved in 
interacting with other viral polypeptides the identity o f which remain to be 
elucidated.
8. F u tu re  W ork
There are still several unanswered questions as to the function o f the UL25 
polypeptide in the virion replicative cycle. As discussed earlier, pre lim inary 
EM analysis ot a relatively small number of virus infected cells illustrated that 
ts l204 can penetrate the cell membrane, but fails to uncoat the viral genome at 
the NPT. The analysis of a larger number of virus-infected cells at the NPT 
would confirm the preliminary findings.
Marker rescue experiments have localized the ts l204 mutation to a 400bp 
region in DNA fragment BamHIu. Cloning and sequencing of this fragment w ill 
allow the precise bp change of the tsl204 mutation to be determined.
The location of the UL25 gene product in the infected cell remains to be 
elucidated. These studies have been hindered by the lack of an anti-UL25 
antibody able to recognise the protein on western blots or immunofluorescence 
assays. The production of a suitable anti-UL25 antibody which recognises the 
protein on both western blots and immunofluorescence assays w ill facilitate 
further analysis of the cellular location of the UL25 gene product.
Expression of the UL25 protein in bacterial and baculovirus expression 
systems is currently under way and it is hoped that the expressed proteins w ill 
be useful in generating antisera for localisation studies.
Finally, due to the proposed role of the UL25 gene product in capsid 
stability, it would be interesting to investigate whether the UL25 gene product 
interacts w ith other viral proteins. These studies could be carried out using a 
pull-down assay, with a GST-UL25 fusion protein.
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The studies presented in this thesis iden tified  two cDNA clones 
representing polyA+ KNA which accumulate in tsT204 infected 1IFL cells at the 
NPT. The identity of the protein products encoded by these po lyA+ RNAs 
remains to be elucidated. It is likely that the C6 cDNA represents a fu ll length 
polyA+ RNA. Sequencing of the entire C6 cDNA would lead to the identification 
of the putative C6 ORF. Comparative analysis of the C6 sequence data w ith 
sequences stored in the GEN-EMBL databases could also aid in the identification 
of the C6 polypeptide.
The isolation of a fu ll length C4 cDNA would be useful in determining the size of 
the polypeptide encoded by the corresponding polyA+ RNA using an in vitro 
transcription and translation system. A full length C4 cDNA could be isolated by 
screening the cDNA library with a C4-specific probe.
There is a possibility that the C4 cDNA encodes the p56 protein (see previous 
discussion). This could be investigated using hybrid arrested translation, in 
which the C4 cDNA is annealled to polyA+ RNA isolated from cells infected with 
ts l204  at the NPT prior to in vitro translation of the RNA. If the C4 cDNA 
contains a portion of the p56 ORF, this w ill result in the in h ib ition  of 
translation of the p56 polyA+ RNA.
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